<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:7ddad2a4-3920-4c0c-912b-fbd34dc14568,g:359b17b0-5eb4-4227-94d2-10b868fd75ed,d:4194f427d28d478983f182f54c3aa849--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:bmy="http://www.bms.com/20230331" xmlns="http://www.w3.org/1999/xhtml" xmlns:srt="http://fasb.org/srt/2022" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:currency="http://xbrl.sec.gov/currency/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:us-gaap-supplement="http://fasb.org/us-gaap-sup/2022q3" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bmy-20230331</title><script >bazadebezolkohpepadr="852337227"</script><script type="text/javascript" src="https://www.sec.gov/akam/13/32cda1fc"  defer></script></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80L2ZyYWc6MDkzMGMxYmUyNzQxNGY5Zjk0OThhMzNhNTNkZTdhYWYvdGFibGU6ZmQxY2M1YTcxYWI2NDY3ZWE0ZDEzN2ZhMTZlZmU1MDUvdGFibGVyYW5nZTpmZDFjYzVhNzFhYjY0NjdlYTRkMTM3ZmExNmVmZTUwNV80LTEtMS0xLTE5MzkzNw_9076198d-6239-40c8-b99a-e220089f3a0a">0000014272</ix:nonNumeric><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80L2ZyYWc6MDkzMGMxYmUyNzQxNGY5Zjk0OThhMzNhNTNkZTdhYWYvdGFibGU6ZmQxY2M1YTcxYWI2NDY3ZWE0ZDEzN2ZhMTZlZmU1MDUvdGFibGVyYW5nZTpmZDFjYzVhNzFhYjY0NjdlYTRkMTM3ZmExNmVmZTUwNV82LTEtMS0xLTE5MzkzNw_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80L2ZyYWc6MDkzMGMxYmUyNzQxNGY5Zjk0OThhMzNhNTNkZTdhYWYvdGFibGU6ZmQxY2M1YTcxYWI2NDY3ZWE0ZDEzN2ZhMTZlZmU1MDUvdGFibGVyYW5nZTpmZDFjYzVhNzFhYjY0NjdlYTRkMTM3ZmExNmVmZTUwNV83LTEtMS0xLTE5MzkzNw_603c5d68-fb71-49f5-9bc2-4917002dfc3f">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80L2ZyYWc6MDkzMGMxYmUyNzQxNGY5Zjk0OThhMzNhNTNkZTdhYWYvdGFibGU6ZmQxY2M1YTcxYWI2NDY3ZWE0ZDEzN2ZhMTZlZmU1MDUvdGFibGVyYW5nZTpmZDFjYzVhNzFhYjY0NjdlYTRkMTM3ZmExNmVmZTUwNV84LTEtMS0xLTE5MzkzNw_b44714a4-516d-4798-a21d-a46959e2bc26">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:AmendmentFlag" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80L2ZyYWc6MDkzMGMxYmUyNzQxNGY5Zjk0OThhMzNhNTNkZTdhYWYvdGFibGU6ZmQxY2M1YTcxYWI2NDY3ZWE0ZDEzN2ZhMTZlZmU1MDUvdGFibGVyYW5nZTpmZDFjYzVhNzFhYjY0NjdlYTRkMTM3ZmExNmVmZTUwNV85LTEtMS0xLTE5MzkzNw_13fe9ef2-7423-4ed6-88bd-ac3270ed37eb">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80L2ZyYWc6MDkzMGMxYmUyNzQxNGY5Zjk0OThhMzNhNTNkZTdhYWYvdGFibGU6ZmQxY2M1YTcxYWI2NDY3ZWE0ZDEzN2ZhMTZlZmU1MDUvdGFibGVyYW5nZTpmZDFjYzVhNzFhYjY0NjdlYTRkMTM3ZmExNmVmZTUwNV8xMC0xLTEtMS0xOTM5Mzc_e665e000-74a1-4967-88db-5b1b6c229f43">FALSE</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bmy-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2bda09e4a8a4c0b8646630af89a641e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:CommonStock0.10ParValueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia44f500456834760bfae19b9494f52e4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:A1.000Notesdue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5294c538e22f4480b1064dd2008e9a80_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:A1.750Notesdue2035Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic99c81cdd4be4938bd54129840aa0f08_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bmy:CelgeneContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2639f048af2d48f69a7b8f1ca961fb27_I20230420"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-04-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ia9743917d08843a9aef1e820c7408c2b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NetProductSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i7d3f27eeeffc4566bd88f9b6c6361d8a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NetProductSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd4dff08326040c6a0845b3c5c81dd51_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic91604ed164a4507af0c948088e52cf8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AllianceandotherrevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i1bde7edbb7c14fa0b263eca4aead487e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i173cd3ea7b2b49529ff5d4c934429570_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9853bb7a3895445aab6c6693e972cc56_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i346eafc8325f4939af4f85fbfc5a4e5b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd76db2ade274e46ba258d30b2022262_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AllianceRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i106b7888c0d4475ca672b2990121652e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AllianceRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9f38be1de6e418a9100809da7cdb025_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OtherRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9005dc7cca64546bba589775f2c0f67_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OtherRevenuesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab1f376ea16745d39dcf169d3a0625fb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d9a7f5682bd4f3ea9809e96155311f0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SalesRevenueGrossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68b384362e5b4a4ca35bb47d2056fe5f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i043c94c3aa43445c8b5bd7432db5efb8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:ChargebacksandcashdiscountsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd3beba77678438b8c93338a7baf0121_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa468a5115d642289601acca9b294408_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:MedicaidandMedicarerebatesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic926a6234acf46308d4781fcfb69fcc8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c3d8c39af0943a686c9297a3ff439dd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:GrosstoNetAdjustmentsAxis">bmy:OtherrebatesreturnsdiscountsandadjustmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i550f9cdc66f14d14be10a0e16721e06c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d21276df0654c93ac72564897390491_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:EliquisMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba31dcfa9f97415da194fce9717945ee_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i935d511681b44311b77fcd048a596f5b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdivoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide0eebf4c1f24d7ea96125b4672a257e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36562bdd0f9d404da404a64fdbe1b819_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:PomalystImnovidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i684eddc0ed0f422d84a72f985b5acb14_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4f5ed9fb204498e985cc069ccb2cac5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OrenciaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic552854582594f8a9d86650c33edb9d9_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c9e4138cdb04e95932538b195d467c9_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SprycelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia15a9a5a37fa4ce99118099835e83d47_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf01ba9b2bd04e61bfdeec113aec9883_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:YervoyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie34e3bdb7b974245b9c3a458ac182c70_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureAndOtherBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacfccb3322104d9f98b17a7e3ee77f95_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:MatureAndOtherBrandsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfcba87ce4d7402a97ddd8b043a00d0f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3c33f2316564a6687c81c63859a8121_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i19d681d267ed470d92055de618442973_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17c04937169b41e28af50bc46b8c6243_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ReblozylMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9daae08c8b5b4a2990fc48e673346e07_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if16220a1074c4178b586f8672a245ab8_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbecmaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia810bb4feab540b3bb279294f08ae5be_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdualagMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7210ecbfb34d4072b9b3daef617d021a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OpdualagMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie264859463454f7aab4b1bcadca31d52_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib75e656d6c2a4bdbb038a99086b5d4b3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:ZeposiaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99674bf7bc7f4f1fae6f2e954d2c1080_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib25ddf2fc0af4e3aaf5e4d4f71f025f5_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:BreyanziMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d605144ae12487fbcf1e66017e0af99_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb3378a6ba164e65b9c453e2b9fa12ba_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:OnuregMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77fa41b67a214ec99ae4d515ebedf5d5_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i88a7bd6f4529464aa797e1bccdae2e1f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InrebicMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b1a96a082b849a1afa19a2fed8c8f2b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:CamzyosMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a00804d88364600b9343b4f9a9f695b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:CamzyosMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9e55a2a221624cab9060feb297795982_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SotyktuMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd9c0b8e56d5487d862427480a3abe85_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:SotyktuMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06c3122817d84e0bbbe027811b040b2d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NewProductPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife82d21870f24374afc6a8f381521c1f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NewProductPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4425816889d41f0a77dd79b6d214c8e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsAndNewProductPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibafe51b214744a71a14666c467535d3d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:InLineProductsAndNewProductPortfolioMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia41d93840a164c9682ba57d236c10e66_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28fd71210e154f5ea1d41b826ea7e616_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:RevlimidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7298e6cc42f14e8db56eab123591f5d1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i038c8893bf7c49568e3d297a1326a9a4_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:AbraxaneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib051c93d8fa746df8573fe4d43d3d286_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:LOEProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i833010ee3d67415ca63784bc59b3f01e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:LOEProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i919ad3fb38924026a1650aee80ef490f_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i595f0cde583c48e18c1990d194cf6026_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a2e138038934b3eaee966f3ea69eb83_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice2bf4e3d79649f6862b6e220b5651eb_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73d2450f8121446394c1d8106b31d0cc_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i020d63941fc3402e93cff5669ffb1e7b_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">bmy:OtherRegionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie2be3c2b38fe4e72b09d02cb4134e874_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NetProductSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2286d4f4caee42e08974d4c3dd485d8c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">bmy:NetProductSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c79ba48a24a4449bd97ec2873563b4b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idc858bda8adb4c3fa1af6150e7de2e63_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc11bddafe3247ceb277ed8aa08dbd78_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i669af0d6c71643c09655afe1a25c8cd1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ff9a072cbcd468fbb0ba290ad9d4371_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic99faa9fe613448bbad022be735707c0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:DiabetesBusinessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i83ea1356422e43819f8645e5934cfe06_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3ee005bf8f142cca2ddb4edd2acff48_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea9a971c0b5344f29eb96b5b19b870a3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">bmy:MatureBrandsAndOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:CheplapharmMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a6fdf9bc0ba4203acdd73d50b55a69d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49988370bf5e41738d52d3a570580e68_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:KeytrudaRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb692e81d8754e46b8fe9f14155a023b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b0c2ebd4a93440ea5aa2d81a13cbebf_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:TecentriqRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73db99dc30d84cadbcf710d8b4bc949c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a6b79b66e884d8d83432f2ebbbe73c7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:OtherRoyaltiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78b757ad36634d1d80030dba29f7e6e9_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:ImmaticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id52b753521774addbcfdc534e4ab4c62_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:DragonflyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d3e51fba4a94ba686245b14967e651f_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:NimbusTherapueticsTYK2InhibitorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09688e31f1224e86b9cbe88539af9e20_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:NimbusTherapueticsTYK2InhibitorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:NimbusTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ief3c35e8db3d4577b4932518cea38278_I20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:NimbusTherapueticsTYK2InhibitorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:NimbusTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7480b54585f34368b4296b7c142bae61_I20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">bmy:NimbusTherapeuticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1afdba68341942c180cc5c017cb0c5b5_D20230201-20230228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:NimbusTherapueticsTYK2InhibitorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-02-01</xbrli:startDate><xbrli:endDate>2023-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3e74378db2c4df69dd991ad2f02c807_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="bmy:LicensingAndOtherArrangementsAxis">bmy:NimbusTherapueticsTYK2InhibitorMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i781c6b749cec4403995ae4192bf4a6e7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44b7e0dd88f7442eb9ada653b02796b5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd27622aa4284e0bae46ba60135d8c67_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60310b1a57dc4e7eb67336d876feec68_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic747ce574e0c4e43947638c951cc006e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:CelgeneIntegrationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if74867368269444eadf64059422c5acc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">bmy:MyoKardiaAcquisitionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d5ed5411a6f44adad6a2fafa7a07b71_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78cff693ad5a4423abe55a1f70a20cbd_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic40cc8e1a8704933a5e9e7779a3257e8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2d6f04e5b6a421bab39cccd2a64bca3_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b3fceca00e340e4988c254e71262a6c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie06401d4a0fc4667a4c6ad88ffc12538_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac4c3c432dec4175884bcb7121ad7b2e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6661c44be2040ddb58e23420f3a637a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ce7d0b07b1b424498f8e2bc0a5a6111_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0632013d3854087980e90d795c1d8d2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8864048307a4f86a8062658906f4268_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e01113e4591475099df5c4095d6e115_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id21490322ff9415aaea6cdeb5ee3ee11_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie566e0e0c4944fb491ddbe3b1c9ff862_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7dfa02c176c44b3eaa296d1e976cb5fe_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae64455b039742d787ed2de5fd251442_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03fc8f9965414a0b804d69bb0c52f940_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a360ac8b1d44afd9d65385129373f29_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84eee663f7a54ab6981f1221be773582_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie78114eba6d1431e8eb7de14cb30d209_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe8ca2459264488eb91f63c4799ca142_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0873c9ac73324059911ec26977fd62b7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i781c7d4e422d4246a9f62677261a6759_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f61e0b967e941f3a13b8cdae92da602_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe21eb2b773241f9975587ff0d8c4222_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice34df82dfdc4797b4a08dd853517723_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59d461f0363f4426b69a52fb5f5622fa_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i39d1821f5f4446deb6d810a66e604eee_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa0d2ac040da41489147ca9c96170c3d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3125f46fdab84e90911ceb3d16a6f77a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6eb6f8e5a38c4a0e8374ef965064fe35_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6af8bc7b28d042ba94f91804fafa4966_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4dc3e7bf51d41f39850d2ccaddabf1e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52e3749bff1746a68a8dbf08ac2f7f8f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i341f444f1ff84f0393e86932e2bbcb98_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14834d88f10b45639a717a5dfcb76963_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea7520f9b6d647d5a6e43c02f239fa52_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67aea7fd88984640aed0e394579193a2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">bmy:ContingentValueRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib65a4a2a6c3c4f89bb86f0d4068fe25b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc622a66bb01497482da48709daace5b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CertificatesOfDepositMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6c0fe73a8454867a2e1e14954eae15c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic3c2fd3c0be4401480de8de24cb596eb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4430059dc6204ccb8d6012d670a5011e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia41d2cc5ab0c42feaa7a631ecbb22c3d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib10f8c00022a496aa567f0b2b08b1734_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefc7a3eb0fe54e43af4dac01fc5e96bd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7361bec49a941e5b6e8ee3761986ec8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:JPY</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35cd3e93ee9f44a4863c125f17563e83_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i48499737f5104edab86a6d804fd035ab_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="eur"><xbrli:measure>iso4217:EUR</xbrli:measure></xbrli:unit><xbrli:context id="icf13f856670744549308e754a728bc4b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f78af08373f410f81a0ec2062e53827_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fea4d1110624ccc8643189b89b7a264_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3f3d1009dc364c098f6d58018920196a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib010a27d7530452ba7bcd495694e0d53_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f5389c38b2f4d118e6e6c3efcb730f5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8230d684b10a4394bebb9852f5a60f05_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1f02eb7d5604819aa8d7f7f56a7cb5c_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id817fc04753e4b50b4934057f0e357b1_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34faa5c1dd2d412abced6fba5cb5b34e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia4236d1cdf3948fd8751a4d9c4cc7e5f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3029667aba2c41ac801aca48ee182c97_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bb614bb6595439091cb705f7444f43b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:CashFlowHedgingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c6b2f57ba9146748914be4aa6f07a1e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd1e462128ec4e4ab153cea1e6830820_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4c44eb56471340c0b0549845ec48e95f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1425120cc214e32ba4675730b4b6cc8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f36cd1dbe6a46b1bf7919a5697fb286_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29e1112374584215b2d716c9948e2cbb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentsGainLossByHedgingRelationshipAxis">us-gaap:NetInvestmentHedgingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5f0db91831245a98d378841a723e8a7_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb81acd0695b4f10a417aade9fb25bb8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i42d797e1487542f49ef9a8d6421d410d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic568e0cfa6234853938bade8f38decad_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b5edd69ff1345a1a484c9fa4c96354b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5802b471774f467b8b4ed57b33660afa_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ec0fba4252a4678af79e56fbc82990b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c615915438143509820de8d42395deb_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2ea56b8ce1eb4d8688de33c49740c7a8_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c8cfb2e34204828954f511d64e793e4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia03b42d55e3746beb0b9a7a7be2a3315_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4be2043674aa491d9adeb9750ff992df_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4e61e9185bb4a9eb351c39c8c716d28_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41ae6cb2b6dd42b08133b40ee51acc39_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9d38948aff744438294caa148a86cdd_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f582f93ce4e422da958adfc85f8013b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i218b6bfa5bcf40ed94120181ea6072f6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i155f9dbf83674147910134de5a163ed4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:OtherContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b8a2e45ab5549aca7483a4ba3d74c5d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8774af6abd064ed2b9c32e4f303cb6ad_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0029eb5bdf0846248e8e29997e46a635_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89c73a3314ab4790b9e60806224792a6_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94eff2d4f4604ee199bd197d534ba249_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a3ce303deb04bbea208aaaf9f054027_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied4b9a9b25904161948918d8f323eaee_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib96567e0e08a4221b8584758e37a4903_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacb22a8aff1d4787af26ce4bf67bd4e0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7143836d84524e0eb66c9ee86bec7021_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaeb32b12d8649ee88455540c089d95d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52dcaa608a2c4d148e4e9058ddb3d78c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53ddf55104c94d75828ca22f5cd5e168_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66daa1b3774a4b1fa720d6f344a56f88_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14e072e009b24d0fbc03953d84900001_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ec0938f6ae44036b63ab13982399e4c_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:CrossCurrencyInterestRateContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i142b933b2c0a4ebf99bd86392c2fc463_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30dcc2a7227940dc98817acc647ec278_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fd0cb5b96ca42cfb7053fa86c81220b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae5cf489d3cd46718423344f12b2cb5e_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb244ebbca7645918a749ff83a2caf20_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id87dc345b8de442ea6f8dbbd65882071_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i530680c85a9a4881b88dc94c1c16baf6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A2750NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieaa68541a773415fae251b23e344c1b9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A2750NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09440f9d290b4a47b0cf4ce858f35aeb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A3250NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i525174948c6543dc8a99d3c14aab9da3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">bmy:A3250NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1bd9d27dbe94da7a5c4c2fea8a920da_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">bmy:A5BillionMaximumBorrowingCapacityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd5a938b770d4b608475507fe2c5a3b1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i937b0f049dac419089d03f3d635323d2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="customer"><xbrli:measure>bmy:customer</xbrli:measure></xbrli:unit><xbrli:context id="i6ed144f6904d4064a626d5562e3a0cf0_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2324127f89494362aa7de6e45d6fe141_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24309b9bca4c40368e5159601708371e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:InventoryPurchasePriceFairValueAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i356526281a974299bee8ad28a8382769_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">bmy:InventoryPurchasePriceFairValueAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i992fa4fd6b824e2683dbabd9dd0c89e4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2c43168d4d54c40bfe5f8121d462432_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24f0783a75914d6fb1fa14e52521a824_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab8479bd02c1490b86a3ffe3c165e4cc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i54eeb91dff47450f9197c56c4e45698b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcc4055c8f054f2abaf55e899844ae79_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc1472b3deb34e4c82ecf9b4d7d07ef9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb63487db81d44389500ff3f59b06f62_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TechnologyBasedIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic79428ebec0f445285e266d25006a85a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifbd254642fa845128c263c3a56052a25_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i854b50008d0b47298b884695f1fe2849_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib06140d1825848a3a6fb79f4c1f62258_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:ComputerSoftwareIntangibleAssetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iee21a224006b4db88a4217127cb842f4_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2820f2c35291457db2f7410b787ba2ef_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaacb967952a84c929370c1cb0330584a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2b8d04f91f24ab3b1bd4cadae97cd15_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e3fe6d813fb473a96593961f0613f55_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07ad784c18b14feaa7917cf92952a3bb_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4908dc165f094814bdc03777b63fb228_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i348f12df9a624cae9f58f9b3c31d39ed_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5c74a80333814fbaa942fa8f31104499_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b6c8f98ac334b77bf25a681324b57f4_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf6faba6b2d14225a15359de6482cf78_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6d9986c20824a5f97eef514fd6a36eb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i66f6c8d4c2724b14ae661ab77a33fa56_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibda2aa440a934e82a577fb958f23e939_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iffe2252e37b146c6bd1dc58ef04b15ce_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99c36bec5b554b1f8b32d6267ac52c8b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d4801a688a148d1bbef6616d73a97b9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3941b5a9b1234e72b36561a89af511d3_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4792b9bd5d914473a84cba87ee6517b9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab8c8cc0509f4dd19eff9d892f06c4df_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icd8e035725b3442db86565959545c35a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie716e8002a604614bf64186acced27ad_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic73d338c52b542ddae2377e527c62f2c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i062ca60f3e7247c4b8d90925c36406d5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib68d187be7b0471c86033eada0951b2b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1cc25cac945148a18864b628022c5492_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3af1b75f0b44a79abbf15f10c511c29_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1eb982410931493f88491ecf96248f25_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71d99781047f4d6ab3714d4919eef6f2_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida75d697bc6043da9dc1a66ef54149fc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4506a3f2ee45401d9643dde5c3b241dd_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6b9651239b0491abf8341b486a23dc1_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d753b05e49247a7998fcd56ba7831aa_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3207d415b9154ca9b0988b77bdf66bf8_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic21692a74de649678999f109fd39cfab_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59d5a4da3d5948e495ffaf1f84fe5f34_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i597908d9a603482f9546e5ee2009c406_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bmy:A2022ASRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i972712cf0b124b2b81b3419d5de38db0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">bmy:A2022ASRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9528bb81e4942ea87d6a91f7811416b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52b2c97066a745b09e18d1483477cdfc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i11aa5d30ad2e4cf0a7f5b87650286b64_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie85008ffba0c418b907e7b2edc3a23e0_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmy:MarketShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i917a6c3322bf456581cd7294c96b0493_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90e84082105e45269a4ddf3f2b924403_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaa01413dd4ef4e92b1e5f19fc5bc3d5d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">bmy:MarketShareUnitsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c11a22415bf463a8cafb058afaacf34_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib59c6e4a5c1c488fbf9892f2e7f21e74_D20150901-20150930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AntiPD1AntibodyLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2015-09-01</xbrli:startDate><xbrli:endDate>2015-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="patent"><xbrli:measure>bmy:patent</xbrli:measure></xbrli:unit><xbrli:context id="ife4c00620e3f4227b0f107ac12a3b75b_D20191201-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i00f02f6049c84c88a97ca32784154910_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19139b5b67d7410eac12e965d900e982_D20200401-20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i489f54c5481c45389d5768b529b57a7c_I20200430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:CARTKiteLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d07349c8cef4e61981e90034abd80a9_D20100301-20100331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:PlavixAustraliaIntellectualPropertyMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:AUD</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-03-01</xbrli:startDate><xbrli:endDate>2010-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="aud"><xbrli:measure>iso4217:AUD</xbrli:measure></xbrli:unit><xbrli:context id="i807bbc34413a49f2b3a1bd3b88436021_D20100301-20100331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:PlavixAustraliaIntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2010-03-01</xbrli:startDate><xbrli:endDate>2010-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9fff68fd41f46f0b5f79d52f510a8af_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7485741c1fa8485b841b4582095e2ce9_D20210201-20210228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">bmy:BristolMyersSquibbMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-01</xbrli:startDate><xbrli:endDate>2021-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic41a7b117f4d4e6ab13b8a793bc5b7a9_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:AbilifyProductLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>bmy:lawsuit</xbrli:measure></xbrli:unit><xbrli:context id="i9b4fe50bec2c45748e74cea112ead142_I20220330"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:OnglyzaProductLiabilityLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86a96cbd433c48ec9f16fa3b1e3beef4_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2602abf9fb744d1b514e7cd6d92d706_I20220630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:MolinaLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="claim"><xbrli:measure>bmy:claim</xbrli:measure></xbrli:unit><xbrli:context id="if83448985121404b8a86bb8584503c4f_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">bmy:OptOutEntitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie45c0ee3f040490991410c1a6b57a08c_I20220401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000014272</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-04-01</xbrli:instant></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNi0zLTEtMS0xOTM5Mzc_f1836a67-b49d-4c03-b5c5-8a9d77a35f93 id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNi0xLTEtMS0xOTM5Mzc_6b9de68a-9723-4428-aebc-1d69712f7f07" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RleHRyZWdpb246ZWE1MzExZTExNmUyNDljZTkyOWMyYmUyYjA4ODVmMWRfMzU2_3574f4fe-9630-42e4-9b26-c10c12a9f2eb" order="1"></ix:relationship></ix:resources></ix:header></div><div id="i4194f427d28d478983f182f54c3aa849_1"></div><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2.5pt solid #000000;border-top:2.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:100%">FORM <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDcy_4bf92cae-dabf-41bb-b959-b1cc95ddd7ea">10-Q</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDU5_2517b6be-7549-4b5a-a379-a018efc4e88f">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNjc_59f7ff9a-3e3d-499e-acfa-86039a92e5a8">March&#160;31, 2023</ix:nonNumeric></span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDY1_257cd394-f6e4-4cf6-8222-f348219e500d">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from ______ to _______</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDY2_d64d5260-63eb-4f7c-a784-5a6a9964d91c">001-01136</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDcz_c1b677cc-a60f-4818-af42-04b0b48ba371">BRISTOL-MYERS SQUIBB COMPANY</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6ZTc1ODQ2N2MxMWNlNGIxMGJjZWI0NzE4N2VlNDVmNGMvdGFibGVyYW5nZTplNzU4NDY3YzExY2U0YjEwYmNlYjQ3MTg3ZWU0NWY0Y18wLTAtMS0xLTE5MzkzNw_83745724-9128-4647-9060-5328d4e11a3f">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6ZTc1ODQ2N2MxMWNlNGIxMGJjZWI0NzE4N2VlNDVmNGMvdGFibGVyYW5nZTplNzU4NDY3YzExY2U0YjEwYmNlYjQ3MTg3ZWU0NWY0Y18wLTItMS0xLTE5MzkzNw_b1cff1bc-2928-44c8-a42f-3d76580842c0">22-0790350</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(State or other jurisdiction of<br/>incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">I.R.S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%"> Employer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:100%">Identification No.)</span></div></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDYx_38d33cc8-f3c9-42b5-9043-1fee449cd393">430 E. 29th Street, 14FL</ix:nonNumeric>, <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDYy_177c54e2-4ef8-4661-a912-e4a1071eaecf">New York</ix:nonNumeric>, <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDY4_0f7d95ff-cc49-4cde-8864-616e8143624d">NY</ix:nonNumeric> <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDYz_2d55d439-18d9-4525-bd0c-9f649e74970b">10016</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Address of principal executive offices) (Zip Code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDcw_59714e78-2521-4f37-b5cd-d9986e776de5">212</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDY5_3edd2725-e3c7-4f2e-b254-2ac155b30d7b">546-4200</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">___________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:700;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:38.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia2bda09e4a8a4c0b8646630af89a641e_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18xLTAtMS0xLTE5MzkzNw_819bf5a9-d5e1-4038-b9dc-93ae848dd97b">Common Stock, $0.10 Par Value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia2bda09e4a8a4c0b8646630af89a641e_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18xLTEtMS0xLTE5MzkzNw_b91f5dc4-6c18-4e74-bec2-fee7924ce7e1">BMY</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia2bda09e4a8a4c0b8646630af89a641e_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18xLTItMS0xLTE5MzkzNw_94c6fb64-5473-4b81-b919-761c08cbba7b">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia44f500456834760bfae19b9494f52e4_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18yLTAtMS0xLTE5MzkzNw_443624f9-4cdc-4e6f-88c7-1e4ec8e29cc3">1.000% Notes due 2025</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia44f500456834760bfae19b9494f52e4_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18yLTEtMS0xLTE5MzkzNw_f4403f61-aa6f-4021-a1ba-87221b4f73b8">BMY25</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia44f500456834760bfae19b9494f52e4_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18yLTItMS0xLTE5MzkzNw_b8fd4cf9-9d39-4fdb-9f95-139801aa7a79">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5294c538e22f4480b1064dd2008e9a80_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18zLTAtMS0xLTE5MzkzNw_7540ad35-4d7b-4bc2-b41c-ef6304401d57">1.750% Notes due 2035</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5294c538e22f4480b1064dd2008e9a80_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18zLTEtMS0xLTE5MzkzNw_5b141714-066d-4340-acbd-ce04bf42cb51">BMY35</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i5294c538e22f4480b1064dd2008e9a80_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y18zLTItMS0xLTE5MzkzNw_8857bfb9-db62-466f-bb84-1417e8ce9c16">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic99c81cdd4be4938bd54129840aa0f08_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y180LTAtMS0xLTE5MzkzNw_924120e9-9b80-40e8-828f-c3b979b46201">Celgene Contingent Value Rights</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic99c81cdd4be4938bd54129840aa0f08_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y180LTEtMS0xLTE5MzkzNw_2367d2b0-e664-4289-9fbe-658b1f2e6472">CELG RT</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic99c81cdd4be4938bd54129840aa0f08_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGFibGU6NmY0MjY5NTU2NTlhNDBkYzgzYTcwMmUxNmI3MDJlNWMvdGFibGVyYW5nZTo2ZjQyNjk1NTY1OWE0MGRjODNhNzAyZTE2YjcwMmU1Y180LTItMS0xLTE5MzkzNw_592739fd-5401-4054-a2be-7d36fb152a03">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to the filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDY0_5b8560da-7158-434f-90e9-8271214b62cd">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160; No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDU3_cecc917d-9760-4fb4-b4db-62feeb060695">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of &#8220;<ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDY3_19f00b12-d202-4f4f-af5b-3eefeea0077b">large accelerated filer</ix:nonNumeric>,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Large accelerated filer&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Accelerated filer&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Non-accelerated filer&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Smaller&#160;reporting&#160;company&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8.69pt;font-weight:700;line-height:100%">Emerging growth company&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDU4_52291101-e523-404b-80eb-f5e0fcc919fe">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:3pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).   &#160;Yes&#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yNDcx_0ae9cf8e-0fa9-4fe8-95cc-23ad80b59e85">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">  &#160; No &#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APPLICABLE ONLY TO CORPORATE ISSUERS:</span></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">At April&#160;20, 2023, there were <ix:nonFraction unitRef="shares" contextRef="i2639f048af2d48f69a7b8f1ca961fb27_I20230420" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xL2ZyYWc6Y2Q4M2FiMGQ4YjY0NDlmZWJjNWZkZWNmM2FjZTcwMmEvdGV4dHJlZ2lvbjpjZDgzYWIwZDhiNjQ0OWZlYmM1ZmRlY2YzYWNlNzAyYV8yMzg1_0297e7be-bfdc-4450-8184-cd843e912479">2,100,847,138</ix:nonFraction> shares outstanding of the Registrant&#8217;s $0.10 par value common stock.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:2.5pt solid #000000;border-top:2.5pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_10"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BRISTOL-MYERS SQUIBB COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO FORM 10-Q</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">March&#160;31, 2023</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:90.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.650%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART I&#8212;FINANCIAL INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_16">Financial Statements:</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_19">Consolidated Statements of Earnings and Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_22">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_22">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_28">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_28">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_31">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_31">6</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_97">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_97">31</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;3.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_172">Quantitative and Qualitative Disclosure About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_172">48</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;4.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_175">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_175">48</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II&#8212;OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_181">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_181">49</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_184">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_184">49</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_187">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_187">49</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_190">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_190">50</a></span></div></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_193">Summary of Abbreviated Terms</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_193">51</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_196">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i4194f427d28d478983f182f54c3aa849_196">52</a></span></div></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Indicates brand names of products which are trademarks not owned by BMS. Specific trademark ownership information is included in the Exhibit Index at the end of this Quarterly Report on Form 10-Q.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_13"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I&#8212;FINANCIAL INFORMATION</span></div><div><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_16"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. FINANCIAL STATEMENTS</span></div><div id="i4194f427d28d478983f182f54c3aa849_19"></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BRISTOL-MYERS SQUIBB COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF EARNINGS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollars in millions, except per share data</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.750%"><tr><td style="width:1.0%"></td><td style="width:74.568%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.503%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.715%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EARNINGS</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9743917d08843a9aef1e820c7408c2b_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMi0xLTEtMS0xOTM5Mzc_9d9aa366-f614-4d94-9c9f-9c5e2a93aacb">11,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d3f27eeeffc4566bd88f9b6c6361d8a_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMi0zLTEtMS0xOTM5Mzc_c338cf6f-d1d3-4845-80ba-707281069193">11,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance and other revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd4dff08326040c6a0845b3c5c81dd51_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMy0xLTEtMS0xOTM5Mzc_05e6d6be-41c0-4f6a-a932-87c9dd076acf">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic91604ed164a4507af0c948088e52cf8_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMy0zLTEtMS0xOTM5Mzc_e7b46ebd-11a8-4050-b7d4-e7b7e4ec6b97">340</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNC0xLTEtMS0xOTM5Mzc_889568c5-21f3-4418-8ef0-de35cd7f67f4">11,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNC0zLTEtMS0xOTM5Mzc_b5217066-592f-4cd4-afa8-03ed1aebabcc">11,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNi0xLTEtMS0xOTM5Mzc_6b9de68a-9723-4428-aebc-1d69712f7f07">2,566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNi0zLTEtMS0xOTM5Mzc_f1836a67-b49d-4c03-b5c5-8a9d77a35f93">2,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNy0xLTEtMS0xOTM5Mzc_5263a531-d5ce-40b9-bfec-f87548801342">1,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfNy0zLTEtMS0xOTM5Mzc_1b8bb6be-b67c-4ee2-8493-2bfb1557f738">1,831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfOC0xLTEtMS0xOTM5Mzc_28744651-755f-479e-ab70-b59c49a1a70f">2,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfOC0zLTEtMS0xOTM5Mzc_31c0641f-e384-4679-8bdf-84d3ea8fc0d9">2,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPRD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:AcquiredIPRD" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfOS0xLTEtMS0xOTM5Mzc_dbe2d16c-e03d-44d2-b36e-dc3fee996c38">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:AcquiredIPRD" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfOS0zLTEtMS0xOTM5Mzc_a75d87ad-e863-4f75-a3a8-e37f25b64ff8">333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:AmortizationofAcquiredIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTAtMS0xLTEtMTkzOTM3_2d74bbb3-bb16-46a1-8b41-eb75ede8d4a9">2,256</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:AmortizationofAcquiredIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTAtMy0xLTEtMTkzOTM3_980ac577-ea18-47bd-9448-117739821263">2,417</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTEtMS0xLTEtMTkzOTM3_0551e595-4812-4b94-a483-a9908983bd3b">413</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTEtMy0xLTEtMTkzOTM3_e37efe9e-c9b2-4ac0-80f9-f18ba0a6f128">649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTItMS0xLTEtMTkzOTM3_200c0ba7-92de-47ae-b246-11a4f7e8d6a9">8,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTItMy0xLTEtMTkzOTM3_bd4638b6-8796-4f36-a5f6-ce3b16cb3527">9,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTQtMS0xLTEtMTkzOTM3_a427cad0-cf42-4d34-99eb-8f21834c28a0">2,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTQtMy0xLTEtMTkzOTM3_af7bd38a-a76b-4aa6-aec6-8acd70161669">1,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTUtMS0xLTEtMTkzOTM3_2d677608-edef-48d1-9c2e-a7c3afa181dd">503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTUtMy0xLTEtMTkzOTM3_7e9ddacb-d7c4-437a-89d2-590568803cae">404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTYtMS0xLTEtMTkzOTM3_3132ec37-df8a-4233-9185-bd1d8ad9d735">2,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTYtMy0xLTEtMTkzOTM3_624e344a-68e8-4733-ab3b-98467255c5f5">1,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTctMS0xLTEtMTkzOTM3_3e495aa8-dd18-4cb6-b4d0-a885003148df">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTctMy0xLTEtMTkzOTM3_8a695154-f481-45f8-bd6f-c32f38477a6b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to BMS</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTgtMS0xLTEtMTkzOTM3_b3f5e624-0742-453c-b863-1037486f6d79">2,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMTgtMy0xLTEtMTkzOTM3_d88daf19-c436-4e61-970d-2a81f1c53907">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMjEtMS0xLTEtMTkzOTM3_04414f89-39de-49e3-a69c-44ec253f05f6">1.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMjEtMy0xLTEtMTkzOTM3_c680c448-605c-40a5-bd7d-f0c1466eaa59">0.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMjItMS0xLTEtMTkzOTM3_c91d200c-c5c7-4b74-9ee2-51f829a8781b">1.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjcwMzU2ZjY3MGVjNTQ4YzliZmJlMWFmYzdiZGE3MWYyL3RhYmxlcmFuZ2U6NzAzNTZmNjcwZWM1NDhjOWJmYmUxYWZjN2JkYTcxZjJfMjItMy0xLTEtMTkzOTM3_431db98c-10c5-4142-95df-c2bc9b5e2acc">0.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;<ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RleHRyZWdpb246ZWE1MzExZTExNmUyNDljZTkyOWMyYmUyYjA4ODVmMWRfMzU2_3574f4fe-9630-42e4-9b26-c10c12a9f2eb" footnoteRole="http://www.xbrl.org/2003/role/footnote">Excludes amortization of acquired intangible assets</ix:footnote>.</span></div><div style="margin-top:9pt"><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollars in millions</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">COMPREHENSIVE INCOME</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMi0xLTEtMS0xOTM5Mzc_1cc6b8e8-02ef-45b8-b3b8-4997fae7de2c">2,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMi0zLTEtMS0xOTM5Mzc_13fc241e-5cd4-4144-a5d2-796eddcdc38a">1,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income, net of taxes and reclassifications to earnings:</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNC0xLTEtMS0xOTM5Mzc_6d2089b5-a26a-4308-9cc9-25e953dfa8b1">124</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNC0zLTEtMS0xOTM5Mzc_3e603ec5-5476-44c8-8f23-37f98de4b73f">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNS0xLTEtMS0xOTM5Mzc_8f0f6366-94a8-439f-b7c0-4de31cbbbd85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNS0zLTEtMS0xOTM5Mzc_6d2004da-d1cd-4ce6-85e5-7a657ca590aa">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNi0xLTEtMS0xOTM5Mzc_98f61630-02d6-407b-baab-5fa78bc5b5e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNi0zLTEtMS0xOTM5Mzc_197c7c72-04f8-4170-b921-52240a722af9">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNy0xLTEtMS0xOTM5Mzc_18ea3891-c906-40b4-8c39-6cd76cea894b">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfNy0zLTEtMS0xOTM5Mzc_54dcf994-2784-47c0-8028-6aebaba23cf4">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Other comprehensive (loss)/income</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfOC0xLTEtMS0xOTM5Mzc_c72a1a23-c9c8-45d0-8c6e-fe211f8ea537">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfOC0zLTEtMS0xOTM5Mzc_563a07ac-10d3-4219-bbb4-fd76a3c681de">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMTAtMS0xLTEtMTkzOTM3_5464a0ea-2a6d-4a4f-929a-7f53cd50297c">2,180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMTAtMy0xLTEtMTkzOTM3_088b9cf8-ceea-4703-bf3c-88436427eae9">1,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMTEtMS0xLTEtMTkzOTM3_3e495aa8-dd18-4cb6-b4d0-a885003148df">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMTEtMy0xLTEtMTkzOTM3_8a695154-f481-45f8-bd6f-c32f38477a6b">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to BMS</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMTItMS0xLTEtMTkzOTM3_e90ddbbb-36a6-4552-98fd-07ab989effc9">2,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xOS9mcmFnOmVhNTMxMWUxMTZlMjQ5Y2U5MjljMmJlMmIwODg1ZjFkL3RhYmxlOjQ4ZTU0YTgyMWI4NzQxMmZiNzRlZDU3NmIxMTg5MjVjL3RhYmxlcmFuZ2U6NDhlNTRhODIxYjg3NDEyZmI3NGVkNTc2YjExODkyNWNfMTItMy0xLTEtMTkzOTM3_afac6346-db93-4788-a279-d3e83eeb8d81">1,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_22"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BRISTOL-MYERS SQUIBB COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollars in millions</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMi0xLTEtMS0xOTM5Mzc_a3d3d19b-77c6-4512-8816-64c740113f7d">8,995</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMi0zLTEtMS0xOTM5Mzc_b172f977-613f-43ba-8b99-74d34a783f59">9,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMy0xLTEtMS0xOTM5Mzc_993d7c68-56a7-42c1-abc9-4cc513d9c3b7">274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:MarketableSecuritiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMy0zLTEtMS0xOTM5Mzc_b0f96b8d-c762-4a27-bd9e-d0ac8aa092f8">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNC0xLTEtMS0xOTM5Mzc_7fd3d481-a9c0-4af9-979c-42b278ed7ce4">10,054</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNC0zLTEtMS0xOTM5Mzc_6e17e589-b175-4a57-9f70-21318f07dc81">9,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNS0xLTEtMS0xOTM5Mzc_ba69ad3f-861e-44bc-a81e-b381778ad895">2,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNS0zLTEtMS0xOTM5Mzc_0700906e-5a49-44e2-aa58-d9227cfac2dc">2,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNi0xLTEtMS0xOTM5Mzc_692cf222-7014-405b-8915-bd21985982f7">5,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNi0zLTEtMS0xOTM5Mzc_ca8fb9c4-d9a2-4960-8b29-845f0dab90e1">5,795</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNy0xLTEtMS0xOTM5Mzc_7b6ac0f2-873d-4631-887e-647157eb867b">27,086</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNy0zLTEtMS0xOTM5Mzc_95af985e-5a8d-4e9d-9af1-7f376d33c73b">27,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfOC0xLTEtMS0xOTM5Mzc_da12876a-d9f0-4794-996f-d681089600d6">6,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfOC0zLTEtMS0xOTM5Mzc_46c6cbc1-af2b-4112-8d2d-ce3e04fc9588">6,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfOS0xLTEtMS0xOTM5Mzc_019e6ea2-e278-40dc-9024-9b60ce868810">21,162</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfOS0zLTEtMS0xOTM5Mzc_a637472e-bf94-43bc-82b3-7cf4ecbdcf91">21,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTAtMS0xLTEtMTkzOTM3_b509253f-fec2-4d80-9db4-aa8cc3f26e51">33,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTAtMy0xLTEtMTkzOTM3_e88b6148-f769-4e78-95f8-eb53e6627da3">35,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTEtMS0xLTEtMTkzOTM3_d17d48b1-91bf-41bf-81f0-73f444fdb684">1,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTEtMy0xLTEtMTkzOTM3_bb2d42b3-c906-49e4-a06e-867bff692691">1,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTMtMS0xLTEtMTkzOTM3_eb57073d-c2b9-4720-a201-5d7afefa4591">4,868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTMtMy0xLTEtMTkzOTM3_a57ae653-31a0-425f-ad15-1b0532505242">4,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTQtMS0xLTEtMTkzOTM3_be6553d1-d979-445f-94f2-4277c0e75a22">94,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTQtMy0xLTEtMTkzOTM3_bbcdf693-1770-44a0-b96a-471a8fc4d798">96,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">LIABILITIES</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt obligations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTgtMS0xLTEtMTkzOTM3_88ff07ca-3da3-48c6-bbc3-f036caf7a74a">2,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:DebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTgtMy0xLTEtMTkzOTM3_dcbce047-f6c9-4dd5-b62f-4d068061844c">4,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTktMS0xLTEtMTkzOTM3_084227dd-1225-46e3-9e42-66536ad0e12d">3,194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMTktMy0xLTEtMTkzOTM3_39b45ac7-6e96-49dd-903e-5ee049d1cf92">3,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjAtMS0xLTEtMTkzOTM3_3987d116-41da-4a24-b29b-529e7d96a4b1">13,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjAtMy0xLTEtMTkzOTM3_549a822b-9b07-41bc-96a1-76b594e00aca">14,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjEtMS0xLTEtMTkzOTM3_32071144-af35-4215-81fb-553bef51dea3">19,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjEtMy0xLTEtMTkzOTM3_e4cd11cd-7707-41c2-85d3-805970c1a563">21,890</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjItMS0xLTEtMTkzOTM3_b9f98955-04dd-4b3c-802e-daa1129de5dc">1,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjItMy0xLTEtMTkzOTM3_fc479911-071a-4653-886c-f14311f1c3b4">2,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjMtMS0xLTEtMTkzOTM3_11fa5be5-68f2-4f56-bcf0-e5a513215a0a">35,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjMtMy0xLTEtMTkzOTM3_b25fc408-3dbc-45af-9ba2-c2d43ba1796e">35,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjQtMS0xLTEtMTkzOTM3_54b8bd5f-0e0f-4a44-8708-933a89b74e46">6,664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjQtMy0xLTEtMTkzOTM3_c9eee618-4da7-4368-b6cb-94171581585c">6,590</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjUtMS0xLTEtMTkzOTM3_a40e6ccd-0f2c-4799-8126-5f88e90e6e5d">62,395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjUtMy0xLTEtMTkzOTM3_538d572f-69e2-4c45-8a63-57807e7f1b4d">65,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and Contingencies</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjctMS0xLTEtMTkzOTM3_912ed084-5deb-4b6f-8ce1-95ed23451dae"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMjctMy0xLTEtMTkzOTM3_7db60af1-0a6f-4e21-a1ab-b1f412f4e724"></ix:nonFraction></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">EQUITY</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BMS Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzEtMS0xLTEtMTkzOTM3_9ea0a082-58a5-434d-9f34-bb2e7d40c992">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzEtMy0xLTEtMTkzOTM3_cfd33413-8427-4a68-b1f8-be1d02899b67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzItMS0xLTEtMTkzOTM3_2e7db4c4-14d8-4471-a7fb-4d6d07f3598d">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzItMy0xLTEtMTkzOTM3_94a23a09-ecef-4bb7-a609-486d380ff50f">292</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital in excess of par value of stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzMtMS0xLTEtMTkzOTM3_8abb0954-1d68-481e-96d5-7a793a627d87">45,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzMtMy0xLTEtMTkzOTM3_f717a6ce-d3e0-456b-927f-0a4818c2d9ce">45,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzQtMS0xLTEtMTkzOTM3_c1a9375b-f791-46ce-9653-fb68d7786321">1,368</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzQtMy0xLTEtMTkzOTM3_a0433b61-17eb-4e0b-87c3-08fa237e2bd9">1,281</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzUtMS0xLTEtMTkzOTM3_cf063c4f-4475-4980-a19a-c45d825b3e56">26,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzUtMy0xLTEtMTkzOTM3_072399fa-7db8-4748-81db-963211abe4f6">25,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less cost of treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzYtMS0xLTEtMTkzOTM3_a19d5f2b-f2dc-48a2-abd7-f0bba79e77cc">38,808</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzYtMy0xLTEtMTkzOTM3_9d24fd0a-78b1-45ab-9f43-fbad50dba6a2">38,618</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total BMS Shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzctMS0xLTEtMTkzOTM3_70b4c310-609e-49d5-b0df-328e0c0afea7">31,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzctMy0xLTEtMTkzOTM3_d176b372-d1d4-4c8a-b981-d17e6ec035cf">31,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzgtMS0xLTEtMTkzOTM3_fa359998-dc95-46b9-80f7-15be86969f90">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzgtMy0xLTEtMTkzOTM3_460f71c4-39cb-46cf-bf8e-8dacd77acb13">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzktMS0xLTEtMTkzOTM3_224a3189-9cf1-468c-9be8-fafb25989158">31,886</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfMzktMy0xLTEtMTkzOTM3_19495236-0f3a-459b-9539-7a52af675b73">31,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Liabilities and Equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNDAtMS0xLTEtMTkzOTM3_bdeb8c03-0f77-43bb-bee5-ec3ab21df825">94,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yMi9mcmFnOmVhOTFlYTJlNzNiYTRiMTg5NDQ4MzM4Mjg4ZDdlZDllL3RhYmxlOjA1NzgxNmFhZDM3YzRhMmRhYTdiMTU4MWE1MDE3NjU4L3RhYmxlcmFuZ2U6MDU3ODE2YWFkMzdjNGEyZGFhN2IxNTgxYTUwMTc2NThfNDAtMy0xLTEtMTkzOTM3_901768f7-8930-490b-9a7d-f02896a70316">96,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_28"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BRISTOL-MYERS SQUIBB COMPANY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dollars in millions</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(UNAUDITED)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows From Operating Activities:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMy0xLTEtMS0xOTM5Mzc_aa339976-2d05-4f64-a74c-851393c167ed">2,267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMy0zLTEtMS0xOTM5Mzc_166f9707-a725-4ce8-92d2-d4db3ded6ece">1,283</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net earnings to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNS0xLTEtMS0xOTM5Mzc_624cad41-fa32-41da-bcfc-970c7628f226">2,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNS0zLTEtMS0xOTM5Mzc_cb000889-e21b-4bb3-9ced-79bcd7e5a4ef">2,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNi0xLTEtMS0xOTM5Mzc_9a9d8d55-1706-421f-add1-c46dce17f6a0">548</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNi0zLTEtMS0xOTM5Mzc_26eac0d4-6854-4091-b196-ec0d45a76f3b">687</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNy0xLTEtMS0xOTM5Mzc_bd759c41-9729-46d3-93c9-ca302ed31854">122</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNy0zLTEtMS0xOTM5Mzc_4ec828dc-9d33-420e-8eb3-97ddded729b7">107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfOC0xLTEtMS0xOTM5Mzc_66c7f93a-bb59-40cd-8626-dc32bf084eed">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfOC0zLTEtMS0xOTM5Mzc_4585c8e7-04ba-4340-a09a-44f5f320dc2c">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture gains and royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:Divestituregainsandroyalties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTAtMS0xLTEtMTkzOTM3_c16ced75-6444-4fc3-9826-4d2d90bdc7dc">194</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:Divestituregainsandroyalties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTAtMy0xLTEtMTkzOTM3_8649f58e-d843-45aa-b678-1d1cc6589d1c">387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPRD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:AcquiredIPRD" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTEtMS0xLTEtMTkzOTM3_f7b37ca1-c4d4-44fd-ba18-d21c95db49ce">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:AcquiredIPRD" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTEtMy0xLTEtMTkzOTM3_4c86b1b8-c1a8-48fe-9321-5151e77b7949">333</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment losses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTItMS0xLTEtMTkzOTM3_9c41e2a1-7af4-402a-8a25-685c3a2febb2">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTItMy0xLTEtMTkzOTM3_3804737f-dd6d-4633-bd34-b7e3db4ba029">644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTQtMS0xLTEtMTkzOTM3_251f9d83-a15d-4aa2-96b4-d7318173e5bf">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTQtMy0xLTEtMTkzOTM3_460020fe-4c7f-4409-a29b-60a9080e1af4">256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTYtMS0xLTEtMTkzOTM3_b1cd6962-e679-4ecd-ab26-79678880aaeb">175</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTYtMy0xLTEtMTkzOTM3_fe5ae3dd-afe2-48eb-b228-d49d57902604">786</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTctMS0xLTEtMTkzOTM3_8d979563-8cc6-4c67-911d-504a538c027e">282</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTctMy0xLTEtMTkzOTM3_148bc2c2-6c1d-454c-836f-070ce8ec3fd7">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTgtMS0xLTEtMTkzOTM3_5d5f5cf2-ef5c-47a0-9bab-e56e8bf95148">187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTgtMy0xLTEtMTkzOTM3_8272a6f3-2022-401d-b8ac-07fb0d7f68a7">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates and discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTktMS0xLTEtMTkzOTM3_beeb8a8e-09cf-4715-80ca-d5da3277ba3d">910</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMTktMy0xLTEtMTkzOTM3_ee851414-3061-4264-89f3-088138e139da">930</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjAtMS0xLTEtMTkzOTM3_7490c3e5-3178-448c-92dd-941fe2d23d44">884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjAtMy0xLTEtMTkzOTM3_9f8a18d7-2d18-4fe4-bfcd-c565974d87c2">831</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjEtMS0xLTEtMTkzOTM3_3f271d84-7a01-481a-953e-369f6db07801">1,064</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjEtMy0xLTEtMTkzOTM3_8b1ac005-9bc8-46d4-b036-f65c12422b79">1,073</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjItMS0xLTEtMTkzOTM3_c2f7191b-9758-43a0-bbe2-319446c6cec1">2,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjItMy0xLTEtMTkzOTM3_fa9266f8-974c-42a1-b935-cf4d7176071b">3,812</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows From Investing Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale and maturities of marketable debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjQtMS0xLTEtMTkzOTM3_17688cf6-391e-4c56-8f75-196079938efe">57</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjQtMy0xLTEtMTkzOTM3_add05a28-36bf-48b5-9beb-c3a05f0acda5">2,100</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjUtMS0xLTEtMTkzOTM3_f7414ffd-b0ce-4dd9-a9be-d70f8503b49e">200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireMarketableSecurities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjUtMy0xLTEtMTkzOTM3_ee93c9d5-e01b-4b77-9dc4-b548eab9beac">1,714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sales of equity investment securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjYtMS0xLTEtMTkzOTM3_d60d498c-e4b0-4117-8b0c-e77e01fa750e">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjYtMy0xLTEtMTkzOTM3_915fe0cf-7806-4291-8ab7-ee84d93987a2">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjctMS0xLTEtMTkzOTM3_f3827c24-9b8c-40a5-bd5d-753fc316bdef">278</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjctMy0xLTEtMTkzOTM3_600bdfd5-c36a-43e9-8898-0684e09d4131">253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture and other proceeds</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:Divestitureandotherproceeds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjgtMS0xLTEtMTkzOTM3_1e6fe6c9-be46-4aca-9811-92d6ab38e49d">227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:Divestitureandotherproceeds" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjgtMy0xLTEtMTkzOTM3_d1801086-bca5-423c-a31d-4ea2373c024b">402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition and other payments, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjktMS0xLTEtMTkzOTM3_f2dde5f9-50c6-48cf-8e2c-98da3af3548e">78</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMjktMy0xLTEtMTkzOTM3_d459e40e-53fd-4748-88a6-c8f3ea65c15c">442</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in)/provided by investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzAtMS0xLTEtMTkzOTM3_dabc78a6-79c5-4ce9-9904-19a1b0fcfa59">210</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzAtMy0xLTEtMTkzOTM3_5cd3c1b7-7533-4feb-b95f-8f3428458d67">95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash Flows From Financing Activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt obligations, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzItMS0xLTEtMTkzOTM3_63f14b32-6b46-44ed-afc4-ec7159691f55">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromRepaymentsOfShortTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzItMy0xLTEtMTkzOTM3_a3588f1e-882e-484b-8244-66671f8ddae9">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzMtMS0xLTEtMTkzOTM3_b2654642-dd29-4ac0-9c34-c2613106c9c8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromIssuanceOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzMtMy0xLTEtMTkzOTM3_14685cf9-842b-4354-95cd-f287c4dba147">5,926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repayment of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzQtMS0xLTEtMTkzOTM3_e5afdf27-97e1-4bed-a8fb-bd39777c75f8">1,640</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzQtMy0xLTEtMTkzOTM3_7f9c155d-a27f-48f1-985c-7418136aae5a">5,769</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzUtMS0xLTEtMTkzOTM3_60ecd8ae-43b1-413e-be93-fea9da0a6d2a">250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzUtMy0xLTEtMTkzOTM3_63c14911-e40b-4cbd-a328-34da0682929e">5,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzYtMS0xLTEtMTkzOTM3_2a61cc61-6270-44aa-8402-b30270b12d8d">1,196</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzYtMy0xLTEtMTkzOTM3_2b257b3f-ffb3-413b-aef3-94a4fbe7cc9c">1,185</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock option proceeds and other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="bmy:PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzctMS0xLTEtMTkzOTM3_9d29df06-d1ad-4a0f-8af8-0aff78184301">92</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:PaymentsForProceedsFromStockOptionExercisesAndOtherAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzctMy0xLTEtMTkzOTM3_1d794f78-c498-42de-bc07-f65eb47a4e3c">333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzgtMS0xLTEtMTkzOTM3_c36e7b9b-6123-4c39-8db2-6bf3752b9c1c">3,050</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzgtMy0xLTEtMTkzOTM3_d3467725-c881-42fe-9e38-50b25b83c46d">5,653</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rates on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzktMS0xLTEtMTkzOTM3_5bb0cd89-5efe-449e-a17f-711885294258">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfMzktMy0xLTEtMTkzOTM3_1d57d46c-bba4-4ba4-9b5a-b892bc444049">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNDAtMS0xLTEtMTkzOTM3_bbf04f32-d381-4fe3-a0e9-5eb17325abad">277</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNDAtMy0xLTEtMTkzOTM3_5416eb85-7a91-41b7-8cbe-a107e86e6caa">1,737</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNDEtMS0xLTEtMTkzOTM3_14e13534-5618-4fa8-8c4a-a9b391dc2ddc">9,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9853bb7a3895445aab6c6693e972cc56_I20211231" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNDEtMy0xLTEtMTkzOTM3_44eac29c-1427-46e3-ac30-c885143aa1aa">14,316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNDItMS0xLTEtMTkzOTM3_97241554-39a2-42bf-8b9b-cd66af0b98ea">9,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i346eafc8325f4939af4f85fbfc5a4e5b_I20220331" decimals="-6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8yOC9mcmFnOmU5ZmNkM2I5OTA0ODQxYzc4MjJmNThhYjYyYTAwNzY5L3RhYmxlOjExZTMyMTg3N2E1ZjQyZmI4MDUxYjUxNmQwOGFjMGMxL3RhYmxlcmFuZ2U6MTFlMzIxODc3YTVmNDJmYjgwNTFiNTE2ZDA4YWMwYzFfNDItMy0xLTEtMTkzOTM3_08f46d1f-5167-4480-a93c-8491a0164b13">12,579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="margin-top:3pt;text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_31"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Note 1. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zMS9mcmFnOjYzNzQ3MTEwYjgyNDQyMzE4NGUzZmE5OGYwM2IwMWYyL3RleHRyZWdpb246NjM3NDcxMTBiODI0NDIzMTg0ZTNmYTk4ZjAzYjAxZjJfNzY_773c8e45-0455-432d-b239-a593a94c5fa2" continuedAt="i4c17ff62bad14b78bcbb7b9962eef686" escape="true">BASIS OF PRESENTATION AND RECENTLY ISSUED ACCOUNTING STANDARDS</ix:nonNumeric></span></div><div><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_34"></div><ix:continuation id="i4c17ff62bad14b78bcbb7b9962eef686" continuedAt="i61e0f99bcadc482683c0fb069f7d3e50"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNC9mcmFnOjkzZGYyNDAxNjY3ODRlMDQ4OTZmMmQxOGNlZGNlZjIyL3RleHRyZWdpb246OTNkZjI0MDE2Njc4NGUwNDg5NmYyZDE4Y2VkY2VmMjJfNTYyNQ_8518bb1c-15c4-478b-a3b0-376b9f40590b" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Consolidation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bristol-Myers Squibb Company ("BMS", "we", "our", "us" or "the Company") prepared these unaudited consolidated financial statements following the requirements of the SEC and U.S. GAAP for interim reporting. Under those rules, certain footnotes and other financial information that are normally required for annual financial statements can be condensed or omitted. The Company is responsible for the consolidated financial statements included in this Quarterly Report on Form 10-Q, which include all adjustments necessary for a fair presentation of the financial position of the Company as of March&#160;31, 2023 and December&#160;31, 2022, the results of operations and cash flows for the three months ended March&#160;31, 2023 and 2022. All intercompany balances and transactions have been eliminated. These consolidated financial statements and the related footnotes should be read in conjunction with the audited consolidated financial statements of the Company for the year ended December&#160;31, 2022 included in the 2022 Form&#160;10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNC9mcmFnOjkzZGYyNDAxNjY3ODRlMDQ4OTZmMmQxOGNlZGNlZjIyL3RleHRyZWdpb246OTNkZjI0MDE2Njc4NGUwNDg5NmYyZDE4Y2VkY2VmMjJfNTYzOQ_a8f1181c-1b8f-4e25-a30b-c534496c5d0d" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Segment Information</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS operates in a single segment engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of innovative medicines that help patients prevail over serious diseases. A global research and development organization and supply chain organization are responsible for the discovery, development, manufacturing and supply of products. Regional commercial organizations market, distribute and sell the products. The business is also supported by global corporate staff functions. Consistent with BMS's operational structure, the Chief Executive Officer ("CEO"), as the chief operating decision maker, manages and allocates resources at the global corporate level. Managing and allocating resources at the global corporate level enables the CEO to assess both the overall level of resources available and how to best deploy these resources across functions, therapeutic areas, regional commercial organizations and research and development projects in line with our overarching long-term corporate-wide strategic goals, rather than on a product or franchise basis. The determination of a single segment is consistent with the financial information regularly reviewed by the CEO for purposes of evaluating performance, allocating resources, setting incentive compensation targets, and planning and forecasting future periods. For further information on product and regional revenue, see "&#8212;Note 2. Revenue".</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNC9mcmFnOjkzZGYyNDAxNjY3ODRlMDQ4OTZmMmQxOGNlZGNlZjIyL3RleHRyZWdpb246OTNkZjI0MDE2Njc4NGUwNDg5NmYyZDE4Y2VkY2VmMjJfNTY0Mg_9c42825b-3adf-40fe-9dd2-97e4e0c3c7c6" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates and Judgments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues, expenses, assets and liabilities can vary during each quarter of the year. Accordingly, the results and trends in these unaudited consolidated financial statements may not be indicative of full year operating results. The preparation of financial statements requires the use of management estimates, judgments and assumptions. The most significant assumptions are estimates used in determining accounting for acquisitions; impairments of intangible assets; charge-backs, cash discounts, sales rebates, returns and other adjustments; legal contingencies; and income taxes. Actual results may differ from estimates.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNC9mcmFnOjkzZGYyNDAxNjY3ODRlMDQ4OTZmMmQxOGNlZGNlZjIyL3RleHRyZWdpb246OTNkZjI0MDE2Njc4NGUwNDg5NmYyZDE4Y2VkY2VmMjJfNTYzNA_de405c6b-3061-4ea9-884f-90621a61a185" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications were made to conform the prior period consolidated financial statements to the current period presentation.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNC9mcmFnOjkzZGYyNDAxNjY3ODRlMDQ4OTZmMmQxOGNlZGNlZjIyL3RleHRyZWdpb246OTNkZjI0MDE2Njc4NGUwNDg5NmYyZDE4Y2VkY2VmMjJfNTY1Mg_0cfa60a9-b7d6-4b92-bce4-b44cf546d59e" continuedAt="ideafcff3bb38433fa34f355e578c8b8b" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Fair Value Measurements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the FASB issued amended guidance on measuring the fair value of an equity security subject to contractual restrictions that prohibit the sale of an equity security. The guidance clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair value. The guidance also clarifies that an entity cannot, as a separate unit of account, recognize and measure a contractual sale restriction. The amendment requires the following disclosures for equity securities subject to contractual sale restrictions: the fair value of equity securities subject to contractual sale restrictions reflected in the balance sheet; the nature and remaining duration of the restriction(s); and the circumstances that could cause a lapse in the restriction(s). The amended guidance is effective January 1, 2024 on a prospective basis. Early adoption is permitted. The guidance was adopted on January 1, 2023 and the adoption did not have an impact on our consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i61e0f99bcadc482683c0fb069f7d3e50"><ix:continuation id="ideafcff3bb38433fa34f355e578c8b8b"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Business Combinations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the FASB issued amended guidance on accounting for contract assets and contract liabilities from contracts with customers in a business combination. The guidance is intended to address inconsistency related to recognition of an acquired contract liability and payment terms and their effect on subsequent revenue recognized. At the acquisition date, an entity should account for the related revenue contracts in accordance with existing revenue recognition guidance generally by assessing how the acquiree applied recognition and measurement in their financial statements. The guidance was adopted on January 1, 2023 and the adoption did not have an impact on our consolidated financial statements.</span></div></ix:continuation></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_37"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfOTk3_a39425e4-59f7-4926-839e-e81b62db5d8e" continuedAt="i9c3665deba834aefbc9b4f1abb104c8d" escape="true">REVENUE</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i9c3665deba834aefbc9b4f1abb104c8d" continuedAt="i50e8534f654145f4be8c883e73694970"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfMTAwOQ_b28325f0-6c81-41b3-a4b7-3864c1dcff84" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by nature:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9743917d08843a9aef1e820c7408c2b_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfMi0xLTEtMS0xOTM5Mzc_9d9aa366-f614-4d94-9c9f-9c5e2a93aacb">11,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d3f27eeeffc4566bd88f9b6c6361d8a_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfMi0zLTEtMS0xOTM5Mzc_c338cf6f-d1d3-4845-80ba-707281069193">11,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd76db2ade274e46ba258d30b2022262_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfMy0xLTEtMS0xOTM5Mzc_6a370da4-1ba1-46ed-8d2b-022649d1188f">144</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i106b7888c0d4475ca672b2990121652e_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfMy0zLTEtMS0xOTM5Mzc_2364299f-7df2-437c-8377-d115630d9b8b">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie9f38be1de6e418a9100809da7cdb025_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfNC0xLTEtMS0xOTM5Mzc_71a9a9e3-efde-4563-b26c-fd61c311b7dd">145</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9005dc7cca64546bba589775f2c0f67_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfNC0zLTEtMS0xOTM5Mzc_b3d4faec-4110-4123-a6a8-766027903861">152</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfNS0xLTEtMS0xOTM5Mzc_d863e3d9-4ed1-4bf0-be11-ab05dc0ab600">11,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjk0NzBjMzZhMjk0NTQ1ZjNhYjU4ZWQ5Y2ViNmUwZWQ2L3RhYmxlcmFuZ2U6OTQ3MGMzNmEyOTQ1NDVmM2FiNThlZDljZWI2ZTBlZDZfNS0zLTEtMS0xOTM5Mzc_32b0ecf5-e019-4b0c-be96-194705ef148c">11,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="bmy:ReconciliationofGrossProductSalestoNetProductSalesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfOTk5_97ed379e-8768-42d6-94af-585b7c84357c" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes GTN adjustments:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab1f376ea16745d39dcf169d3a0625fb_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfMi0xLTEtMS0xOTM5Mzc_4f06b79a-b4fc-4cda-81ce-b580e3d35f8b">17,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d9a7f5682bd4f3ea9809e96155311f0_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfMi0zLTEtMS0xOTM5Mzc_2d5b3ab1-d077-4f73-a2f7-4c218f3fde09">16,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i68b384362e5b4a4ca35bb47d2056fe5f_D20230101-20230331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNC0xLTEtMS0xOTM5Mzc_244c200d-3f01-43d2-a46f-406727e790b3">2,091</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i043c94c3aa43445c8b5bd7432db5efb8_D20220101-20220331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNC0zLTEtMS0xOTM5Mzc_0dc18df4-71f1-4e25-a430-48369adc3b6b">1,763</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Medicare rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd3beba77678438b8c93338a7baf0121_D20230101-20230331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNS0xLTEtMS0xOTM5Mzc_3f3e7577-beb5-4a7b-80d7-8f2fb55c98b8">2,482</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa468a5115d642289601acca9b294408_D20220101-20220331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNS0zLTEtMS0xOTM5Mzc_d67880f0-7b9b-48a6-889d-994ce2edbacd">2,084</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other rebates, returns, discounts and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic926a6234acf46308d4781fcfb69fcc8_D20230101-20230331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNi0xLTEtMS0xOTM5Mzc_37e96d5c-2485-4025-be0c-f5d4f5bb5afd">1,667</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c3d8c39af0943a686c9297a3ff439dd_D20220101-20220331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNi0zLTEtMS0xOTM5Mzc_b17dca1d-6065-45b1-b148-dfc4033c2d68">1,495</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total GTN adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNy0xLTEtMS0xOTM5Mzc_a0b90a36-40a8-4cef-91f2-95bfe76ffd4c">6,240</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:GrosstoNetAdjustments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfNy0zLTEtMS0xOTM5Mzc_d898e331-c6c8-45ca-983f-c7d7b3122bb5">5,342</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9743917d08843a9aef1e820c7408c2b_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfOC0xLTEtMS0xOTM5Mzc_1d8312b7-0b32-4c9b-9a00-86908b9bf9c0">11,048</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d3f27eeeffc4566bd88f9b6c6361d8a_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjU2MWNkZDdmMjg4MTQ2YTBiYTEyN2U3ZjA2MTVmOGQwL3RhYmxlcmFuZ2U6NTYxY2RkN2YyODgxNDZhMGJhMTI3ZTdmMDYxNWY4ZDBfOC0zLTEtMS0xOTM5Mzc_dbf3031b-8c10-4c26-97d8-a94298906009">11,308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes adjustments for provisions for product sales made in prior periods resulting from changes in estimates of $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfODc5NjA5MzAyNDE2Mg_dce04e51-aab6-4f54-b1b6-54fe2862fa4f">87</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:PriorPeriodGrosstoNetAdjustmentImpactedbyNewAccountingPronouncement" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfODc5NjA5MzAyNDE2NA_912a1d31-525a-4224-b447-c758156cb945">74</ix:nonFraction>&#160;million for the three months ended March 31, 2023, and 2022, respectively.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i50e8534f654145f4be8c883e73694970"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfMTAwNw_b7fb20ee-e198-4e07-ae0a-735ee609a5c4" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the disaggregation of revenue by product and region:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-Line Products</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Eliquis</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i550f9cdc66f14d14be10a0e16721e06c_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMy0xLTEtMS0xOTM5Mzc_97df4735-abf2-4ddf-b78a-9ed696a85526">3,423</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d21276df0654c93ac72564897390491_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMy0zLTEtMS0xOTM5Mzc_f91983d7-6344-492a-b5d8-84a092225296">3,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba31dcfa9f97415da194fce9717945ee_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNC0xLTEtMS0xOTM5Mzc_5877ca97-869b-4c34-9c9c-9fd8a546d232">2,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i935d511681b44311b77fcd048a596f5b_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNC0zLTEtMS0xOTM5Mzc_f1d2b80d-8fd3-4724-acd1-b1b0c38cbfb9">1,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pomalyst/Imnovid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide0eebf4c1f24d7ea96125b4672a257e_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNS0xLTEtMS0xOTM5Mzc_4c8ee0bb-160a-4be0-be60-f55259ee9f3c">832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36562bdd0f9d404da404a64fdbe1b819_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNS0zLTEtMS0xOTM5Mzc_6f0d2fc9-c63b-47f7-b9f7-0878afb675f5">826</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Orencia</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i684eddc0ed0f422d84a72f985b5acb14_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNi0xLTEtMS0xOTM5Mzc_4f6da18a-ff17-4728-be99-b0ebc5573d37">764</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4f5ed9fb204498e985cc069ccb2cac5_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNi0zLTEtMS0xOTM5Mzc_fb481ccb-d78f-4529-bd0d-79a9e093014a">792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sprycel</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic552854582594f8a9d86650c33edb9d9_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNy0xLTEtMS0xOTM5Mzc_bd36e4ab-f5ae-499c-8a27-f36226c91388">429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c9e4138cdb04e95932538b195d467c9_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfNy0zLTEtMS0xOTM5Mzc_211a22ca-3d2e-45ce-a566-c313fbed1269">483</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yervoy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia15a9a5a37fa4ce99118099835e83d47_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfOC0xLTEtMS0xOTM5Mzc_ca017902-0afa-40d6-96c7-ed57327d9d5c">508</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf01ba9b2bd04e61bfdeec113aec9883_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfOC0zLTEtMS0xOTM5Mzc_ddf44fd7-e673-467a-9b93-b08be4d3814a">515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature and other products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie34e3bdb7b974245b9c3a458ac182c70_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTAtMS0xLTEtMTkzOTM3_1c65e2f8-ab2d-40eb-94b7-c9d60e199393">467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacfccb3322104d9f98b17a7e3ee77f95_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTAtMy0xLTEtMTkzOTM3_64169542-4d76-4614-87af-71e7e2e855c9">537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total In-Line Products </span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfcba87ce4d7402a97ddd8b043a00d0f_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTEtMS0xLTEtMTkzOTM3_931d44d8-2071-416d-9a11-bba3f0a22422">8,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3c33f2316564a6687c81c63859a8121_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTEtMy0xLTEtMTkzOTM3_9a9138c2-1ccc-4ce7-b96e-7688b3c5f90f">8,287</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Product Portfolio</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reblozyl</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19d681d267ed470d92055de618442973_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTMtMS0xLTEtMTkzOTM3_b82e5c8c-45ae-452d-9e48-7ca1a10535b4">206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17c04937169b41e28af50bc46b8c6243_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTMtMy0xLTEtMTkzOTM3_de2c6b95-acfe-487d-9e09-b7c79e0e05b7">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abecma</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9daae08c8b5b4a2990fc48e673346e07_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTQtMS0xLTEtMTkzOTM3_c19b6efa-ad20-4851-8b3b-d9746927d55f">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if16220a1074c4178b586f8672a245ab8_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTQtMy0xLTEtMTkzOTM3_70e7d8a0-857b-4e68-b9a5-13ef461a0978">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdualag</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia810bb4feab540b3bb279294f08ae5be_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTUtMS0xLTEtMTk1NDk5_ad3db66a-538a-4ce5-aa8b-d687c8551f92">117</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7210ecbfb34d4072b9b3daef617d021a_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTUtMy0xLTEtMTk1NDk5_5cb0fa5e-eb0d-458a-b772-86c84e7221bc">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Zeposia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie264859463454f7aab4b1bcadca31d52_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTUtMS0xLTEtMTkzOTM3_85576caf-d6e9-43e4-9cc5-b1b914237478">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib75e656d6c2a4bdbb038a99086b5d4b3_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTUtMy0xLTEtMTkzOTM3_e3760017-acd9-421b-9131-b511478f50c4">36</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Breyanzi</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99674bf7bc7f4f1fae6f2e954d2c1080_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTYtMS0xLTEtMTkzOTM3_1122ac46-a16e-4f8d-aa84-23b36877ac16">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib25ddf2fc0af4e3aaf5e4d4f71f025f5_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTYtMy0xLTEtMTkzOTM3_f477c683-7613-429d-99e3-10ce3827e444">44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Onureg</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d605144ae12487fbcf1e66017e0af99_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTgtMS0xLTEtMTk1NTA3_c0219ebb-b8cb-4a92-9ebb-8cc4eb9c45f6">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb3378a6ba164e65b9c453e2b9fa12ba_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTgtMy0xLTEtMTk1NTA3_e05ed104-7e88-441a-a644-518548760784">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Inrebic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i77fa41b67a214ec99ae4d515ebedf5d5_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTctMS0xLTEtMTkzOTM3_13cbccc2-a2a3-4d2d-a9e2-b83920aeb2f6">25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88a7bd6f4529464aa797e1bccdae2e1f_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMTctMy0xLTEtMTkzOTM3_f34cdc8b-441a-41e9-9738-9b11139402d9">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Camzyos</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b1a96a082b849a1afa19a2fed8c8f2b_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjAtMS0xLTEtMTkzOTM3_60f75565-a44d-4fcb-8f64-774b29ded686">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a00804d88364600b9343b4f9a9f695b_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjAtMy0xLTEtMTkzOTM3_f83ae871-7156-4a9c-b2e7-025ecd09e6b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sotyktu</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e55a2a221624cab9060feb297795982_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjEtMS0xLTEtMTkzOTM3_2059f728-4ade-4e9b-afe4-2806494f6882">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd9c0b8e56d5487d862427480a3abe85_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjEtMy0xLTEtMTkzOTM3_11b42549-bf75-447a-8ea2-e9909fb0694d">&#8212;</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total New Product Portfolio</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06c3122817d84e0bbbe027811b040b2d_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjItMS0xLTEtMTkzOTM3_b4598269-f224-467c-a4b5-a0956ee47837">723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife82d21870f24374afc6a8f381521c1f_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjItMy0xLTEtMTkzOTM3_011b56ed-091a-4d78-bc5c-8bdf96caf610">350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total In-Line Products and New Product Portfolio</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4425816889d41f0a77dd79b6d214c8e_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjMtMS0xLTEtMTkzOTM3_bc5337fc-fd13-4dd7-97df-fc2f7791c074">9,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibafe51b214744a71a14666c467535d3d_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjMtMy0xLTEtMTkzOTM3_f53095ef-008c-45d1-9e70-eaf3bc47c28d">8,637</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recent LOE Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Revlimid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia41d93840a164c9682ba57d236c10e66_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjUtMS0xLTEtMTkzOTM3_b7087f72-0362-4690-9502-d9a505f51920">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28fd71210e154f5ea1d41b826ea7e616_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjUtMy0xLTEtMTkzOTM3_8eb45ff9-39d1-498e-8924-d33b0a9a9130">2,797</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abraxane</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7298e6cc42f14e8db56eab123591f5d1_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjYtMS0xLTEtMTkzOTM3_4ab6e187-9330-4366-b994-39513104968f">239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i038c8893bf7c49568e3d297a1326a9a4_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjYtMy0xLTEtMTkzOTM3_d189e0c2-54e6-440d-8f7f-0dc085a04068">214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Recent LOE Products</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib051c93d8fa746df8573fe4d43d3d286_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjctMS0xLTEtMTkzOTM3_ff03bf3c-053b-456c-a0b0-9bf79a07dae9">1,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i833010ee3d67415ca63784bc59b3f01e_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjctMy0xLTEtMTkzOTM3_07a8624f-4925-4e9c-9703-dc82a6ace499">3,011</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjgtMS0xLTEtMTkzOTM3_5943a4bf-7a52-4466-8168-58959bde64d6">11,337</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMjgtMy0xLTEtMTkzOTM3_e74c4a40-2845-4f96-9e21-4024976b63c4">11,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i919ad3fb38924026a1650aee80ef490f_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzAtMS0xLTEtMTkzOTM3_4af050e5-a909-4469-9764-de2d83524a85">8,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i595f0cde583c48e18c1990d194cf6026_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzAtMy0xLTEtMTkzOTM3_fb229da2-2529-4138-9192-aee410673442">7,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a2e138038934b3eaee966f3ea69eb83_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzEtMS0xLTEtMTkzOTM3_cef9a6b5-e248-40c1-a7e4-5ab824cf14bf">3,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice2bf4e3d79649f6862b6e220b5651eb_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzEtMy0xLTEtMTkzOTM3_a940ab82-d10f-484f-b598-29330b98b38b">3,727</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73d2450f8121446394c1d8106b31d0cc_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzItMS0xLTEtMTkzOTM3_0c5c6e3e-2aaa-4530-a06e-c245321278ec">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i020d63941fc3402e93cff5669ffb1e7b_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzItMy0xLTEtMTkzOTM3_49786e1b-e04d-48ac-adec-e91a0705b759">227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzMtMS0xLTEtMTkzOTM3_944bee52-b9d5-42c2-99c9-f0c54623326f">11,337</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RhYmxlOjI1OGE0ODFkOTdmMzQyMTdhODI4M2NmMDRmZGNmYzY3L3RhYmxlcmFuZ2U6MjU4YTQ4MWQ5N2YzNDIxN2E4MjgzY2YwNGZkY2ZjNjdfMzMtMy0xLTEtMTkzOTM3_4548b201-dde5-4950-b456-71770fa8bc8d">11,648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Recent LOE Products include products with significant decline in revenue from the prior reporting period as a result of a loss of exclusivity.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by BMS's regional commercial organizations.</span></div></ix:nonNumeric><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized from performance obligations satisfied in prior periods was $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfNzgy_fedffcb7-0f64-4c4b-a14d-9cab7a436149">166</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8zNy9mcmFnOjljZjgzN2YwOTk1ODQwZDZiNjMyM2UxMTVjMDFhNmI4L3RleHRyZWdpb246OWNmODM3ZjA5OTU4NDBkNmI2MzIzZTExNWMwMWE2YjhfNzg5_9ffcd926-4be7-4f3a-9d19-0698a955a47f">147</ix:nonFraction> million for the three months ended March&#160;31, 2023 and 2022, respectively, consisting primarily of royalties for out-licensing arrangements and revised estimates for GTN adjustments related to prior period sales.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_40"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RleHRyZWdpb246YjBlY2U4Zjc3ODhlNDhhMjkyM2RmYmU2ZjY2ZTdiMWZfMzk2MA_3dd6a12b-b1aa-4721-9eef-28c029d09b9b" continuedAt="i214698c0d84e4c6b8b2c4fc176fcd09a" escape="true">ALLIANCES</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i214698c0d84e4c6b8b2c4fc176fcd09a" continuedAt="ic0fb41031f4840caa19f98b6cae76d0f"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS enters into collaboration arrangements with third parties for the development and commercialization of certain products. Although each of these arrangements is unique in nature, both parties are active participants in the operating activities of the collaboration and exposed to significant risks and rewards depending on the commercial success of the activities. BMS refers to these collaborations as alliances and its partners as alliance partners.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RleHRyZWdpb246YjBlY2U4Zjc3ODhlNDhhMjkyM2RmYmU2ZjY2ZTdiMWZfMzk2Ng_ac3e4aa9-763f-40ec-bc3d-adf523817bff" continuedAt="i0d9b0af06399425d88317c3ffb82ad19" escape="true">Selected financial information pertaining to alliances was as follows, including net product sales when BMS is the principal in the third-party customer sale for products subject to the alliance. Expenses summarized below do not include all amounts attributed to the activities for the products in the alliance, but only the payments between the alliance partners or the related amortization if the payments were deferred or capitalized.</ix:nonNumeric></span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="ic0fb41031f4840caa19f98b6cae76d0f" continuedAt="i96676c1f6ef74235a0b0a0d54d4b0259"><div style="margin-top:5pt;text-align:justify"><ix:continuation id="i0d9b0af06399425d88317c3ffb82ad19" continuedAt="ieca4bcdac2354f758af24a5304ffeded"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenues from alliances</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie2be3c2b38fe4e72b09d02cb4134e874_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfMy0xLTEtMS0xOTM5Mzc_e299e06d-67a7-4deb-9633-7899a6c305b7">3,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2286d4f4caee42e08974d4c3dd485d8c_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfMy0zLTEtMS0xOTM5Mzc_34f97b80-4ab9-441c-a019-2aeef75ce5a8">3,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance revenues</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd76db2ade274e46ba258d30b2022262_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfNC0xLTEtMS0xOTM5Mzc_6a370da4-1ba1-46ed-8d2b-022649d1188f">144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i106b7888c0d4475ca672b2990121652e_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfNC0zLTEtMS0xOTM5Mzc_2364299f-7df2-437c-8377-d115630d9b8b">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total alliance revenues</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c79ba48a24a4449bd97ec2873563b4b_D20230101-20230331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfNS0xLTEtMS0xOTM5Mzc_3f89e55f-25e9-4087-8ead-f7f0184cae62">3,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc858bda8adb4c3fa1af6150e7de2e63_D20220101-20220331" decimals="-6" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfNS0zLTEtMS0xOTM5Mzc_3bb93a94-6f6f-4e40-bf7a-2c28380eebda">3,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Payments to/(from) alliance partners</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c79ba48a24a4449bd97ec2873563b4b_D20230101-20230331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfOC0xLTEtMS0xOTM5Mzc_73161496-6696-4edf-a078-53146cd7599d">1,706</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc858bda8adb4c3fa1af6150e7de2e63_D20220101-20220331" decimals="-6" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfOC0zLTEtMS0xOTM5Mzc_8422780e-4a2e-4c7f-971f-6ad642de6484">1,556</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c79ba48a24a4449bd97ec2873563b4b_D20230101-20230331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfOS0xLTEtMS0xOTM5Mzc_a451af61-31b7-4777-8d3a-ee87eca0ded5">74</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc858bda8adb4c3fa1af6150e7de2e63_D20220101-20220331" decimals="-6" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfOS0zLTEtMS0xOTM5Mzc_dd8a093f-0fbc-4925-83db-567aac7f02af">54</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c79ba48a24a4449bd97ec2873563b4b_D20230101-20230331" decimals="-6" name="bmy:ResearchAndDevelopmentExpenseCollaborativeArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfMTAtMS0xLTEtMTkzOTM3_a95a50ce-ce20-40f7-962c-6d7e5ff99fac">44</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc858bda8adb4c3fa1af6150e7de2e63_D20220101-20220331" decimals="-6" name="bmy:ResearchAndDevelopmentExpenseCollaborativeArrangement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfMTAtMy0xLTEtMTkzOTM3_6c3d2ab3-b113-4847-9f7c-0bdcf1edb7de">22</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4c79ba48a24a4449bd97ec2873563b4b_D20230101-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfMTItMS0xLTEtMTkzOTM3_7b227b68-1008-42c3-9137-6e61142743a9">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc858bda8adb4c3fa1af6150e7de2e63_D20220101-20220331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjliMzFkMjZmNzYxZDQ4NjdiOTBmNGFkOTk1YzY5M2QzL3RhYmxlcmFuZ2U6OWIzMWQyNmY3NjFkNDg2N2I5MGY0YWQ5OTVjNjkzZDNfMTItMy0xLTEtMTkzOTM3_f44d2b90-09da-4a9a-8990-d21bed37ecc3">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="ieca4bcdac2354f758af24a5304ffeded" continuedAt="i80191361e61b4043b3fc58acd441cf15"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Selected alliance balance sheet information</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables &#8211; from alliance partners</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc11bddafe3247ceb277ed8aa08dbd78_I20230331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjYyMDEwZTA1NzFmMTQzM2FiMWM4NzU1NmZhYzVlMjI1L3RhYmxlcmFuZ2U6NjIwMTBlMDU3MWYxNDMzYWIxYzg3NTU2ZmFjNWUyMjVfMi0xLTEtMS0xOTM5Mzc_40a6ee6e-d9a3-41ca-8f82-34e216c6bfd8">274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i669af0d6c71643c09655afe1a25c8cd1_I20221231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjYyMDEwZTA1NzFmMTQzM2FiMWM4NzU1NmZhYzVlMjI1L3RhYmxlcmFuZ2U6NjIwMTBlMDU3MWYxNDMzYWIxYzg3NTU2ZmFjNWUyMjVfMi0zLTEtMS0xOTM5Mzc_573fe8af-0b4b-4141-a6a8-2a3a8f7c6d80">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable &#8211; to alliance partners</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc11bddafe3247ceb277ed8aa08dbd78_I20230331" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjYyMDEwZTA1NzFmMTQzM2FiMWM4NzU1NmZhYzVlMjI1L3RhYmxlcmFuZ2U6NjIwMTBlMDU3MWYxNDMzYWIxYzg3NTU2ZmFjNWUyMjVfMy0xLTEtMS0xOTM5Mzc_678df0ce-0047-4777-8612-bd04e1d62cae">1,623</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i669af0d6c71643c09655afe1a25c8cd1_I20221231" decimals="-6" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjYyMDEwZTA1NzFmMTQzM2FiMWM4NzU1NmZhYzVlMjI1L3RhYmxlcmFuZ2U6NjIwMTBlMDU3MWYxNDMzYWIxYzg3NTU2ZmFjNWUyMjVfMy0zLTEtMS0xOTM5Mzc_dafca4bf-586c-4c42-9077-34d0b677f7e7">1,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income &#8211; from alliances</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc11bddafe3247ceb277ed8aa08dbd78_I20230331" decimals="-6" name="us-gaap:DeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjYyMDEwZTA1NzFmMTQzM2FiMWM4NzU1NmZhYzVlMjI1L3RhYmxlcmFuZ2U6NjIwMTBlMDU3MWYxNDMzYWIxYzg3NTU2ZmFjNWUyMjVfNC0xLTEtMS0xOTM5Mzc_faa519f5-6666-400a-97d1-0d27edec1ffe">314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i669af0d6c71643c09655afe1a25c8cd1_I20221231" decimals="-6" name="us-gaap:DeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80MC9mcmFnOmIwZWNlOGY3Nzg4ZTQ4YTI5MjNkZmJlNmY2NmU3YjFmL3RhYmxlOjYyMDEwZTA1NzFmMTQzM2FiMWM4NzU1NmZhYzVlMjI1L3RhYmxlcmFuZ2U6NjIwMTBlMDU3MWYxNDMzYWIxYzg3NTU2ZmFjNWUyMjVfNC0zLTEtMS0xOTM5Mzc_468b4db9-514c-40ce-b289-6e21d2bb0650">289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></ix:continuation><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i80191361e61b4043b3fc58acd441cf15">  Includes unamortized upfront and milestone payments.</ix:continuation> </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i96676c1f6ef74235a0b0a0d54d4b0259">The nature, purpose, significant rights and obligations of the parties and specific accounting policy elections for each of the Company's significant alliances are discussed in the 2022 Form 10-K.</ix:continuation> </span></div><div><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_43"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfNjEwMg_aec9b66f-c35f-4ab2-aaaf-e2a60fdbaf38" continuedAt="i56bde5ad1b5c4737b9434357a921ff21" escape="true">DIVESTITURES, LICENSING AND OTHER ARRANGEMENTS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i56bde5ad1b5c4737b9434357a921ff21" continuedAt="i9b83756859c245ea89c5416ee6559967"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestitures</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfNjEwNQ_11838ae5-863e-49d0-a08c-bda3e4dcfabd" continuedAt="i8f741a27fffc4f0a9f93bfe9c3984902" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of divestitures including royalties, which are included in Other (income)/expense, net. Revenue and pretax earnings related to all divestitures were not material in all periods presented (excluding divestiture gains or losses).</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.573%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Proceeds</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Divestiture (Gains)/Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Royalty Income</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diabetes business</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff9a072cbcd468fbb0ba290ad9d4371_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfMy0xLTEtMS0xOTM5Mzc_ecb3e5b1-c276-4667-9461-c4de1d26c975">216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic99faa9fe613448bbad022be735707c0_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfMy0zLTEtMS0xOTM5Mzc_6fd1901d-e066-4bb2-bcec-81551608971a">172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff9a072cbcd468fbb0ba290ad9d4371_D20230101-20230331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfMy01LTEtMS0xOTM5Mzc_ac488c87-c507-42fb-855d-d72aaf2f6313">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic99faa9fe613448bbad022be735707c0_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfMy03LTEtMS0xOTM5Mzc_c5153722-32c2-4e95-b920-f58f21c9c597">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ff9a072cbcd468fbb0ba290ad9d4371_D20230101-20230331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfMy05LTEtMS0xOTM5Mzc_84288481-f9a1-4384-8deb-c9c44e5a789a">188</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic99faa9fe613448bbad022be735707c0_D20220101-20220331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfMy0xMS0xLTEtMTkzOTM3_949b51cc-e9c0-4a18-bb61-93851740e905">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature products and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ea1356422e43819f8645e5934cfe06_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfNy0xLTEtMS0xOTM5Mzc_87f45a70-21e7-4822-8cb7-4726f53a343f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3ee005bf8f142cca2ddb4edd2acff48_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfNy0zLTEtMS0xOTM5Mzc_27f1cdee-61bf-40cc-8923-23e679980590">225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ea1356422e43819f8645e5934cfe06_D20230101-20230331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfNy01LTEtMS0xOTM5Mzc_2288a8b3-3a24-4100-a089-91cc3dea90c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ee005bf8f142cca2ddb4edd2acff48_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfNy03LTEtMS0xOTM5Mzc_e2510f5e-e1a4-49a5-a4f0-690e3ca04008">211</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i83ea1356422e43819f8645e5934cfe06_D20230101-20230331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfNy05LTEtMS0xOTM5Mzc_11ff3b37-a70b-429b-92fc-38bfa1968023">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie3ee005bf8f142cca2ddb4edd2acff48_D20220101-20220331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfNy0xMS0xLTEtMTkzOTM3_d77ab360-e93c-495c-b4bd-acb6fd8d4779">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfOC0xLTEtMS0xOTM5Mzc_12425b83-9fd8-4754-a6b3-ee6186ffd3f8">220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfOC0zLTEtMS0xOTM5Mzc_5541271b-ba61-4080-bb7c-dd415a284dfe">397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfOC01LTEtMS0xOTM5Mzc_37332d7e-fd74-42fc-8790-88b72a82f9d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfOC03LTEtMS0xOTM5Mzc_78e93e93-bdc4-42c7-8142-173ebd0f60ed">211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfOC05LTEtMS0xOTM5Mzc_b2a4baea-7bff-435f-b328-23a2579bdda0">188</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjkzNTkxM2Y2MTJkZDQ0ZDdhNDlhMDZlYzBiMTU3YTJjL3RhYmxlcmFuZ2U6OTM1OTEzZjYxMmRkNDRkN2E0OWEwNmVjMGIxNTdhMmNfOC0xMS0xLTEtMTkzOTM3_a48fa2be-66da-4c39-8b68-66c826886f08">171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="i8f741a27fffc4f0a9f93bfe9c3984902">(a)&#160;&#160;&#160;&#160;Net proceeds for diabetes business relates to net proceeds from royalties received subsequent to the sale of the diabetes business.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Mature Products and Other</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, product rights to several mature products were sold to Cheplapharm, resulting in cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="iea9a971c0b5344f29eb96b5b19b870a3_D20220101-20220331" decimals="-6" name="us-gaap:ProceedsFromDivestitureOfBusinessesNetOfCashDivested" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMzI0MQ_52945466-36a6-4211-99f7-d1a241b0480c">221</ix:nonFraction>&#160;million and a divestiture gain of $<ix:nonFraction unitRef="usd" contextRef="ie3ee005bf8f142cca2ddb4edd2acff48_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMzI3MA_02781fb5-1d60-480f-8fe5-6a5fdf065326">211</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i9b83756859c245ea89c5416ee6559967"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Licensing and Other Arrangements</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="bmy:LicensingAndOtherArrangementsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfNjA5Nw_c7365928-ca7a-48e1-b53b-46466d9829ff" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial impact of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tecentriq*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> royalties, upfront licensing fees and milestones for products that have not obtained commercial approval, which are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a6fdf9bc0ba4203acdd73d50b55a69d_D20230101-20230331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfMi0xLTEtMS0xOTM5Mzc_2b475c2b-b896-4fff-8049-d6f88f5821c5">279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i49988370bf5e41738d52d3a570580e68_D20220101-20220331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfMi0zLTEtMS0xOTM5Mzc_2ea2fb17-ea20-46a7-8174-faa7e36384d6">221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* royalties</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb692e81d8754e46b8fe9f14155a023b_D20230101-20230331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfMy0xLTEtMS0xOTM5Mzc_0629391f-8980-4379-b7b8-c9e1d889d222">30</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b0c2ebd4a93440ea5aa2d81a13cbebf_D20220101-20220331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfMy0zLTEtMS0xOTM5Mzc_c19b7fe0-82a7-4cbe-b618-18b2f72e6b12">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent milestone income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:ContingentRegulatoryMilestoneIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfNS0xLTEtMS0xOTM5Mzc_f8a4f7b2-53c3-42f2-b5ca-3e2edafea065">31</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:ContingentRegulatoryMilestoneIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfNS0zLTEtMS0xOTM5Mzc_b0d16b76-dc2e-4572-84ab-ff3b2b34a062">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:AmortizationOfDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfNi0xLTEtMS0xOTM5Mzc_8439189f-12ae-4762-8706-8d94d5fb213b">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:AmortizationOfDeferredIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfNi0zLTEtMS0xOTM5Mzc_9c65ed5e-8ea6-491f-bb04-632084c72ebb">12</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other royalties and licensing income </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73db99dc30d84cadbcf710d8b4bc949c_D20230101-20230331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfOC0xLTEtMS0xOTM5Mzc_c5a85cd8-ea26-4e06-840d-4212f70dda9a">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a6b79b66e884d8d83432f2ebbbe73c7_D20220101-20220331" decimals="-6" name="us-gaap:RoyaltyIncomeNonoperating" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfOC0zLTEtMS0xOTM5Mzc_493988b1-10e9-43cf-ac42-9d902c769d32">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:LicensingAndOtherArrangementsIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfOS0xLTEtMS0xOTM5Mzc_d54019ea-3771-40bf-b5b6-8d242bebc40a">363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:LicensingAndOtherArrangementsIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RhYmxlOjlkYmJhOTUzN2YyNzQwNjE4ZDY1YjY1ODAzMDNlMDUxL3RhYmxlcmFuZ2U6OWRiYmE5NTM3ZjI3NDA2MThkNjViNjU4MDMwM2UwNTFfOS0zLTEtMS0xOTM5Mzc_2629d398-7b11-4f53-a5e4-3f01f8c3c197">306</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Immatics</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, BMS obtained a global exclusive license to Immatics' TCR bispecific IMA401 program. which is being studied in oncology. The trial commenced in May 2022. BMS and Immatics collaborate on the development and BMS will be responsible for the commercialization of IMA401 worldwide, including strategic decisions, regulatory responsibilities, funding and manufacturing. Immatics has the option to co-fund U.S. development in exchange for enhanced U.S. royalty payments and/or to co-promote IMA401 in the U.S. The transaction included an upfront payment of $<ix:nonFraction unitRef="usd" contextRef="i78b757ad36634d1d80030dba29f7e6e9_I20220331" decimals="-6" name="bmy:LicenseAndOtherArrangementsUpfrontPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfNDI0Ng_ebd56ca7-6916-4271-a539-4b6324db9215">150</ix:nonFraction>&#160;million which was expensed to Acquired IPRD in the first quarter of 2022. Immatics is eligible to receive contingent development, regulatory and sales-based milestones of up to $<ix:nonFraction unitRef="usd" contextRef="i78b757ad36634d1d80030dba29f7e6e9_I20220331" decimals="-6" name="bmy:ContingentAndRegulatoryMilestonePayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfNDQxOA_e3bf66e6-807b-4819-b019-4b45301be5cc">770</ix:nonFraction>&#160;million as well as royalties on global net sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dragonfly</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, a Phase I development milestone for interleukin-12 ("IL-12") was achieved resulting in a $<ix:nonFraction unitRef="usd" contextRef="id52b753521774addbcfdc534e4ab4c62_I20220331" decimals="-6" name="bmy:LicenseAndOtherArrangementsUpfrontPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfNDU5Nw_cbb99ebd-38c1-4c39-b3cb-8497e9cd0fe2">175</ix:nonFraction>&#160;million payment to Dragonfly and an Acquired IPRD charge. The parties also amended the terms of three future milestones by requiring the achievement of certain criteria by specified dates unless BMS notifies Dragonfly that it will discontinue development of IL-12. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, BMS notified Dragonfly that it was terminating the global exclusive license that relates to Dragonfly&#8217;s IL-12. All rights to IL-12 were reverted back to Dragonfly effective April 18, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Other </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nimbus Change of Control Income</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, BMS and Nimbus Therapeutics entered into a settlement resolving all legal claims and business interests pertaining to Nimbus' TYK2 inhibitor resulting in $<ix:nonFraction unitRef="usd" contextRef="i6d3e51fba4a94ba686245b14967e651f_D20220101-20221231" decimals="-6" name="us-gaap:ProceedsFromLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMTkxMDI_501f3002-bc27-49b3-a693-9a749181a942">40</ix:nonFraction>&#160;million of income included in Other (income)/expense. The settlement also provides for BMS to receive additional amounts for contingent development, regulatory approval and sales-based milestones and <ix:nonFraction unitRef="number" contextRef="i09688e31f1224e86b9cbe88539af9e20_I20221231" decimals="3" name="bmy:SettlementContingentDevelopmentChangeInControlProceeds" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMTkxMDY_64840105-97f4-43ed-88b0-5bd3e68f9a76">10</ix:nonFraction>% of any change in control proceeds received by Nimbus Therapeutics related to its TYK2 inhibitor. In February 2023, Takeda acquired <ix:nonFraction unitRef="number" contextRef="ief3c35e8db3d4577b4932518cea38278_I20230228" decimals="INF" name="bmy:AssetAcquisitionPercentageOfOwnershipAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMTkxMTA_08abc4dc-1edb-4439-9c81-37e967351eb0">100</ix:nonFraction>% ownership of Nimbus Therapeutics' TYK2 inhibitor for approximately $<ix:nonFraction unitRef="usd" contextRef="i7480b54585f34368b4296b7c142bae61_I20230228" decimals="-8" name="bmy:LicenseAndOtherArrangementsUpfrontPayments" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMTkxMTQ_36275dad-1600-418d-914b-8a906594fc48">4.0</ix:nonFraction>&#160;billion in upfront proceeds plus contingent sales-based milestones aggregating up to $<ix:nonFraction unitRef="usd" contextRef="i1afdba68341942c180cc5c017cb0c5b5_D20230201-20230228" decimals="-8" name="bmy:CollaborativeArrangementContingentPaymentsMaximumExposure" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMTkxMjI_1593e7d0-afe4-481e-b133-0c0be27222a5">2.0</ix:nonFraction>&#160;billion. As a result, $<ix:nonFraction unitRef="usd" contextRef="ic3e74378db2c4df69dd991ad2f02c807_D20230101-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncome" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80My9mcmFnOmViYTY1ZTcxYzI4YzQ5YTlhZTUxYzFkNzJiNDBjYjk0L3RleHRyZWdpb246ZWJhNjVlNzFjMjhjNDlhOWFlNTFjMWQ3MmI0MGNiOTRfMTkxMTg_cbb8c996-670a-4d9d-a3f0-3f008ea1845a">400</ix:nonFraction>&#160;million of income related to the change of control provision is included in Other (income)/expense during the first quarter of 2023 and is expected to be received in the second quarter of 2023.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_49"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:OtherIncomeAndOtherExpenseDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RleHRyZWdpb246ODgyNjc3MzM2NjEwNGU4YWE4ZDEwNGI4ZGQ5YzUzNGVfNDg_a2a790f6-d92d-4d88-8ea1-e0a6294c6237" continuedAt="i96999c19f23d4a8c9c69134728dc26f3" escape="true">OTHER (INCOME)/EXPENSE, NET</ix:nonNumeric></span></div><ix:continuation id="i96999c19f23d4a8c9c69134728dc26f3"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="bmy:ScheduleOfOtherIncomeExpenseTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RleHRyZWdpb246ODgyNjc3MzM2NjEwNGU4YWE4ZDEwNGI4ZGQ5YzUzNGVfNTI_6e4cba0a-f264-4619-8447-d410136f4b30" escape="true"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (Note 10)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMi0xLTEtMS0xOTM5Mzc_434044ce-76ce-4587-aaf4-95c9a5d119b0">288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMi0zLTEtMS0xOTM5Mzc_4f3d4305-91c5-4a45-be13-863cb29ab910">326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty and licensing income (Note 4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:BusinessRoyaltyAndLicensingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMy0xLTEtMS0xOTM5Mzc_d6c17d8f-6fe9-4ae4-954e-b49a0a645f9a">363</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:BusinessRoyaltyAndLicensingIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMy0zLTEtMS0xOTM5Mzc_cde5b39e-1c29-4157-8462-430fd425675c">306</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty income - divestiture (Note 4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:BusinessSaleRoyaltyIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNC0xLTEtMS0yMDE1NTY_5645143a-8e77-47dd-8829-1fb509106cdf">188</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:BusinessSaleRoyaltyIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNC0zLTEtMS0xOTg4ODc_5dc1b86b-c0be-4e58-8124-e36448bde18d">171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment losses (Note 9)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNS0xLTEtMS0yMjY4ODA_a917a1a3-389d-44bc-bae6-f359b8c2f84b">155</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNS0zLTEtMS0yMjY4ODA_3a2cee87-80d5-40cf-922f-d3daa66c87d4">644</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses (Note 6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNi0xLTEtMS0yMjY4ODY_3d6582d1-6642-475f-86c1-7b9b8af3b4e0">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNi0zLTEtMS0yMjY4ODY_b67d633c-a720-48a8-bc7a-ff5c753ed4c2">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption (Note 10)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNy0xLTEtMS0yMjY4OTU_88b4ef92-5e0f-4694-94f6-829c682ca8f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNy0zLTEtMS0yMjY4OTU_0094f611-01f4-4df9-9ea4-28375aa7e4c2">275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture gains (Note 4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfOC0xLTEtMS0yMjY4OTU_b74c3f43-e922-4b01-b2fe-a223610fa3ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfOC0zLTEtMS0yMjY4OTU_895baec9-d3e4-441d-ab46-9900a2e9d7b1">211</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and other settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNS0xLTEtMS0yMjY0Mjc_3eb2b0a8-5c13-498c-a432-40a32a029a18">325</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:GainLossRelatedToLitigationSettlement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNS0zLTEtMS0yMjY0Mjc_5fd62728-048c-45ab-b439-472e8d513423">37</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNy0xLTEtMS0yMjYzMjQ_701d112c-8e0b-4f3e-b56d-3055f472f390">102</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfNy0zLTEtMS0yMjYzMjQ_a9b3a131-4c7a-40a8-a9f0-9f4f2495ec22">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring (Note 6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfOC0xLTEtMS0xOTM5Mzc_b40e11b1-c0e7-49df-b038-732580ecc916">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfOC0zLTEtMS0xOTM5Mzc_1207b304-9fe2-4b5e-a176-738f09bd2bd5">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:OtherOtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMTgtMS0xLTEtMTkzOTM3_8f4237c4-65be-47f8-a6f2-56a27b2f9d7f">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="bmy:OtherOtherIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMTgtMy0xLTEtMTkzOTM3_0e61b4fd-8990-49f1-8a10-0a5fb43d57ff">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMTktMS0xLTEtMTkzOTM3_eae279b0-eed4-43ce-b590-9883ad6ead0a">413</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RhYmxlOjc0NWZkMDg4NjA1ZDQ3NjM4MTQ0MjU2M2QzMGI4YmIxL3RhYmxlcmFuZ2U6NzQ1ZmQwODg2MDVkNDc2MzgxNDQyNTYzZDMwYjhiYjFfMTktMy0xLTEtMTkzOTM3_a813939c-8a9b-4c3f-a547-94e8357dcd6e">649</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes $<ix:nonFraction unitRef="usd" contextRef="ic3e74378db2c4df69dd991ad2f02c807_D20230101-20230331" decimals="-6" name="us-gaap:ProceedsFromLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV80OS9mcmFnOjg4MjY3NzMzNjYxMDRlOGFhOGQxMDRiOGRkOWM1MzRlL3RleHRyZWdpb246ODgyNjc3MzM2NjEwNGU4YWE4ZDEwNGI4ZGQ5YzUzNGVfMjc0ODc3OTA3MzczNw_ab2889b6-b4b5-46be-a348-d58b93088861">400</ix:nonFraction>&#160;million of income recorded in connection with Nimbus' TYK2 program change of control provision for the three months ended March 31, 2023. Refer to "&#8212;Note 4. Divestitures, Licensing and Other Arrangements" for further information.</span></div></ix:nonNumeric></ix:continuation><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_52"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfMTk4Ng_731ba384-69af-4131-85ec-02c64f83e103" continuedAt="if8cc9ac9518f468292f211e89d2b668d" escape="true">RESTRUCTURING</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="if8cc9ac9518f468292f211e89d2b668d" continuedAt="i3d5681b1f68645a9830352ec337e23e8"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Celgene Acquisition Plan</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Celgene Acquisition Plan, the Company expects to incur charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i781c6b749cec4403995ae4192bf4a6e7_I20230331" decimals="-8" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfNDkz_3e846c58-5e9e-4b46-91da-704066d9bc86">3.5</ix:nonFraction>&#160;billion, including cash outlays of approximately $<ix:nonFraction unitRef="usd" contextRef="i781c6b749cec4403995ae4192bf4a6e7_I20230331" decimals="-8" name="bmy:Cashoutlays" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfNTY0_2735029a-6d19-4375-8b4f-043946530e62">3.1</ix:nonFraction>&#160;billion. Cumulative charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i781c6b749cec4403995ae4192bf4a6e7_I20230331" decimals="-8" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfNjA0_548e2f33-bf73-420f-b6cd-1a7644c5b95e">3.1</ix:nonFraction>&#160;billion have been recognized to date including integration planning and execution expenses, employee termination benefit costs and accelerated stock-based compensation, contract termination costs and other shutdown costs associated with site exits. The remaining charges are primarily related to IT system integration which are expected to be incurred through 2024. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Restructuring</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Restructuring and integration plans were initiated to realize expected cost synergies resulting from cost savings and avoidance from the Turning Point acquisition in 2022 and the MyoKardia acquisition in 2020. Charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i44b7e0dd88f7442eb9ada653b02796b5_I20230331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfMTMyOQ_42821fef-558d-4ef5-8158-85cf6e3e9bcc">250</ix:nonFraction>&#160;million are expected to be incurred through the end of 2023 and consist of integration planning and execution expenses, employee termination benefit costs and other costs. Cumulative charges of approximately $<ix:nonFraction unitRef="usd" contextRef="i44b7e0dd88f7442eb9ada653b02796b5_I20230331" decimals="-6" name="us-gaap:RestructuringAndRelatedCostCostIncurredToDate1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfMTUxOQ_e7be9ec3-e616-4e9b-988d-29ae2adf44a4">180</ix:nonFraction> million have been recognized for these actions to date. In the first quarter of 2023, certain restructuring activities occurred resulting in employee termination costs of $<ix:nonFraction unitRef="usd" contextRef="ifd27622aa4284e0bae46ba60135d8c67_D20230101-20230331" decimals="-6" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfNTQ5NzU1ODI3NDc0_27bb813b-681f-4364-ad9f-ec044949ff78">61</ix:nonFraction>&#160;million, which are primarily attributed to changes in our operating model to accelerate the delivery of medicines to patients.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfRestructuringAndRelatedCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfMTk4OA_79273de4-c6b3-4f5d-ad1f-48a58b6efccd" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provides the charges related to restructuring initiatives by type of cost:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene Acquisition Plan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60310b1a57dc4e7eb67336d876feec68_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMi0xLTEtMS0xOTM5Mzc_ced0eb1b-ff62-49e4-8579-990f319abe92">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic747ce574e0c4e43947638c951cc006e_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMi0zLTEtMS0xOTM5Mzc_2c8d991f-ef2c-4dd5-905e-bf6cb0e5e689">127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other Restructuring </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd27622aa4284e0bae46ba60135d8c67_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMy0xLTEtMS0xOTM5Mzc_c762b13c-9a91-4378-b06e-36f9bb9b7ac4">78</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if74867368269444eadf64059422c5acc_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMy0zLTEtMS0xOTM5Mzc_e8fedee8-6aec-4147-98fd-878decf58b51">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfNS0xLTEtMS0xOTM5Mzc_435cb982-b75b-454a-add6-88fbf1a24e09">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfNS0zLTEtMS0xOTM5Mzc_5f83d7cc-02bb-4f37-a2be-a48a5870bcce">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee termination costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfNy0xLTEtMS0xOTM5Mzc_8d6c03fd-0f1c-4f1e-8a01-6825e694d642">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:SeveranceCosts1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfNy0zLTEtMS0xOTM5Mzc_bf28ec25-a592-4cdf-b74f-01ee295ea385">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other termination costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfOC0xLTEtMS0xOTM5Mzc_322b528b-6803-45a8-956b-e28fc67be728">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherRestructuringCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfOC0zLTEtMS0xOTM5Mzc_d932b6a8-aade-43b5-8ed8-92c91b61a39a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfOS0xLTEtMS0xOTM5Mzc_1c7083bb-e8cd-4253-add3-dfa7e5f5eed7">67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfOS0zLTEtMS0xOTM5Mzc_968625bb-7902-45a8-b4a1-575a9ba1f478">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTAtMS0xLTEtMTkzOTM3_7314cfc9-229b-4d13-9a81-a0055d24b6c4">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:BusinessCombinationIntegrationRelatedCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTAtMy0xLTEtMTkzOTM3_51c44af7-f82f-4368-9dac-31c75df0f2e6">105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringReserveAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTEtMS0xLTEtMTkzOTM3_6bbdf0b0-55bb-4259-8c7a-7ad657511091">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringReserveAcceleratedDepreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTEtMy0xLTEtMTkzOTM3_4cd80990-2b88-47ab-a241-8a0c8f08692a">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTQtMS0xLTEtMTkzOTM3_50dbc602-03e9-42e6-b410-196605656b30">135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTQtMy0xLTEtMTkzOTM3_c44ff89d-3669-4a9e-aaa3-ba28f33e6a69">130</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d5ed5411a6f44adad6a2fafa7a07b71_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTYtMS0xLTEtMTkzOTM3_78968530-4600-4098-9a16-605ff3ff058e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78cff693ad5a4423abe55a1f70a20cbd_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTYtMy0xLTEtMTkzOTM3_c72d9b3a-206a-4d17-ad5b-b9677d61d516">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40cc8e1a8704933a5e9e7779a3257e8_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTctMS0xLTEtMTkzOTM3_11d28bfa-9eda-4add-a9eb-b078be269223">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2d6f04e5b6a421bab39cccd2a64bca3_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTctMy0xLTEtMTkzOTM3_9418c65f-e56e-46fb-8943-21b5bfe44f3f">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b3fceca00e340e4988c254e71262a6c_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTktMS0xLTEtMTkzOTM3_1a9872d7-8e71-4980-948c-10ce1019d38b">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie06401d4a0fc4667a4c6ad88ffc12538_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMTktMy0xLTEtMTkzOTM3_fa333cbb-c1aa-43ff-8a00-342e8d24f206">128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMjAtMS0xLTEtMTkzOTM3_256bb28b-7f25-4cf8-bf7d-c109cb4dc3e8">135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringCostsAndAssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjk4ZmJhNmJlYjdmNjQzM2M5Y2M0NmJiMTkyMGU0MDdiL3RhYmxlcmFuZ2U6OThmYmE2YmViN2Y2NDMzYzljYzQ2YmIxOTIwZTQwN2JfMjAtMy0xLTEtMTkzOTM3_3754faaf-5e5f-43a8-b4fa-9b572536e543">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i3d5681b1f68645a9830352ec337e23e8" continuedAt="iffaac3ae900f45b9b3591eca12c8fe6c"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfMTk4OQ_66707be2-8774-4cc9-9866-aec432e834ba" continuedAt="i0b41a9cbf43a436e8d1f399eb2329257" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the charges and spending related to restructuring plan activities:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance </span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfMi0xLTEtMS0xOTM5Mzc_2227650a-9e62-4026-968d-b3781964fc78">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9853bb7a3895445aab6c6693e972cc56_I20211231" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfMi0zLTEtMS0xOTM5Mzc_2cbd6e9c-a210-42e4-97e2-16ea6ffcc8b5">101</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfMy0xLTEtMS0xOTM5Mzc_92f09bb3-8f44-49fb-a978-ef9c9148c0f2">67</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:RestructuringChargesExcludingAcceleratedStockbasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfMy0zLTEtMS0xOTM5Mzc_1e4fb051-71dc-4709-bdbe-c244ddd82124">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfNC0xLTEtMS0xOTM5Mzc_e9bd38fb-1803-4080-a67d-2a622754e629">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:RestructuringReserveTranslationAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfNC0zLTEtMS0xOTM5Mzc_d93126d5-2de3-4471-9216-6f6aed71061a">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfNS0xLTEtMS0xOTM5Mzc_91b961e1-98bf-42e6-a4f0-4cc5890f2b63">17</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:PaymentsForRestructuring" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfNS0zLTEtMS0xOTM5Mzc_0f67c8b2-73dc-4742-bafa-ad1be5263ff1">21</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfNi0xLTEtMS0xOTM5Mzc_d424f44c-7c01-4877-b517-1cb7b8622fb4">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i346eafc8325f4939af4f85fbfc5a4e5b_I20220331" decimals="-6" name="us-gaap:RestructuringReserve" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RhYmxlOjViYTNiYTI4MmYzNDQ3MzViYmJlNTRiZDNkNzJiZjI2L3RhYmxlcmFuZ2U6NWJhM2JhMjgyZjM0NDczNWJiYmU1NGJkM2Q3MmJmMjZfNi0zLTEtMS0xOTM5Mzc_79b652da-eddd-48ad-a60c-e8a9cf9b2db1">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="iffaac3ae900f45b9b3591eca12c8fe6c"><ix:continuation id="i0b41a9cbf43a436e8d1f399eb2329257">(a)&#160;&#160;&#160;&#160;Includes a reduction of the liability resulting from changes in estimates of $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfMTgzOA_51a81171-ee28-4959-8fe2-da0ecb5395e8">3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:RestructuringReserveAccrualAdjustment1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81Mi9mcmFnOjdlYTNkMDEyODY5MzQ0ZDZhOGFmZWViYmJlNzA3YzM5L3RleHRyZWdpb246N2VhM2QwMTI4NjkzNDRkNmE4YWZlZWJiYmU3MDdjMzlfMTA5OTUxMTYyOTg3NQ_523d657e-96cf-4fa4-a166-94536295b9bd">9</ix:nonFraction> million for the three months ended March 31, 2023 and 2022, respectively.</ix:continuation></ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_55"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfMTk0Nw_bdaf4d09-11f8-4b08-915d-0d9a4c78b978" continuedAt="i900b54cf83144b2ea9def8b095690732" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="i900b54cf83144b2ea9def8b095690732"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="bmy:ScheduleOfProvisionForIncomeTaxesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfMTk0MQ_d6743b5e-8173-4536-a917-f49e04989199" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RhYmxlOmIwMGM4MWUxOWFiMDRmZTFiODYzNzJlODA4NzAwNmU4L3RhYmxlcmFuZ2U6YjAwYzgxZTE5YWIwNGZlMWI4NjM3MmU4MDg3MDA2ZThfMi0xLTEtMS0xOTM5Mzc_a427cad0-cf42-4d34-99eb-8f21834c28a0">2,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RhYmxlOmIwMGM4MWUxOWFiMDRmZTFiODYzNzJlODA4NzAwNmU4L3RhYmxlcmFuZ2U6YjAwYzgxZTE5YWIwNGZlMWI4NjM3MmU4MDg3MDA2ZThfMi0zLTEtMS0xOTM5Mzc_af7bd38a-a76b-4aa6-aec6-8acd70161669">1,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RhYmxlOmIwMGM4MWUxOWFiMDRmZTFiODYzNzJlODA4NzAwNmU4L3RhYmxlcmFuZ2U6YjAwYzgxZTE5YWIwNGZlMWI4NjM3MmU4MDg3MDA2ZThfMy0xLTEtMS0xOTM5Mzc_2d677608-edef-48d1-9c2e-a7c3afa181dd">503</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RhYmxlOmIwMGM4MWUxOWFiMDRmZTFiODYzNzJlODA4NzAwNmU4L3RhYmxlcmFuZ2U6YjAwYzgxZTE5YWIwNGZlMWI4NjM3MmU4MDg3MDA2ZThfMy0zLTEtMS0xOTM5Mzc_7e9ddacb-d7c4-437a-89d2-590568803cae">404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RhYmxlOmIwMGM4MWUxOWFiMDRmZTFiODYzNzJlODA4NzAwNmU4L3RhYmxlcmFuZ2U6YjAwYzgxZTE5YWIwNGZlMWI4NjM3MmU4MDg3MDA2ZThfNC0xLTEtMS0xOTM5Mzc_504ec3fc-f17f-452f-8393-45a88db0ba2b">18.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RhYmxlOmIwMGM4MWUxOWFiMDRmZTFiODYzNzJlODA4NzAwNmU4L3RhYmxlcmFuZ2U6YjAwYzgxZTE5YWIwNGZlMWI4NjM3MmU4MDg3MDA2ZThfNC0zLTEtMS0xOTM5Mzc_4e69d025-33a0-4f4d-8d99-67b6bff44fd4">23.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes in interim periods are determined based on the estimated annual effective tax rates and the tax impact of discrete items that are reflected immediately. The <ix:nonFraction unitRef="number" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxSettlements" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfODc5NjA5MzAzMzU0Ng_31b4dea8-8f56-40e7-958b-e0f659ee6efe">5.7</ix:nonFraction>% decrease in our effective tax rate is primarily due to jurisdictional earnings mix resulting from amortization of acquired intangible assets, equity investment losses, litigation and other settlements, as well as releases of income tax reserves of $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxReconciliationTaxSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfMjc0ODc3OTA4MTM0NQ_b2b485df-2337-4e46-95fc-91881ecc787f">89</ix:nonFraction> million related to the resolution of Celgene's 2009-2011 IRS audits, partially offset by the impact of changes in our Puerto Rico tax decree that eliminated a previously creditable excise tax. Additional changes to the effective tax rate may occur in future periods due to various reasons, including changes to the estimated pretax earnings mix and tax reserves and revised interpretations or changes to the relevant tax code. Income tax payments were $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfODc5NjA5MzAyOTU0Ng_354c8d7d-9f9f-4592-99a6-e4315f40f45a">149</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:IncomeTaxesPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfODc5NjA5MzAyOTU1Nw_efa7dcd5-1ef4-4e75-9c1c-c004abc0727b">255</ix:nonFraction>&#160;million for the three months ended March 31, 2023 and 2022, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS is currently under examination by a number of tax authorities that proposed or are considering proposing material adjustments to tax positions for issues such as transfer pricing, certain tax credits and the deductibility of certain expenses. As previously disclosed, BMS received several notices of proposed adjustments from the IRS related to transfer pricing and other tax issues for the 2008 to 2012 tax years. BMS disagrees with the IRS's positions and continues to work cooperatively with the IRS to resolve these issues. In the fourth quarter of 2022, BMS entered the IRS administrative appeals process to resolve these matters. Timing of the final resolution of these complex matters is uncertain and could have a material impact on BMS's consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that the amount of unrecognized tax benefits as of March&#160;31, 2023 could decrease in the range of approximately $<ix:nonFraction unitRef="usd" contextRef="iac4c3c432dec4175884bcb7121ad7b2e_I20230331" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfODIx_1fc0a86b-46a0-4be1-a052-6f1ec748beb0">40</ix:nonFraction> million to $<ix:nonFraction unitRef="usd" contextRef="id6661c44be2040ddb58e23420f3a637a_I20230331" decimals="-6" name="us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV81NS9mcmFnOmMyNDYwZDVjNzQ1NzQwZWFiMDI2MThiYzJlMWY5ODMxL3RleHRyZWdpb246YzI0NjBkNWM3NDU3NDBlYWIwMjYxOGJjMmUxZjk4MzFfODI3_41a6f19b-77e9-4633-8f6a-5267d6739a22">60</ix:nonFraction> million in the next twelve months as a result of the settlement of certain tax audits and other events. The expected change in unrecognized tax benefits may result in the payment of additional taxes, adjustment of certain deferred taxes and/or recognition of tax benefits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is reasonably possible that new issues will be raised by tax authorities that may increase unrecognized tax benefits, however, an estimate of such increases cannot reasonably be made at this time. BMS believes that it has adequately provided for all open tax years by jurisdiction.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_61"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RleHRyZWdpb246YjdlZjJkOWQ1M2RhNDZkMGFiM2MxYTJiZDM5MjBlYTdfMjI4_3002fcb6-1cfa-4064-a1c5-dcbd8b761189" continuedAt="id7888796ddb84a12ab77511acc228867" escape="true">EARNINGS PER SHARE</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:justify"><ix:continuation id="id7888796ddb84a12ab77511acc228867" continuedAt="i29a5e18e7c754caa91cb820e3224faf4"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RleHRyZWdpb246YjdlZjJkOWQ1M2RhNDZkMGFiM2MxYTJiZDM5MjBlYTdfMjM2_d3135f4f-6282-4d11-b52f-0ae01520dba5" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions, except per share data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to BMS </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfMi0xLTEtMS0xOTM5Mzc_adc5be29-3e7f-45f1-b6d3-7f6787589800">2,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfMi0zLTEtMS0xOTM5Mzc_3dbdf914-7829-43b8-9767-00f9320bfc9b">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding &#8211; basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfNC0xLTEtMS0xOTM5Mzc_2b60d731-c508-4c92-8950-63d10bca53a1">2,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfNC0zLTEtMS0xOTM5Mzc_7e3f00fc-7e4c-4cd5-ab9c-154fc89b6145">2,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Incremental shares attributable to share-based compensation plans</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfNS0xLTEtMS0xOTM5Mzc_2654a662-5b8b-490c-b395-7807901deaf1">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfNS0zLTEtMS0xOTM5Mzc_652341cf-2091-4a39-929d-2ec9724dcc71">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfNi0xLTEtMS0xOTM5Mzc_3bff1eee-7225-41e6-95df-c1642d8e443c">2,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfNi0zLTEtMS0xOTM5Mzc_631ca816-8ec9-4796-9381-8a90161efb6b">2,164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfOS0xLTEtMS0xOTM5Mzc_04414f89-39de-49e3-a69c-44ec253f05f6">1.08</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfOS0zLTEtMS0xOTM5Mzc_c680c448-605c-40a5-bd7d-f0c1466eaa59">0.60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfMTAtMS0xLTEtMTkzOTM3_c91d200c-c5c7-4b74-9ee2-51f829a8781b">1.07</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82MS9mcmFnOmI3ZWYyZDlkNTNkYTQ2ZDBhYjNjMWEyYmQzOTIwZWE3L3RhYmxlOmYzZjY3OTI2OGI4OTQ0YTA5NGVmMGI2MzJkYjJjNDdlL3RhYmxlcmFuZ2U6ZjNmNjc5MjY4Yjg5NDRhMDk0ZWYwYjYzMmRiMmM0N2VfMTAtMy0xLTEtMTkzOTM3_431db98c-10c5-4142-95df-c2bc9b5e2acc">0.59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i29a5e18e7c754caa91cb820e3224faf4">The total number of potential shares of common stock excluded from the diluted earnings per common share computation because of the antidilutive impact was not material for the three months ended March&#160;31, 2023 and 2022, respectively.</ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_64"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA2NzM_ecf46179-0fbf-4f7d-a954-10540d044e1a" continuedAt="i285a0eb4fe8549a8b42c8a93ad0ccdea" escape="true">FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i285a0eb4fe8549a8b42c8a93ad0ccdea" continuedAt="id12e5eebdc744a75b1e7a2688206d60d"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA3Mzk_9d24f17a-9f55-43f5-a281-8607a740ced7" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial assets and liabilities measured at fair value on a recurring basis are summarized below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash and cash equivalents</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Money market and other securities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ce7d0b07b1b424498f8e2bc0a5a6111_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMi0xLTEtMS0xOTM5Mzc_d8caa5dd-0714-40ed-ae9b-30e48deb3291">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0632013d3854087980e90d795c1d8d2_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMi0zLTEtMS0xOTM5Mzc_c8fbcb81-6e8d-4926-b379-70294798e9e2">7,737</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8864048307a4f86a8062658906f4268_I20230331" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMi01LTEtMS0xOTM5Mzc_eae1282b-499b-41ca-8811-6c2084acf5d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e01113e4591475099df5c4095d6e115_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMi03LTEtMS0xOTM5Mzc_984a3446-4048-4d85-b703-fa7ac31e06a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id21490322ff9415aaea6cdeb5ee3ee11_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMi05LTEtMS0xOTM5Mzc_3e9f4dd1-773c-4d23-a325-f0b812497d17">7,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie566e0e0c4944fb491ddbe3b1c9ff862_I20221231" decimals="-6" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMi0xMS0xLTEtMTkzOTM3_6f946331-02e3-4b04-be72-755d82674205">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7dfa02c176c44b3eaa296d1e976cb5fe_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNC0xLTEtMS0xOTM5Mzc_2fe7306d-79d5-4625-939a-b2dd66287c10">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae64455b039742d787ed2de5fd251442_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNC0zLTEtMS0xOTM5Mzc_a6fd4972-bea8-4a19-9ad7-3e1327dbd550">201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fc8f9965414a0b804d69bb0c52f940_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNC01LTEtMS0xOTM5Mzc_ed0d4532-0233-4b17-9676-89f60b73573d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a360ac8b1d44afd9d65385129373f29_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNC03LTEtMS0xOTM5Mzc_5512ebac-e322-44cf-9919-5e5d767d9916">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84eee663f7a54ab6981f1221be773582_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNC05LTEtMS0xOTM5Mzc_d46d5a42-e8ca-4456-a2f4-7c91fe2a868c">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie78114eba6d1431e8eb7de14cb30d209_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNC0xMS0xLTEtMTkzOTM3_70663db2-55eb-4ee5-a962-e681f5682886">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe8ca2459264488eb91f63c4799ca142_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNS0xLTEtMS0xOTM5Mzc_4115b2a6-3f44-4700-a561-65ddfb803a2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0873c9ac73324059911ec26977fd62b7_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNS0zLTEtMS0xOTM5Mzc_bfef367a-cc3f-4919-8acd-89ee39af2e76">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i781c7d4e422d4246a9f62677261a6759_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNS01LTEtMS0xOTM5Mzc_bbc3935e-e26a-43c8-b6b6-2cb420e84637">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f61e0b967e941f3a13b8cdae92da602_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNS03LTEtMS0xOTM5Mzc_9e0078e0-97c9-4ead-bc6d-b9e8eb9b4f61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe21eb2b773241f9975587ff0d8c4222_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNS05LTEtMS0xOTM5Mzc_638dbc0b-157b-46ac-a92a-be017dc80210">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice34df82dfdc4797b4a08dd853517723_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNS0xMS0xLTEtMTkzOTM3_883599d1-a634-4429-b230-11a6f0d54168">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ce7d0b07b1b424498f8e2bc0a5a6111_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNy0xLTEtMS0xOTM5Mzc_a35044b2-9a26-447d-89ea-9e47370ee717">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0632013d3854087980e90d795c1d8d2_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNy0zLTEtMS0xOTM5Mzc_de468042-4d79-4189-88df-0c7dd6c6dff4">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8864048307a4f86a8062658906f4268_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNy01LTEtMS0xOTM5Mzc_924ec066-4455-4801-aa12-0a754bd315b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e01113e4591475099df5c4095d6e115_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNy03LTEtMS0xOTM5Mzc_61fbf076-d781-47d7-95a4-d2fde242ae81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id21490322ff9415aaea6cdeb5ee3ee11_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNy05LTEtMS0xOTM5Mzc_f90819a3-df84-4a0b-bdf3-87a1aa3a2023">305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie566e0e0c4944fb491ddbe3b1c9ff862_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfNy0xMS0xLTEtMTkzOTM3_4b9526b0-b6f5-4bf1-901e-542c7c7742ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59d461f0363f4426b69a52fb5f5622fa_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOC0xLTEtMS0xOTM5Mzc_d2927642-79cc-43e9-948c-347750fb8e79">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39d1821f5f4446deb6d810a66e604eee_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOC0zLTEtMS0xOTM5Mzc_4018a5da-ebf9-46e9-85b9-ed4656b1d102">614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa0d2ac040da41489147ca9c96170c3d_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOC01LTEtMS0xOTM5Mzc_51e2264c-7eec-4bb9-a535-dd2b3bff7ba4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3125f46fdab84e90911ceb3d16a6f77a_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOC03LTEtMS0xOTM5Mzc_b0563ad6-73a9-4863-97d5-3020d2b6905f">424</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6eb6f8e5a38c4a0e8374ef965064fe35_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOC05LTEtMS0xOTM5Mzc_983b89f1-3477-4927-bde6-8bc3de9bf6b7">680</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6af8bc7b28d042ba94f91804fafa4966_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOC0xMS0xLTEtMTkzOTM3_b6dc3ab0-acf6-47d5-a873-eb222de48cfa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ce7d0b07b1b424498f8e2bc0a5a6111_I20230331" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOS0xLTEtMS0xOTM5Mzc_0df75222-1fc7-43c4-9022-ac6475f63857">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0632013d3854087980e90d795c1d8d2_I20230331" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOS0zLTEtMS0xOTM5Mzc_943dd700-f40d-44e0-a6bb-ae0663ba6982">207</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8864048307a4f86a8062658906f4268_I20230331" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOS01LTEtMS0xOTM5Mzc_19ef689f-11e0-49c5-9de2-8469963912dd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e01113e4591475099df5c4095d6e115_I20221231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOS03LTEtMS0xOTM5Mzc_3b5474f5-7a80-481f-b674-6519c52578ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id21490322ff9415aaea6cdeb5ee3ee11_I20221231" decimals="-6" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOS05LTEtMS0xOTM5Mzc_d92ca86d-5620-472d-9641-1c6dcef2906d">213</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie566e0e0c4944fb491ddbe3b1c9ff862_I20221231" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfOS0xMS0xLTEtMTkzOTM3_3489b1c9-23e2-454f-9654-4ca2f5fd5e96">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Contingent consideration liability</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent value rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4dc3e7bf51d41f39850d2ccaddabf1e_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTEtMS0xLTEtMTkzOTM3_c15e93cd-f7ff-4fd2-a1fb-29589a0acef2">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52e3749bff1746a68a8dbf08ac2f7f8f_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTEtMy0xLTEtMTkzOTM3_a034deb2-9ca0-4827-82a1-b8eb7a883b7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i341f444f1ff84f0393e86932e2bbcb98_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTEtNS0xLTEtMTkzOTM3_0c567915-3985-4b47-af82-34bb64802940">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14834d88f10b45639a717a5dfcb76963_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTEtNy0xLTEtMTkzOTM3_3bf0a159-f6b9-4c53-ba9b-1c19ebe806f3">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iea7520f9b6d647d5a6e43c02f239fa52_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTEtOS0xLTEtMTkzOTM3_fe561717-c9b3-4ffb-8788-de6e3d341775">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67aea7fd88984640aed0e394579193a2_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTEtMTEtMS0xLTE5MzkzNw_d93c0224-f14d-4f69-b9e8-a0cd01de51aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other acquisition related contingent consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ce7d0b07b1b424498f8e2bc0a5a6111_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTItMS0xLTEtMTkzOTM3_a61aec8a-0509-4aef-b461-84d3d5234ccb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib0632013d3854087980e90d795c1d8d2_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTItMy0xLTEtMTkzOTM3_da2f9d2d-d297-4733-8850-fd01fda14e9d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8864048307a4f86a8062658906f4268_I20230331" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTItNS0xLTEtMTkzOTM3_8b2cef73-8316-4495-8c3e-bfc9ab6b1962">18</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e01113e4591475099df5c4095d6e115_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTItNy0xLTEtMTkzOTM3_30834dbd-05d5-4b69-aa74-00ae2009c90e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id21490322ff9415aaea6cdeb5ee3ee11_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTItOS0xLTEtMTkzOTM3_770cbe88-9f4e-46da-844b-959c1d803181">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie566e0e0c4944fb491ddbe3b1c9ff862_I20221231" decimals="-6" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjFhMjEzMDgxZTZhZDQ1YjRhMjVlNDE1ZWY3ODk0ZGFmL3RhYmxlcmFuZ2U6MWEyMTMwODFlNmFkNDViNGEyNWU0MTVlZjc4OTRkYWZfMTItMTEtMS0xLTE5MzkzNw_8b0f040f-6dcf-46df-ab10-a71a118ba1c8">24</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in "Item 8. Financial Statements and Supplementary Data&#8212;Note 9. Financial Instruments and Fair Value Measurements" in the Company's 2022 Form 10-K, the Company's fair value estimates use inputs that are either (1) quoted prices for identical assets or liabilities in active markets (Level 1 inputs); (2) observable prices for similar assets or liabilities in active markets or for identical or similar assets or liabilities in markets that are not active (Level 2 inputs); or (3) unobservable inputs (Level 3 inputs). The fair value of equity investments is&#160;adjusted&#160;for characteristics specific to the&#160;security and is not adjusted&#160;for contractual sale restrictions. Equity investments subject to contractual sale restrictions were not material as of March&#160;31, 2023 and December&#160;31, 2022. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Marketable Debt Securities </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:MarketableSecuritiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA2ODA_95c33714-ecf6-470c-af53-f531af728097" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes marketable debt securities:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Unrealized</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificates of deposit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib65a4a2a6c3c4f89bb86f0d4068fe25b_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy0xLTEtMS0xOTM5Mzc_a16df9de-41b9-4e1e-86df-9943f760a0bb">201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib65a4a2a6c3c4f89bb86f0d4068fe25b_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy0zLTEtMS0xOTM5Mzc_43c983ac-63ff-48b1-8bfd-dac39fdbe44b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib65a4a2a6c3c4f89bb86f0d4068fe25b_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy01LTEtMS0xOTM5Mzc_03334bac-d746-4541-9f3d-64818b2d993f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib65a4a2a6c3c4f89bb86f0d4068fe25b_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy03LTEtMS0xOTM5Mzc_b3c97bdf-bfd1-4e49-95e4-5af29b9df303">201</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc622a66bb01497482da48709daace5b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy05LTEtMS0xOTM5Mzc_92df5114-285d-4672-8097-d7b3aafc91d8">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc622a66bb01497482da48709daace5b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy0xMS0xLTEtMTkzOTM3_2495429f-f8db-494c-b7b7-3c03dfeb01f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc622a66bb01497482da48709daace5b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy0xMy0xLTEtMTkzOTM3_f1747618-0dd3-46d8-90b8-a594b5dd8cf3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc622a66bb01497482da48709daace5b_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfMy0xNS0xLTEtMTkzOTM3_d84f3a7b-00ce-4c26-b54f-7fd7a52ac72b">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commercial paper</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6c0fe73a8454867a2e1e14954eae15c_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC0xLTEtMS0xOTM5Mzc_010b5ad4-a3cd-4861-9230-a07f3481b924">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6c0fe73a8454867a2e1e14954eae15c_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC0zLTEtMS0xOTM5Mzc_a0c9380f-db9c-448d-b6df-e64115ed788b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6c0fe73a8454867a2e1e14954eae15c_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC01LTEtMS0xOTM5Mzc_4e12d9b2-4aaa-48b3-8133-ebbaae2a561f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6c0fe73a8454867a2e1e14954eae15c_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC03LTEtMS0xOTM5Mzc_c6ad5733-f30f-4b70-8fa8-354fbaca9943">73</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3c2fd3c0be4401480de8de24cb596eb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC05LTEtMS0xOTM5Mzc_aba3e687-4f45-48d4-9de3-c22da60ba01d">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3c2fd3c0be4401480de8de24cb596eb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC0xMS0xLTEtMTkzOTM3_8bf3cf35-382c-48c5-9c67-a96091d411ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3c2fd3c0be4401480de8de24cb596eb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC0xMy0xLTEtMTkzOTM3_cdf6d297-1e90-46fd-b70e-79f3c67a2382">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3c2fd3c0be4401480de8de24cb596eb_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNC0xNS0xLTEtMTkzOTM3_fd54068e-35e1-4d61-b722-065cae170ce8">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total marketable debt securities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi0xLTEtMS0xOTM5Mzc_a7141a28-d0a0-4dff-a705-d07e031dd244">274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi0zLTEtMS0xOTM5Mzc_d7661e4c-d276-4a93-ae45-5a3897212588">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi01LTEtMS0xOTM5Mzc_58f948f3-1eea-4991-b57f-a239040aeb2b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi03LTEtMS0xOTM5Mzc_067f4666-44ba-4044-879e-6be7e7c81682">274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi05LTEtMS0xOTM5Mzc_fd44d156-c6d1-4a74-b1b1-ba8e95bc8003">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi0xMS0xLTEtMTkzOTM3_b4bbb050-8b12-4805-87d1-9c5f59961b08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi0xMy0xLTEtMTkzOTM3_ff49ec30-7333-43ce-98ab-a1dfaa8294bf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmIxMzJhYzg1OWE2ODRlZTFiMDdlMzQ2YzAzNDhhYWIxL3RhYmxlcmFuZ2U6YjEzMmFjODU5YTY4NGVlMWIwN2UzNDZjMDM0OGFhYjFfNi0xNS0xLTEtMTkzOTM3_2c24b918-337b-48ae-8fa2-279a22074854">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;All marketable debt securities mature within one year as of March&#160;31, 2023, and December&#160;31, 2022.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="id12e5eebdc744a75b1e7a2688206d60d" continuedAt="i2f78dbf2b30248d9950e749d6137e947"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Investments</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="bmy:ScheduleOfEquityInvestmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA2OTc_26f68c10-0f08-493d-aa0a-cd43ee96865b" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the carrying amount of equity investments:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments with readily determinable fair values</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfMS0xLTEtMS0xOTM5Mzc_d3a97893-75e4-4ca3-8cde-c1a4e7daa14b">907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesFvNi" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfMS0zLTEtMS0xOTM5Mzc_97436c65-f818-4ad9-a5ef-2f85b6806823">1,104</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfMi0xLTEtMS0xOTM5Mzc_53121a6a-62a6-494b-85af-5affc230b477">574</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfMi0zLTEtMS0xOTM5Mzc_1161722b-311b-4c49-911a-f31987947ec8">537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Limited partnerships and other equity method investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfMy0xLTEtMS0xOTM5Mzc_85ff3fd0-546d-497c-a410-fb9db08b2cb5">524</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:EquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfMy0zLTEtMS0xOTM5Mzc_f77df033-ed79-4b19-b34d-4ed8bf6a7359">546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity investments</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="bmy:EquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfNC0xLTEtMS0xOTM5Mzc_255283d3-46aa-4c56-821a-d30b040d8bae">2,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="bmy:EquityInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOmMwMjI5YjAxZmVlZjQ4YmZiODFmN2E5ZTE0YzQ0NGU5L3RhYmxlcmFuZ2U6YzAyMjliMDFmZWVmNDhiZmI4MWY3YTllMTRjNDQ0ZTlfNC0zLTEtMS0xOTM5Mzc_606fe45d-c8af-45e1-b09b-3257771e0c99">2,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:TradingSecuritiesAndCertainTradingAssetsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA3MzU_1367602f-ced5-47a5-8d46-5f59a8b2e9ac" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity investments with readily determinable fair values</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss recognized</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfMy0xLTEtMS0xOTM5Mzc_ce5bd12a-b909-463a-a825-9750e71e7877">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfMy0zLTEtMS0xOTM5Mzc_f9305eea-5f81-4452-bf9e-eecdc66a6ca2">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net gain recognized on investments sold</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfNC0xLTEtMS0xOTM5Mzc_d13ac1b8-b38d-4ade-a54f-e28ec7b08f83">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:EquitySecuritiesFvNiRealizedGainLoss" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfNC0zLTEtMS0xOTM5Mzc_5bd49d75-977d-4273-837e-e3decc313c7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unrealized loss recognized on investments still held</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfNS0xLTEtMS0xOTM5Mzc_9dfcc700-c33b-4f6c-a725-50469f849c3c">140</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:UnrealizedGainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfNS0zLTEtMS0xOTM5Mzc_c282b22d-e4fb-4dff-b8f5-7943f5d52d8d">598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Equity investments without readily determinable fair values</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Upward adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfOC0xLTEtMS0xOTM5Mzc_97615577-95ba-4d95-9d70-eeeb9a20263c">5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfOC0zLTEtMS0xOTM5Mzc_4b453abb-83cc-44e3-a590-18e057b852bc">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairments and downward adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfOS0xLTEtMS0xOTM5Mzc_6b054acb-3618-4a1d-81b4-a362e8d20197">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentAnnualAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfOS0zLTEtMS0xOTM5Mzc_fb23d025-21d6-4985-b0b3-f44a49603de7">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity in net loss of affiliates</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfMTMtMS0xLTEtMTkzOTM3_790ff3ef-6c79-4264-87f3-943ee0cd5b5b">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfMTMtMy0xLTEtMTkzOTM3_8ff32c3c-65bf-4b76-aa9b-11bd36f954fc">50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Equity investment losses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfMTItMS0xLTEtMjEzMzUz_5f0b0ad4-7352-47cf-9944-a534f844e771">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GainLossOnInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjZjN2FhODAwNjhmMTRhYmViOTYzMGE1MzVjYmNlNzU1L3RhYmxlcmFuZ2U6NmM3YWE4MDA2OGYxNGFiZWI5NjMwYTUzNWNiY2U3NTVfMTItMy0xLTEtMjEzMzU2_3ea54e88-9dfb-40f4-827f-ce77ca65fbad">644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cumulative upwards adjustments and cumulative impairments and downward adjustments based on observable price changes in equity investments without readily determinable fair values still held as of March&#160;31, 2023 were $<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentCumulativeAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA5OTUxMTYzOTAxOQ_c4ba4460-b1b0-4995-a667-f084c364fdd7">186</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i346eafc8325f4939af4f85fbfc5a4e5b_I20220331" decimals="-6" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueDownwardPriceAdjustmentCumulativeAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA5OTUxMTYzOTAzMw_884d6f71-415b-49bb-b240-2bff81cd6b0b">61</ix:nonFraction>&#160;million, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Qualifying Hedges and Non-Qualifying Derivatives</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash Flow Hedges</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS enters into foreign currency forward and purchased local currency put option contracts (foreign exchange contracts) to hedge certain forecasted intercompany inventory sales and certain other foreign currency transactions. The objective of these foreign exchange contracts is to reduce variability caused by changes in foreign exchange rates that would affect the U.S. dollar value of future cash flows derived from foreign currency denominated sales, primarily the euro and Japanese yen. The fair values of these derivative contracts are recorded as either assets (gain positions) or liabilities (loss positions) in the consolidated balance sheet. Changes in fair value for these foreign exchange contracts, which are designated as cash flow hedges, is temporarily recorded in Accumulated other comprehensive loss ("AOCL") and reclassified to net earnings when the hedged item affects earnings (typically within the next 24 months). As of March 31, 2023, assuming market rates remain constant through contract maturities, we expect to reclassify pre-tax gains of $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODc3MjI2_b100f6db-797d-424a-80e3-6c8ef36666ad">156</ix:nonFraction>&#160;million into cost of products sold for our foreign exchange contracts out of AOCL during the next 12 months. The notional amount of outstanding foreign currency exchange contracts was primarily $<ix:nonFraction unitRef="usd" contextRef="i4430059dc6204ccb8d6012d670a5011e_I20230331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODY3NTIz_8c076786-d74b-4b71-aa76-c455e9d40aae">4.9</ix:nonFraction>&#160;billion for the euro contracts and $<ix:nonFraction unitRef="usd" contextRef="ia41d2cc5ab0c42feaa7a631ecbb22c3d_I20230331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODY3NTQ3_9363de55-c3d3-4b71-8194-15abd91343b1">1.3</ix:nonFraction>&#160;billion for Japanese yen contracts as of March&#160;31, 2023. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i2f78dbf2b30248d9950e749d6137e947" continuedAt="i0df6c8c74c41402bbcff0fdc51694428"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS also enters into cross-currency swap contracts to hedge exposure to foreign currency exchange rate risk associated with its long-term debt denominated in euros. These contracts convert interest payments and principal repayment of the long-term debt to U.S. dollars from euros and are designated as cash flow hedges. The unrealized gains and losses on these contracts are reported in AOCL and reclassified to Other (income)/expense, net, in the same periods during which the hedged debt affects earnings. The notional amount of cross-currency swap contracts associated with long-term debt denominated in euros was $<ix:nonFraction unitRef="usd" contextRef="ib10f8c00022a496aa567f0b2b08b1734_I20230331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODY4OTIx_7bffad9e-737e-4089-bfa7-337e787b8463">1.2</ix:nonFraction>&#160;billion as of March&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash flow hedge accounting is discontinued when the forecasted transaction is no longer probable of occurring within 60 days after the originally forecasted date or when the hedge is no longer effective. Assessments to determine whether derivatives designated as qualifying hedges are highly effective in offsetting changes in the cash flows of hedged items are performed at inception and on a quarterly basis. The earnings impact related to discontinued cash flow hedges and hedge ineffectiveness was not material during all periods presented. Foreign currency exchange contracts not designated as a cash flow hedge offset exposures in certain foreign currency denominated assets, liabilities and earnings. Changes in the fair value of these derivatives are recognized in earnings as they occur.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Investment Hedges</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross-currency swap contracts of $<ix:nonFraction unitRef="usd" contextRef="iefc7a3eb0fe54e43af4dac01fc5e96bd_I20230331" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODcwMTky_dc2dae9a-8e73-4c77-8221-e916a4d124f4">1.3</ix:nonFraction>&#160;billion as of March&#160;31, 2023 are designated to hedge currency exposure of BMS's net investment in its foreign subsidiaries. Contract fair value changes are recorded in the foreign currency translation component of AOCL with a related offset in derivative asset or liability on the consolidated balance sheet. The notional amount of outstanding cross-currency swap contracts was primarily attributed to the Japanese yen of $<ix:nonFraction unitRef="usd" contextRef="if7361bec49a941e5b6e8ee3761986ec8_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODcwNjM5_186ebbab-e1cb-4aca-8eb1-e8270c94fecb">509</ix:nonFraction>&#160;million and euro of $<ix:nonFraction unitRef="usd" contextRef="i35cd3e93ee9f44a4863c125f17563e83_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODcwNjU1_623638b3-14a1-4981-aa40-ead3caf7bb6a">584</ix:nonFraction>&#160;million as of March&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter 2023, the Company de-designated its remaining net investment hedge in debt denominated in euros of &#8364;<ix:nonFraction unitRef="eur" contextRef="i48499737f5104edab86a6d804fd035ab_I20230331" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODcwNzQ5_fe6f35c7-95c2-4f1e-b8d6-833a015ee642">375</ix:nonFraction>&#160;million. The related net investment hedge was entered into to hedge euro currency exposures of the net investment in certain foreign affiliates and was recognized in long-term debt. The effective portion of foreign exchange gain or loss on the remeasurement of debt denominated in euros was included in the foreign currency translation component of AOCL with the related offset in Long-term debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the three months ended March 31, 2023, the amortization of gains related to the portion of our net investment hedges that was excluded from the assessment of effectiveness was not material.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Hedges</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed to floating interest rate swap contracts are designated as fair value hedges and used as an interest rate risk management strategy to create an appropriate balance of fixed and floating rate debt. The contracts and underlying debt for the hedged benchmark risk are recorded at fair value. The effective interest rate for the contracts is one-month LIBOR (<ix:nonFraction unitRef="number" contextRef="icf13f856670744549308e754a728bc4b_D20230101-20230331" decimals="4" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODY1MzIw_9b90578e-c46b-4179-8db5-f3cdbe0a8f45">4.86</ix:nonFraction>% as of March&#160;31, 2023) plus an interest rate spread of <ix:nonFraction unitRef="number" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="3" name="us-gaap:DerivativeBasisSpreadOnVariableRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfNTQ5NzU1ODY1MzY4_3f25ee6c-3dbf-445d-9d1c-2d8fe570e041">4.6</ix:nonFraction>%. Gains or losses resulting from changes in fair value of the underlying debt attributable to the hedged benchmark interest rate risk are recorded in interest expense with an associated offset to the carrying value of debt. Since the specific terms and notional amount of the swap are intended to align with the debt being hedged, all changes in fair value of the swap are recorded in interest expense with an associated offset to the derivative asset or liability on the consolidated balance sheet. As a result, there was no net impact in earnings. If the underlying swap is terminated prior to maturity, then the fair value adjustment to the underlying debt is amortized as a reduction to interest expense over the remaining term of the debt.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Derivative cash flows, with the exception of net investment hedges, are principally classified in the operating section of the consolidated statements of cash flows, consistent with the underlying hedged item. Cash flows related to net investment hedges are classified in investing activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA2Njk_93f6918c-3e8e-4857-bcf5-d38a6c8567d8" continuedAt="icd30bf43fad242feb16e3cd0f2355088" escape="true">The following table summarizes the fair value and the notional values of outstanding derivatives:</ix:nonNumeric></span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i0df6c8c74c41402bbcff0fdc51694428"><ix:continuation id="icd30bf43fad242feb16e3cd0f2355088"><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:34.704%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.312%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Asset</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Liability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Notional</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f78af08373f410f81a0ec2062e53827_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xLTEtMS0xOTM5Mzc_e5f0b210-9c18-4b9d-a7ee-0ecdea08f8d8">5,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fea4d1110624ccc8643189b89b7a264_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0zLTEtMS0xOTM5Mzc_b5368683-5d35-4044-a3d4-2a86801aff23">208</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f3d1009dc364c098f6d58018920196a_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi01LTEtMS0xOTM5Mzc_afd53dae-b3a8-47d2-a2e4-77ce0fb920a1">2,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fea4d1110624ccc8643189b89b7a264_I20230331" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi03LTEtMS0xOTM5Mzc_15b2f72f-9a6c-41d6-84dc-a21e89d689bb">81</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib010a27d7530452ba7bcd495694e0d53_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi05LTEtMS0xOTM5Mzc_bc46fa67-b71b-4517-b5f8-87214275301c">5,771</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f5389c38b2f4d118e6e6c3efcb730f5_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xMS0xLTEtMTkzOTM3_761eef04-34af-476e-aced-2ea350a32c13">271</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8230d684b10a4394bebb9852f5a60f05_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xMy0xLTEtMTkzOTM3_ecfd8cbb-df3e-4bf3-9260-87aecdedfc4f">2,281</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5f5389c38b2f4d118e6e6c3efcb730f5_I20221231" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xNS0xLTEtMTkzOTM3_43477b80-b6f3-44c0-80e6-733ea3b43c30">80</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f02eb7d5604819aa8d7f7f56a7cb5c_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xLTEtMS0yMTU4Nzk_1e3b6a90-f466-4fe6-b55e-21537d1b7406">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id817fc04753e4b50b4934057f0e357b1_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0zLTEtMS0yMTU4Nzk_552b0947-d6d3-404b-af04-cf78f17f390d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34faa5c1dd2d412abced6fba5cb5b34e_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi01LTEtMS0yMTU4Nzk_2d1462c1-5f86-4a64-b4b6-3ab6a82a08a5">1,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id817fc04753e4b50b4934057f0e357b1_I20230331" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi03LTEtMS0yMTU4Nzk_5bb98138-b0df-4528-836f-e94a83bc7c53">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4236d1cdf3948fd8751a4d9c4cc7e5f_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi05LTEtMS0yMTU4Nzk_a60f7c6a-5d24-47a4-8d1a-1a27fce3fc17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3029667aba2c41ac801aca48ee182c97_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xMS0xLTEtMjE1ODc5_08b397fe-9630-498c-bf7f-d3f99826fbd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bb614bb6595439091cb705f7444f43b_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xMy0xLTEtMjE1ODc5_911f62d9-d4cd-4346-b908-2573fc2d15c3">584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3029667aba2c41ac801aca48ee182c97_I20221231" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNi0xNS0xLTEtMjE1ODc5_2cfed332-d5b5-479f-8755-594d3be9dc32">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as net investment hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c6b2f57ba9146748914be4aa6f07a1e_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xLTEtMS0yMTgwMjA_a1391b3d-2c9e-46f4-8b1c-d9812678ae8b">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd1e462128ec4e4ab153cea1e6830820_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0zLTEtMS0yMTgwMjY_7991bd24-e180-44dc-a633-a3daeb9b6ff3">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4c44eb56471340c0b0549845ec48e95f_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy01LTEtMS0yMTgwMjg_6be2e05c-f7bb-42f8-a2ef-c6c208cc2537">1,182</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibd1e462128ec4e4ab153cea1e6830820_I20230331" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy03LTEtMS0yMTgwMzA_d230dfca-54fa-4039-8156-a330d15559d8">79</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1425120cc214e32ba4675730b4b6cc8_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy05LTEtMS0yMTY4MTA_11f89c89-95ed-4341-bc4f-9c61c8d0d9d2">72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f36cd1dbe6a46b1bf7919a5697fb286_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xMS0xLTEtMjE2ODEw_53189d5e-5a27-48d4-bc84-969d93a2d06a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29e1112374584215b2d716c9948e2cbb_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xMy0xLTEtMjE2ODEw_d9d0a7b7-6bd8-4020-b120-6a60d6fddb38">1,157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0f36cd1dbe6a46b1bf7919a5697fb286_I20221231" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xNS0xLTEtMjE2ODEw_f615ef82-8beb-458f-a02a-499b1ea29b53">78</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Designated as fair value hedges</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5f0db91831245a98d378841a723e8a7_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xLTEtMS0yMTU3NDc_a44ddf81-59a9-4215-bf25-072fcb8f9ac2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb81acd0695b4f10a417aade9fb25bb8_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0zLTEtMS0yMTU3NDc_79a32970-78bb-45f8-899b-709b93f2e006">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42d797e1487542f49ef9a8d6421d410d_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy01LTEtMS0yMTU3NDc_42fc173d-f963-45c1-9659-f340be6f2e41">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ieb81acd0695b4f10a417aade9fb25bb8_I20230331" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy03LTEtMS0yMTU3NDc_bdf65515-1113-4146-91c4-c91153cc39c3">14</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic568e0cfa6234853938bade8f38decad_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy05LTEtMS0yMTU3NDc_d6ff4b22-4850-4f31-a76e-67ed1cb58b77">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b5edd69ff1345a1a484c9fa4c96354b_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xMS0xLTEtMjE1NzQ3_b579f8af-76e5-46bd-bf7b-4f5d0334dc8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5802b471774f467b8b4ed57b33660afa_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xMy0xLTEtMjE1NzQ3_3b6c3af2-44a2-46af-9c21-9fc9b9297389">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1b5edd69ff1345a1a484c9fa4c96354b_I20221231" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfNy0xNS0xLTEtMjE1NzQ3_ee3f10b3-e19f-4b41-b89d-bd461555067b">18</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Not designated as hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ec0fba4252a4678af79e56fbc82990b_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS0xLTEtMS0xOTM5Mzc_2924d88a-dcbd-4094-b6e3-6e68aa19bfc0">2,101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c615915438143509820de8d42395deb_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS0zLTEtMS0xOTM5Mzc_20cda705-546d-4e9e-98da-e6cfdde1a99d">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ea56b8ce1eb4d8688de33c49740c7a8_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS01LTEtMS0xOTM5Mzc_39581b66-d494-4476-9276-13c7cd611d00">1,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3c615915438143509820de8d42395deb_I20230331" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS03LTEtMS0xOTM5Mzc_ada14523-08d9-48ea-8ba8-b476f332b8fd">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9c8cfb2e34204828954f511d64e793e4_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS05LTEtMS0xOTM5Mzc_cb6dfdd9-131c-4d76-8d89-a979deb1f083">1,564</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia03b42d55e3746beb0b9a7a7be2a3315_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS0xMS0xLTEtMTkzOTM3_384c5b0c-abce-43e0-aa0f-b4a917cddfc7">33</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4be2043674aa491d9adeb9750ff992df_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS0xMy0xLTEtMTkzOTM3_c4a3e5ee-b23c-4996-9e51-1ae1be402755">1,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia03b42d55e3746beb0b9a7a7be2a3315_I20221231" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfOS0xNS0xLTEtMTkzOTM3_8d3e47ae-e781-4354-bb07-8fc8f197014f">19</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total return swap contracts </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4e61e9185bb4a9eb351c39c8c716d28_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtMS0xLTEtMTkzOTM3_b22977fb-6e83-4f6f-9744-06544e9bc7dc">360</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae6cb2b6dd42b08133b40ee51acc39_I20230331" decimals="-6" name="us-gaap:DerivativeAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtMy0xLTEtMTkzOTM3_ac700fda-f457-41cc-aa24-1b2c01081304">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9d38948aff744438294caa148a86cdd_I20230331" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtNS0xLTEtMTkzOTM3_dcc868e5-045a-48f7-820d-16591841cc19">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41ae6cb2b6dd42b08133b40ee51acc39_I20230331" decimals="-6" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtNy0xLTEtMTkzOTM3_99a76022-dbaf-464f-9b43-c5b8f34e9b8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f582f93ce4e422da958adfc85f8013b_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtOS0xLTEtMTkzOTM3_a780ef9f-a7fe-4dfe-9fed-ba29120e7297">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i218b6bfa5bcf40ed94120181ea6072f6_I20221231" decimals="-6" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtMTEtMS0xLTE5MzkzNw_035bad6a-b16a-4495-bafc-7bce915daa97">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i155f9dbf83674147910134de5a163ed4_I20221231" decimals="-6" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtMTMtMS0xLTE5MzkzNw_345dfd85-e6af-4161-9971-926116a2ca57">322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i218b6bfa5bcf40ed94120181ea6072f6_I20221231" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjI3M2ZmNWEzOTI2OTRkOTZhMmMxYjllOGQ2ZGU1MzZjL3RhYmxlcmFuZ2U6MjczZmY1YTM5MjY5NGQ5NmEyYzFiOWU4ZDZkZTUzNmNfMTEtMTUtMS0xLTE5MzkzNw_28a56e57-f892-4e85-b928-4db7123ad406">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Included in Other current assets and Other non-current assets.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Included in Other current liabilities and Other non-current liabilities.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Total return swap contracts hedge changes in fair value of certain deferred compensation liabilities.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RleHRyZWdpb246MGZhZjdmYmFkOGZkNDExNmI4NzM4NjRkOTc5OTgxOGFfMTA3MjI_2d17a847-9957-4207-bb1e-64c3b2b6afc2" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedges:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost of products sold</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other (income)/expense, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency exchange contracts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b8a2e45ab5549aca7483a4ba3d74c5d_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi0xLTEtMS0yMTU4OTE_762b1132-b858-444b-88de-316b2c9b9b5c">120</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8774af6abd064ed2b9c32e4f303cb6ad_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi0zLTEtMS0yMTU4OTE_b5bafa8c-fa93-495c-9a08-64aab6ba784d">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0029eb5bdf0846248e8e29997e46a635_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi01LTEtMS0yMTU4OTE_f99c35dd-9b79-49dc-b669-05799a1ee2e0">82</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i89c73a3314ab4790b9e60806224792a6_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi03LTEtMS0yMTU4OTE_84809a07-6c28-47ab-8551-2a2687c71aef">57</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94eff2d4f4604ee199bd197d534ba249_D20230101-20230331" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi0xLTEtMS0yMTU4NjI_ed5b5ee4-023a-43f1-bf78-7ac196fc2678">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a3ce303deb04bbea208aaaf9f054027_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi0zLTEtMS0yMTU4NjI_450a3478-dfb4-4e55-8a9b-9556e4af22cd">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied4b9a9b25904161948918d8f323eaee_D20220101-20220331" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi01LTEtMS0yMTU4NjI_b131b895-3562-4b47-83c3-ddfcc8219d7e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib96567e0e08a4221b8584758e37a4903_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi03LTEtMS0yMTU4NjI_bd9a119a-be8b-4fd8-9fdd-6b760d893734">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iacb22a8aff1d4787af26ce4bf67bd4e0_D20230101-20230331" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi0xLTEtMS0xOTM5Mzc_5bd8428e-edc2-4265-ae46-46f2e5661985">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7143836d84524e0eb66c9ee86bec7021_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi0zLTEtMS0xOTM5Mzc_f3056fb5-2444-4765-a263-6864bef143c9">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaeb32b12d8649ee88455540c089d95d_D20220101-20220331" decimals="-6" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi01LTEtMS0xOTM5Mzc_f52a2393-0ecf-4af7-bbb0-78c08941efa8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52dcaa608a2c4d148e4e9058ddb3d78c_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjkyY2NiYzhkMzg0YjRmODA5N2I0MTYwZTZiNjdiNzQyL3RhYmxlcmFuZ2U6OTJjY2JjOGQzODRiNGY4MDk3YjQxNjBlNmI2N2I3NDJfMi03LTEtMS0xOTM5Mzc_7bea3298-e76a-4558-8989-44b4286ccc64">11</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:5pt;text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the effect of derivative and non-derivative instruments designated as hedges in Other comprehensive income:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange contracts gain/(loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other comprehensive income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i53ddf55104c94d75828ca22f5cd5e168_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfNC0xLTEtMS0xOTM5Mzc_888a4fe6-6456-4bfc-9e7a-55862efde31a">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66daa1b3774a4b1fa720d6f344a56f88_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfNC0zLTEtMS0xOTM5Mzc_4186c7d0-d2cc-461c-b571-a7126cf46521">120</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Cost of products sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b8a2e45ab5549aca7483a4ba3d74c5d_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfNS0xLTEtMS0xOTM5Mzc_8f834b3f-9a7f-4e02-b986-36755c92ebb3">120</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0029eb5bdf0846248e8e29997e46a635_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfNS0zLTEtMS0xOTM5Mzc_df67d63e-4090-48c1-9ce2-44ac166fbd60">82</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts gain/(loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14e072e009b24d0fbc03953d84900001_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfNy0xLTEtMS0xOTM5Mzc_61e40858-40b2-4721-b3a3-c5c9ab2a60b5">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec0938f6ae44036b63ab13982399e4c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfNy0zLTEtMS0xOTM5Mzc_1082e0db-b4b4-4920-b3d2-77aebc667323">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a3ce303deb04bbea208aaaf9f054027_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfOC0xLTEtMS0xOTM5Mzc_0cfafe7d-b1e3-4c61-adb2-b965e86c6625">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib96567e0e08a4221b8584758e37a4903_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfOC0zLTEtMS0xOTM5Mzc_7b9e2a26-2a62-4c1a-8d54-22eace023805">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward starting interest rate swap contract loss:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i142b933b2c0a4ebf99bd86392c2fc463_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfMTAtMS0xLTEtMTkzOTM3_8e6a33ef-8543-41c2-b444-f8ea74dc1301">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i30dcc2a7227940dc98817acc647ec278_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfMTAtMy0xLTEtMTkzOTM3_0c2ba29f-ce46-430c-a6bc-1df2265c55b3">3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives designated as net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cross-currency swap contracts gain/(loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14e072e009b24d0fbc03953d84900001_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfMTYtMS0xLTEtMjAyMTYy_413c9461-e51e-4676-b6d6-89b549042e5a">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ec0938f6ae44036b63ab13982399e4c_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfMTYtMy0xLTEtMjAyMTU1_ab39b861-7ee0-4580-b5ca-4dfd22ecd0de">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Non-derivatives designated as net investment hedges</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non U.S. dollar borrowings gain/(loss):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2fd0cb5b96ca42cfb7053fa86c81220b_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfMjAtMS0xLTEtMjAyMTY5_2a4cae0f-836c-44d9-b612-0a5cab984673">10</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae5cf489d3cd46718423344f12b2cb5e_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82NC9mcmFnOjBmYWY3ZmJhZDhmZDQxMTZiODczODY0ZDk3OTk4MThhL3RhYmxlOjk0MDlkYWI0Y2VlMzQxYzU4ZTBlYzA1MThlOGIxYmM5L3RhYmxlcmFuZ2U6OTQwOWRhYjRjZWUzNDFjNThlMGVjMDUxOGU4YjFiYzlfMjAtMy0xLTEtMjAyMTY5_43fca35b-9d9e-404f-ac1a-0b8c4ecbde8f">15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_1545"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl84Nzk2MDkzMDI4MDAw_c20716b2-7e1c-4f8c-a82a-16ad0c0e596b" continuedAt="ie90829cc850e47f4a3f0d317de6fc1bc" escape="true">FINANCING ARRANGEMENTS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ie90829cc850e47f4a3f0d317de6fc1bc"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfShortTermDebtTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl84Nzk2MDkzMDI4MDMy_38f3c522-8422-4de8-ab52-a9f9fbed6bac" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term debt obligations include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S. short-term borrowings</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:ShortTermBankLoansAndNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV8xLTEtMS0xLTE5NzI4Ng_9ff512fb-e6b0-4ff9-8a97-63af97338104">155</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:ShortTermBankLoansAndNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV8xLTMtMS0xLTE5NzI4Ng_70905f9b-01ea-49b3-a841-636f5366965e">176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of Long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV8yLTEtMS0xLTE5NzI4Ng_77ce9fb1-68a0-4746-b772-b5c3548b7de7">2,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV8yLTMtMS0xLTE5NzI4Ng_1a565440-54bf-4348-883a-6c65b923e9dc">3,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV8zLTEtMS0xLTE5NzI4Ng_be34c68b-cba2-4aa1-a5e4-8c412c8dd3b4">343</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherShortTermBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV8zLTMtMS0xLTE5NzI4Ng_8258c604-4eca-40e9-acfa-9a03a3d999d9">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV80LTEtMS0xLTIxMzQ0Mw_573b9bfd-20ad-425d-948d-a91f5ad79c64">2,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:ShortTermBorrowings" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MTYyZTYwODBmYTMwNGMxOGE0NWQ0YjVjOGFiMTM4NDUvdGFibGVyYW5nZToxNjJlNjA4MGZhMzA0YzE4YTQ1ZDRiNWM4YWIxMzg0NV80LTMtMS0xLTIxMzQ0NQ_17c70c39-67df-4327-b155-385722b681a2">4,264</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl84Nzk2MDkzMDI4MDMz_c5e446a8-54f9-4e4b-870f-6a52c439b7e2" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt and the current portion of Long-term debt include:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal value</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xLTEtMS0xLTE5NzI4Ng_ecafce33-3fe3-4acd-8d60-565f58d1a66b">36,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xLTMtMS0xLTE5NzI4Ng_1b9c71bd-4e37-4436-82c1-97a3c629d69b">38,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to principal value:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value of interest rate swap contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb244ebbca7645918a749ff83a2caf20_I20230331" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml80LTEtMS0xLTE5NzI4Ng_2ae2fe25-9d29-4a52-9878-d82d99b08da2">14</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id87dc345b8de442ea6f8dbbd65882071_I20221231" decimals="-6" sign="-" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml80LTMtMS0xLTE5NzI4Ng_4420da97-d0d8-4c54-9d72-0f6c1c92a4d1">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized basis adjustment from swap terminations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="bmy:UnamortizedBasisAdjustmentFromSwapTerminations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml81LTEtMS0xLTE5NzI4Ng_168c1463-3859-4859-957d-02cf2ca46e63">92</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="bmy:UnamortizedBasisAdjustmentFromSwapTerminations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml81LTMtMS0xLTE5NzI4Ng_955f1ebc-3c8d-4454-a289-7032560ad180">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized bond discounts and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml82LTEtMS0xLTE5NzI4Ng_7199d3f6-2729-4984-b40f-262f90395285">278</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml82LTMtMS0xLTE5NzI4Ng_ec2156f9-d178-4031-8fcd-9d152682fd9d">284</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unamortized purchase price adjustments of Celgene debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml83LTEtMS0xLTE5NzI4Ng_c4645046-fc13-4a21-95b5-4371ed205506">910</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:DebtInstrumentUnamortizedPremium" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml83LTMtMS0xLTE5NzI4Ng_c961bcf0-ad96-41ed-a04d-796f128629ec">924</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml84LTEtMS0xLTIxMzQzNQ_6f96b806-ab3e-4df7-9d81-4760640a2bdd">37,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml84LTMtMS0xLTIxMzQzNw_93be3a5a-c32d-421b-8a70-6fee90a07b1c">38,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of Long-term debt</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xMC0xLTEtMS0xOTcyODY_22f19f66-7980-48c9-96a2-77eb6d9b62f4">2,254</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:LongTermDebtCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xMC0zLTEtMS0xOTcyODY_96f24540-5a46-4099-9ed0-d522646c6257">3,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xMS0xLTEtMS0xOTcyODY_77c5a862-01d2-41b3-adad-2972ee98f1b4">35,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xMS0zLTEtMS0xOTcyODY_1390673b-c49c-4c36-9cd4-7e16b43099b7">35,056</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xMi0xLTEtMS0yMTM0Mzk_6c5b3591-87c4-4fb6-8b65-36674795ac2d">37,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGFibGU6MjE1OTlmM2ZkMjg4NDJjYWFmZDJmOTRhZWU3ZWZmNDIvdGFibGVyYW5nZToyMTU5OWYzZmQyODg0MmNhYWZkMmY5NGFlZTdlZmY0Ml8xMi0zLTEtMS0yMTM0NDE_550a2f4d-d1ab-4f2a-a4c1-177680b8a2b0">38,953</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of Long-term debt was $<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjI3OTg5_009455f6-4b86-41e2-b6b6-e718135908d4">34.5</ix:nonFraction> billion as of March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-8" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjI4MDA3_a113b7d6-c2bc-45b6-98bd-b6b3eb19c808">34.9</ix:nonFraction> billion as of December&#160;31, 2022 valued using Level&#160;2 inputs, which are based upon the quoted market prices for the same or similar debt instruments. The fair value of short-term borrowings approximates the carrying value due to the short maturities of the debt instruments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-8" name="us-gaap-supplement:DebtInstrumentRepaidPrincipal" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMzOTIy_90de8d68-9baa-49fb-a67c-1f96bc2e1dbc">1.6</ix:nonFraction>&#160;billion of debt matured and was repaid including $<ix:nonFraction unitRef="usd" contextRef="i530680c85a9a4881b88dc94c1c16baf6_D20230101-20230331" decimals="-6" name="us-gaap-supplement:DebtInstrumentRepaidPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMzOTA4_e73ecfae-e5ce-484b-aaa0-e791b1c7e08b">750</ix:nonFraction>&#160;million <ix:nonFraction unitRef="number" contextRef="ieaa68541a773415fae251b23e344c1b9_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMzOTM2_b18d30f8-3919-4c93-971b-54f94b26f880">2.750</ix:nonFraction>% Notes and $<ix:nonFraction unitRef="usd" contextRef="i09440f9d290b4a47b0cf4ce858f35aeb_D20230101-20230331" decimals="-6" name="us-gaap-supplement:DebtInstrumentRepaidPrincipal" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMzOTQ0_68248566-b566-45f8-9a86-c13c04b26d16">890</ix:nonFraction>&#160;million <ix:nonFraction unitRef="number" contextRef="i525174948c6543dc8a99d3c14aab9da3_I20230331" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMzOTU4_04e979e1-3fb3-4218-b1bb-2cf018c543bd">3.250</ix:nonFraction>% Notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, BMS issued an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="i346eafc8325f4939af4f85fbfc5a4e5b_I20220331" decimals="-8" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMyMzU3_65f6cc24-776b-4e77-89b9-f74ad82d5a56">6.0</ix:nonFraction>&#160;billion of debt, with maturity dates ranging from 2032 to 2062, with net proceeds of $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-8" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMyMzkw_80bd0c52-b982-4d04-8359-cbe0fa99e078">5.9</ix:nonFraction>&#160;billion. The notes rank equally in right of payment with all of BMS's existing and future senior unsecured indebtedness and are redeemable at any time, in whole, or in part, at varying specified redemption prices plus accrued and unpaid interest. In addition, BMS purchased an aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-8" name="us-gaap:ExtinguishmentOfDebtAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjI4MzU4_386eb17a-71aa-4e77-9b1b-f30c0de60fd6">5.2</ix:nonFraction>&#160;billion of certain of its debt securities for $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-8" name="us-gaap:PaymentsOfDebtExtinguishmentCosts" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjI4NDAw_a9050302-9e98-470b-8674-7a2ce71362bc">5.8</ix:nonFraction>&#160;billion of cash in tender offers. In connection with this transaction, a $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjI4NTAw_fdacc9a5-f6cc-4879-ac2b-d31b4f801fe5">275</ix:nonFraction>&#160;million net loss on debt redemption was recognized based on the carrying value of the debt and included in Other (income)/expense, net.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest payments were $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjI5NzYw_ac863602-d8e7-45be-a362-09dd7100f7e2">324</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjI5NzY4_7a05afa5-66d6-4e92-92b2-26da1543722a">377</ix:nonFraction>&#160;million for the three months ended March 31, 2023 and 2022, respectively, net of amounts related to interest rate swap contracts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Facilities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 31, 2023, BMS had a <ix:nonNumeric contextRef="ic1bd9d27dbe94da7a5c4c2fea8a920da_I20230331" name="us-gaap:LongTermDebtTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl84Nzk2MDkzMDI4MDEz_2c9295f2-a98b-4275-bbc3-dc31fa1ea105">five-year</ix:nonNumeric> $<ix:nonFraction unitRef="usd" contextRef="ic1bd9d27dbe94da7a5c4c2fea8a920da_I20230331" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl8xMDk5NTExNjMwMjQ4_f46da567-6a3e-4c3a-89a1-f0bd68ff7718">5.0</ix:nonFraction>&#160;billion revolving credit facility expiring in January 2028, which is extendable annually by <ix:nonNumeric contextRef="ic1bd9d27dbe94da7a5c4c2fea8a920da_I20230331" name="bmy:LongTermDebtRenewalPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl84Nzk2MDkzMDI4MDIy_74552306-2018-45a1-951c-92de2624bbcf">one year</ix:nonNumeric> with the consent of the lenders. This facility provides for customary terms and conditions with no financial covenants and may be used to provide backup liquidity for our commercial paper borrowings. <ix:nonFraction unitRef="usd" contextRef="idd5a938b770d4b608475507fe2c5a3b1_I20221231" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl81NDk3NTU4MTk0OTM_512f90bb-f703-4eb2-9cbc-1b7fb34a6fe5"><ix:nonFraction unitRef="usd" contextRef="i937b0f049dac419089d03f3d635323d2_I20230331" decimals="INF" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xNTQ1L2ZyYWc6MzJhY2Y4NGMwYzhiNGJhZDliOGE1NDMzYTZhM2YxZGYvdGV4dHJlZ2lvbjozMmFjZjg0YzBjOGI0YmFkOWI4YTU0MzNhNmEzZjFkZl81NDk3NTU4MTk0OTM_d52c9662-2d36-4226-bfee-a5b4847c7da2">No</ix:nonFraction></ix:nonFraction> borrowings were outstanding under the revolving credit facility as of March&#160;31, 2023 and December&#160;31, 2022.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_67"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RleHRyZWdpb246YzFiMzY4MjUyZmIwNDlhNWE1NjEyMTI4ODZkMWJkNmNfMjg1_991da68a-9924-4c08-b3ea-45ea93f09e78" continuedAt="ifb328701e69743b9969d94d6df6292f9" escape="true">RECEIVABLES</ix:nonNumeric></span></div><ix:continuation id="ifb328701e69743b9969d94d6df6292f9"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RleHRyZWdpb246YzFiMzY4MjUyZmIwNDlhNWE1NjEyMTI4ODZkMWJkNmNfMjg3_23fc7245-6282-49c3-80a4-1c5843d3af4f" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade receivables</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfMS0xLTEtMS0xOTM5Mzc_bb24deac-444b-4bde-9e54-12168fa8aa46">8,486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfMS0zLTEtMS0xOTM5Mzc_cc48251f-4dd4-4fa8-bbf9-807a1e9d89b5">8,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="bmy:CashDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfMi0xLTEtMS0xOTM5Mzc_05b1cd25-587f-43aa-95b5-c3bdbfe38112">609</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="bmy:CashDiscounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfMi0zLTEtMS0xOTM5Mzc_b568625b-af55-4fe5-8cf4-772152045037">675</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: allowance for expected credit loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfMy0xLTEtMS0xOTM5Mzc_239e6297-4012-41f0-badc-d73afbef142a">23</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfMy0zLTEtMS0xOTM5Mzc_5c720070-1447-4ae6-a363-a9d0514559f0">22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net trade receivables</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfNC0xLTEtMS0xOTM5Mzc_0512c351-1d8f-4c2a-957f-a49942e0cacd">7,854</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfNC0zLTEtMS0xOTM5Mzc_377cd852-8310-4ba6-be3f-c7f326137ae3">8,151</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alliance, royalties, VAT and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfNS0xLTEtMS0xOTM5Mzc_5352bc2d-4c63-4c60-9bbe-e48b1021b22c">2,200</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherReceivables" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfNS0zLTEtMS0xOTM5Mzc_a2b4b758-de79-4d73-996f-2e3240ddd7d2">1,735</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Receivables</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfNi0xLTEtMS0xOTM5Mzc_4ef9f5c7-6161-4226-80be-df5839dc1919">10,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:ReceivablesNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RhYmxlOjJlMDIxOTcyZjJlMjQyNDVhNjM3MTdjYjA1MzY4ODAwL3RhYmxlcmFuZ2U6MmUwMjE5NzJmMmUyNDI0NWE2MzcxN2NiMDUzNjg4MDBfNi0zLTEtMS0xOTM5Mzc_b8e2b6e2-34b3-4e28-935c-2120afb3ec24">9,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-U.S. receivables sold on a nonrecourse basis were $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="bmy:ReceivablesSoldOnNonrecourseBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RleHRyZWdpb246YzFiMzY4MjUyZmIwNDlhNWE1NjEyMTI4ODZkMWJkNmNfODM_6abf10fc-bce2-4fd9-a3fe-e79c80bb9309">239</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="bmy:ReceivablesSoldOnNonrecourseBasis" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RleHRyZWdpb246YzFiMzY4MjUyZmIwNDlhNWE1NjEyMTI4ODZkMWJkNmNfOTA_bc9ec4cb-56df-4c53-8f3c-9adf0ba29b21">423</ix:nonFraction> million for the three months ended March 31, 2023 and 2022, respectively. Receivables from the <ix:nonFraction unitRef="customer" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="INF" name="bmy:NumberOfLargestPharmaceuticalWholesalers" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RleHRyZWdpb246YzFiMzY4MjUyZmIwNDlhNWE1NjEyMTI4ODZkMWJkNmNfMTQ3_4d9c4e61-8d83-4dfb-8783-b4ae8aaefa35">three</ix:nonFraction> largest customers in the U.S. represented <ix:nonFraction unitRef="number" contextRef="i6ed144f6904d4064a626d5562e3a0cf0_I20230331" decimals="2" name="bmy:PercentageOfAggregateTotalTradeReceivablesDue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RleHRyZWdpb246YzFiMzY4MjUyZmIwNDlhNWE1NjEyMTI4ODZkMWJkNmNfMjA2_c2b29729-f2ff-4514-9fb7-70896c7394d5">69</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i2324127f89494362aa7de6e45d6fe141_I20221231" decimals="2" name="bmy:PercentageOfAggregateTotalTradeReceivablesDue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV82Ny9mcmFnOmMxYjM2ODI1MmZiMDQ5YTVhNTYxMjEyODg2ZDFiZDZjL3RleHRyZWdpb246YzFiMzY4MjUyZmIwNDlhNWE1NjEyMTI4ODZkMWJkNmNfMjEz_1919ad96-a837-410a-aad5-c4315e37c501">66</ix:nonFraction>% of total trade receivables as of March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_70"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RleHRyZWdpb246NDg3NTc2ZGRjZWUzNGYwZjhmODliNjRhMGNlNjBhMDlfMjI3_2f541914-6a6f-44d9-9d56-e4818180c6ee" continuedAt="ife30e4b54fe04f10bbb07f9034e3500d" escape="true">INVENTORIES</ix:nonNumeric></span></div><ix:continuation id="ife30e4b54fe04f10bbb07f9034e3500d"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RleHRyZWdpb246NDg3NTc2ZGRjZWUzNGYwZjhmODliNjRhMGNlNjBhMDlfMjMx_9ae0a65e-9b5f-4405-a236-e4a71b8bd6a4" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfMS0xLTEtMS0xOTM5Mzc_c5efd024-c8f0-49c4-b92d-95cdd5e6869d">594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfMS0zLTEtMS0xOTM5Mzc_dad282a3-0bbd-4de6-a282-fa55739d6866">509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfMi0xLTEtMS0xOTM5Mzc_5bd0e03d-1635-4bf9-8e27-a76648990ce1">1,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:InventoryWorkInProcessNetOfReserves" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfMi0zLTEtMS0xOTM5Mzc_c92c8677-405f-4727-9453-c2e4a3953654">1,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw and packaging materials</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfMy0xLTEtMS0xOTM5Mzc_f389f7a2-ce5b-4e51-823b-6a64bbcbaa4f">594</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfMy0zLTEtMS0xOTM5Mzc_a0e00d60-a77b-4851-8865-9654c721c098">464</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total inventories</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="bmy:Totalinventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfNC0xLTEtMS0xOTM5Mzc_75f02ea4-36f7-4e14-8590-f4f113f5842d">3,128</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="bmy:Totalinventories" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfNC0zLTEtMS0xOTM5Mzc_8eba4083-c75c-4feb-b341-30ccdb989fdc">2,823</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfNi0xLTEtMS0xOTM5Mzc_ba69ad3f-861e-44bc-a81e-b381778ad895">2,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:InventoryNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfNi0zLTEtMS0xOTM5Mzc_0700906e-5a49-44e2-aa58-d9227cfac2dc">2,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfNy0xLTEtMS0xOTM5Mzc_ec87456d-afd7-42bd-92d1-0672d00cbfeb">523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RhYmxlOjIzZGQ0YjNhNTAyYzQxY2NiZTZlMmRhMzc1ZWYwMDVlL3RhYmxlcmFuZ2U6MjNkZDRiM2E1MDJjNDFjY2JlNmUyZGEzNzVlZjAwNWVfNy0zLTEtMS0xOTM5Mzc_3cc608a6-0be6-41e9-88c7-cefc15d598c2">484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value adjustments related to the Celgene acquisition were $<ix:nonFraction unitRef="usd" contextRef="i24309b9bca4c40368e5159601708371e_I20230331" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RleHRyZWdpb246NDg3NTc2ZGRjZWUzNGYwZjhmODliNjRhMGNlNjBhMDlfOTY_4bb6899e-a3c4-4597-b936-cf89a2cbbcc0">32</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i356526281a974299bee8ad28a8382769_I20221231" decimals="-6" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83MC9mcmFnOjQ4NzU3NmRkY2VlMzRmMGY4Zjg5YjY0YTBjZTYwYTA5L3RleHRyZWdpb246NDg3NTc2ZGRjZWUzNGYwZjhmODliNjRhMGNlNjBhMDlfMTEy_09c507d3-34ea-4fda-ae67-f0e86833185d">84</ix:nonFraction> million as of March&#160;31, 2023 and December&#160;31, 2022, respectively.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_73"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 13. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RleHRyZWdpb246M2EwYTc3OWQ2N2FhNDUxYmFiYTVlODE0NTNjNDY4YjZfMTU2_55b40378-977b-405c-b7c3-5cca00bf64e6" continuedAt="i6eedd85ede814fea97889a2c34c7584e" escape="true">PROPERTY, PLANT AND EQUIPMENT</ix:nonNumeric></span></div><ix:continuation id="i6eedd85ede814fea97889a2c34c7584e"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RleHRyZWdpb246M2EwYTc3OWQ2N2FhNDUxYmFiYTVlODE0NTNjNDY4YjZfMTQ2_3e3d320b-85f5-4fc7-974b-5189e38a3d8a" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfMS0xLTEtMS0xOTM5Mzc_fc8b4de0-40fa-44ea-acf8-2956457f57ae">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfMS0zLTEtMS0xOTM5Mzc_dfce43dc-a85a-4755-9459-d005f87dfbe6">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Buildings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfMi0xLTEtMS0xOTM5Mzc_41fdef9f-b203-4e47-a56e-38293e9a011e">5,990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:BuildingsAndImprovementsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfMi0zLTEtMS0xOTM5Mzc_bb9b8065-1615-441f-b579-f2e42a825093">5,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery, equipment and fixtures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfMy0xLTEtMS0xOTM5Mzc_41fb85c3-ea3c-4da7-9e27-03411ba66179">3,295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:MachineryAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfMy0zLTEtMS0xOTM5Mzc_1fddb497-9767-407b-89a4-3ee9fb0990a3">3,284</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNC0xLTEtMS0xOTM5Mzc_899380cd-ab33-4103-a4f3-df137c0dfbc0">1,074</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:ConstructionInProgressGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNC0zLTEtMS0xOTM5Mzc_a6b70996-f341-4bd1-be35-b4616e8cb42c">1,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNS0xLTEtMS0xOTM5Mzc_1239d928-6d25-409e-ae46-2ac3701b2c6b">10,521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNS0zLTEtMS0xOTM5Mzc_6d407b22-85ac-45cf-b27a-9aba70227c7f">10,419</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNi0xLTEtMS0xOTM5Mzc_90f96a7e-cfb2-498d-be06-d82ab688bac4">4,242</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNi0zLTEtMS0xOTM5Mzc_7b627ae7-3df2-4e29-bb5f-353750bc67d7">4,164</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNy0xLTEtMS0xOTM5Mzc_97b098d6-9321-4721-aba5-a57fda052909">6,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RhYmxlOmZkNTgyNjdmNzA0MTQ5NjRiMDY4NWU1OWRmYjI0YzkyL3RhYmxlcmFuZ2U6ZmQ1ODI2N2Y3MDQxNDk2NGIwNjg1ZTU5ZGZiMjRjOTJfNy0zLTEtMS0xOTM5Mzc_9a0ccc4c-48c8-46f4-96da-0e0a3e6e690c">6,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RleHRyZWdpb246M2EwYTc3OWQ2N2FhNDUxYmFiYTVlODE0NTNjNDY4YjZfNzM_f8d3c2e8-9135-42e2-b74f-d15f03db2113">146</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83My9mcmFnOjNhMGE3NzlkNjdhYTQ1MWJhYmE1ZTgxNDUzYzQ2OGI2L3RleHRyZWdpb246M2EwYTc3OWQ2N2FhNDUxYmFiYTVlODE0NTNjNDY4YjZfMTA5OTUxMTYyNzk1Nw_06078aff-0cea-48c2-91f8-1c6ee9f8b484">145</ix:nonFraction> million for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_79"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 14. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RleHRyZWdpb246MmYzMmQwZDc1M2VmNDFhMThmNzkyM2QyZGYwMmY2NTRfMjkxNg_860aeca3-d2fa-4933-bf5a-a256fa7577a6" continuedAt="i001024b871e6488fadba2b309f44b222" escape="true">GOODWILL AND OTHER INTANGIBLE ASSETS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i001024b871e6488fadba2b309f44b222"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RleHRyZWdpb246MmYzMmQwZDc1M2VmNDFhMThmNzkyM2QyZGYwMmY2NTRfMjkxMw_de2cf382-7e84-4bf7-8e70-3fa8fed08a99" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The changes in the carrying amounts in Goodwill were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:87.217%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.583%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjY0NDRmMWZmYTk2NjQzNDQ5MjI2YmY2YTBkODdhODIwL3RhYmxlcmFuZ2U6NjQ0NGYxZmZhOTY2NDM0NDkyMjZiZjZhMGQ4N2E4MjBfMS0zLTEtMS0xOTM5Mzc_4f4482a2-f21a-4b16-98ea-68155a508c9a">21,149</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Currency translation and other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjY0NDRmMWZmYTk2NjQzNDQ5MjI2YmY2YTBkODdhODIwL3RhYmxlcmFuZ2U6NjQ0NGYxZmZhOTY2NDM0NDkyMjZiZjZhMGQ4N2E4MjBfMy0xLTEtMS0yMTM0NjM_b8bbfe65-3053-4d62-b68f-dc8fd08c0e9e">13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjY0NDRmMWZmYTk2NjQzNDQ5MjI2YmY2YTBkODdhODIwL3RhYmxlcmFuZ2U6NjQ0NGYxZmZhOTY2NDM0NDkyMjZiZjZhMGQ4N2E4MjBfNC0xLTEtMS0yMTM0NjM_fe6d69d2-c167-4502-87f1-a4247636ad41">21,162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Intangible Assets</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RleHRyZWdpb246MmYzMmQwZDc1M2VmNDFhMThmNzkyM2QyZGYwMmY2NTRfODc5NjA5MzAyOTExMg_24324367-e60a-4f97-80cf-5cfaa101c963" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other intangible assets consisted of the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:25.120%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.802%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.802%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.802%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.802%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.802%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.807%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated<br/>Useful&#160;Lives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr style="height:33pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amounts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other intangible assets, net </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross carrying amounts</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated amortization</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Other intangible assets, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Licenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i992fa4fd6b824e2683dbabd9dd0c89e4_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC0xLTEtMS0yMDg5NDMvdGV4dHJlZ2lvbjowMzM1ZTIyNGU1ZGI0OGEzYTVhODhjNGExZWVkYTFjZl8xMDk5NTExNjI3Nzkz_a47280a5-84ef-4957-bc8f-02242fdac0e1">5</ix:nonNumeric>&#160;&#8211;&#160;<ix:nonNumeric contextRef="if2c43168d4d54c40bfe5f8121d462432_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC0xLTEtMS0yMDg5NDMvdGV4dHJlZ2lvbjowMzM1ZTIyNGU1ZGI0OGEzYTVhODhjNGExZWVkYTFjZl8xMDk5NTExNjI3Nzk4_d9a9e199-ab6a-45f5-8523-a7402da428b3">15</ix:nonNumeric>&#160;years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24f0783a75914d6fb1fa14e52521a824_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMi0zLTEtMS0yMTM0NzM_2ec59dc9-ad04-4f86-ad0a-17c6d19f8e66">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24f0783a75914d6fb1fa14e52521a824_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMi01LTEtMS0yMTM0NzU_6feb02d9-e513-4a76-9d0b-1e298a45c0b0">136</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24f0783a75914d6fb1fa14e52521a824_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMi03LTEtMS0yMTM0NzU_e5b6fcdc-ddd6-4988-8e84-f824d8b6f291">264</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8479bd02c1490b86a3ffe3c165e4cc_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMi05LTEtMS0yMTM0NzU_21be85c2-4f68-497f-81ed-1f5a6b789546">400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab8479bd02c1490b86a3ffe3c165e4cc_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMi0xMS0xLTEtMjEzNDc1_7066f657-4223-4997-9e14-2631972e43a9">128</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8479bd02c1490b86a3ffe3c165e4cc_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMi0xMy0xLTEtMjEzNDc1_2b63a034-0325-48f8-94c7-fd26e867fabe">272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired marketed product rights</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i54eeb91dff47450f9197c56c4e45698b_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNS0xLTEtMS0yMDg5NDMvdGV4dHJlZ2lvbjo3ZTUzZjAzOGYxN2Q0MzZlYTE2YTQ1Njk4YzQ5MmRjM18xMDk5NTExNjI3Nzkz_bbfadbe3-be95-4193-8958-b13a92684c6f">3</ix:nonNumeric>&#160;&#8211;&#160;<ix:nonNumeric contextRef="idcc4055c8f054f2abaf55e899844ae79_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNS0xLTEtMS0yMDg5NDMvdGV4dHJlZ2lvbjo3ZTUzZjAzOGYxN2Q0MzZlYTE2YTQ1Njk4YzQ5MmRjM18xMDk5NTExNjI3Nzk4_2e107ad1-cdb7-4c18-bd32-50b178c2d714">15</ix:nonNumeric>&#160;years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc1472b3deb34e4c82ecf9b4d7d07ef9_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMy0zLTEtMS0yMTM0NzM_e64fee5a-7816-445b-82a1-3526c53b8bbd">59,576</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc1472b3deb34e4c82ecf9b4d7d07ef9_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMy01LTEtMS0yMTM0NzU_a6d314f5-a3b3-42f6-8149-5b6c2804f40d">33,297</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc1472b3deb34e4c82ecf9b4d7d07ef9_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMy03LTEtMS0yMTM0NzU_6d0a7187-8b9f-40d3-ab22-69854f295f3e">26,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb63487db81d44389500ff3f59b06f62_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMy05LTEtMS0yMTM0NzU_3ca8c3fb-c066-408b-80c5-027cf939e80f">60,477</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb63487db81d44389500ff3f59b06f62_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMy0xMS0xLTEtMjEzNDc1_6d95a518-d90d-46e1-ad0a-d39ebded7d92">31,949</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb63487db81d44389500ff3f59b06f62_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfMy0xMy0xLTEtMjEzNDc1_9d71edca-b46a-4269-b6d2-fa2c9c93a7c0">28,528</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic79428ebec0f445285e266d25006a85a_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi0xLTEtMS0yMDg5NDMvdGV4dHJlZ2lvbjozNmEzNjgzOTA3NTI0ZDFhYWM4N2YwNzVmODM0OWI0OF8xMDk5NTExNjI3Nzkz_8fc925b3-6541-4ab3-b103-adefff160cc9">3</ix:nonNumeric>&#160;&#8211;&#160;<ix:nonNumeric contextRef="ifbd254642fa845128c263c3a56052a25_D20230101-20230331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi0xLTEtMS0yMDg5NDMvdGV4dHJlZ2lvbjozNmEzNjgzOTA3NTI0ZDFhYWM4N2YwNzVmODM0OWI0OF8xMDk5NTExNjI3Nzk4_807fc8dc-cfd9-4702-b25d-3bacebcc8a62">10</ix:nonNumeric>&#160;years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i854b50008d0b47298b884695f1fe2849_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC0zLTEtMS0yMTM0NzM_429787c0-b3f2-4070-9dca-a0aea23ab979">1,583</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i854b50008d0b47298b884695f1fe2849_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC01LTEtMS0yMTM0NzU_bebecea9-7e99-4629-86a7-fa5c1d78da56">1,097</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i854b50008d0b47298b884695f1fe2849_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC03LTEtMS0yMTM0NzU_ec3aa19b-3b84-48a2-b239-5557009c5ecd">486</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib06140d1825848a3a6fb79f4c1f62258_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC05LTEtMS0yMTM0NzU_4519e1b3-3c16-4a07-85c2-178ab4fcbb73">1,555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib06140d1825848a3a6fb79f4c1f62258_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC0xMS0xLTEtMjEzNDc1_a49312c2-21eb-41e2-a1ee-7cf2670ace43">1,056</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib06140d1825848a3a6fb79f4c1f62258_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNC0xMy0xLTEtMjEzNDc1_67abeb9b-cc52-46da-93c9-1a657a698748">499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee21a224006b4db88a4217127cb842f4_I20230331" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNS0zLTEtMS0yMTM0NzM_cf03197b-074c-4f1f-ac34-4c37fb3002e2">6,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee21a224006b4db88a4217127cb842f4_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNS03LTEtMS0yMTM0NzU_b6f9c4a0-746a-41b6-9d16-0e1ce860e8dc">6,540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2820f2c35291457db2f7410b787ba2ef_I20221231" decimals="-6" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNS05LTEtMS0yMTM0NzU_09ae2b08-cf50-46bb-b9c6-6537d7771430">6,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2820f2c35291457db2f7410b787ba2ef_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNS0xMy0xLTEtMjEzNDc1_ec65d3d7-0545-4deb-8def-4dc89c400e1e">6,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi0zLTEtMS0yMTM0NzM_65e39b0b-f37c-4bae-874c-b4988f24b70b">68,099</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi01LTEtMS0yMTM0NzU_1ab72604-c7cb-42d7-bcf9-65ffc0cdedac">34,530</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi03LTEtMS0yMTM0NzU_58de0f82-dcec-4fce-8448-ae72dd7e12a3">33,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi05LTEtMS0yMTM0NzU_c14256d4-e5df-43a5-bf17-7b62bc3faa7a">68,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi0xMS0xLTEtMjEzNDc1_f96bf273-b776-48f7-b933-856a5503e757">33,133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RhYmxlOjcyMTJiODFmMDhmZjQzZjE5NTBhMjIxYjFhNmIwNmQ4L3RhYmxlcmFuZ2U6NzIxMmI4MWYwOGZmNDNmMTk1MGEyMjFiMWE2YjA2ZDhfNi0xMy0xLTEtMjEzNDc1_3916e5d3-0207-4409-8100-7045301934c2">35,859</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense of Other intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RleHRyZWdpb246MmYzMmQwZDc1M2VmNDFhMThmNzkyM2QyZGYwMmY2NTRfMzY0_ee3a6463-520a-4361-8dcf-803a2bd8e84a">2.3</ix:nonFraction> billion and $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-8" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RleHRyZWdpb246MmYzMmQwZDc1M2VmNDFhMThmNzkyM2QyZGYwMmY2NTRfMTA5OTUxMTYzMjc4MA_86c25e88-2a1a-4b1a-8054-5642c076c176">2.5</ix:nonFraction> billion for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPRD impairment charges were $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RleHRyZWdpb246MmYzMmQwZDc1M2VmNDFhMThmNzkyM2QyZGYwMmY2NTRfOTM0NTg0ODg0NDI2Ng_3d3939d2-83ff-4573-b995-061befce44d8">20</ix:nonFraction>&#160;million in the first quarter of 2023 and $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV83OS9mcmFnOjJmMzJkMGQ3NTNlZjQxYTE4Zjc5MjNkMmRmMDJmNjU0L3RleHRyZWdpb246MmYzMmQwZDc1M2VmNDFhMThmNzkyM2QyZGYwMmY2NTRfODEyNA_c3bf63c7-db81-4bb7-b2c7-fbe43694a018">40</ix:nonFraction>&#160;million in the first quarter of 2022 and were included in Research and development expense. The charges represented full write-downs.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_82"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 15. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RleHRyZWdpb246OWU2ZGYzZjRmNWYxNGI1NmI5OWRlODFhNjY3N2RjYzlfNDg0_48e78a46-5214-4c0f-814b-a1b0662ba77c" continuedAt="i377e0b4d0af34612ad7ee8083b1352f0" escape="true">SUPPLEMENTAL FINANCIAL INFORMATION</ix:nonNumeric></span></div><ix:continuation id="i377e0b4d0af34612ad7ee8083b1352f0" continuedAt="i930b0dcaf27c46cdb221578564fef2ea"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfOtherCurrentAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RleHRyZWdpb246OWU2ZGYzZjRmNWYxNGI1NmI5OWRlODFhNjY3N2RjYzlfNDkz_5e9007ee-b35c-40e8-a90c-5db9486ff4df" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfMS0xLTEtMS0xOTM5Mzc_7ec600c4-31b5-4ddc-840d-adffa39c481b">2,846</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:PrepaidTaxes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfMS0zLTEtMS0xOTM5Mzc_eeb03c26-5bf2-4986-917d-f726c62d78bd">3,547</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="bmy:ResearchandDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfMi0xLTEtMS0xOTM5Mzc_671098c2-60f1-41e2-8904-d3ea1b19f9da">704</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="bmy:ResearchandDevelopment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfMi0zLTEtMS0xOTM5Mzc_0fff8b21-a03c-4f81-9670-b1b40e82fa36">579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfMy0xLTEtMS0xOTM5Mzc_a651974a-6187-4933-9597-21185d23b91d">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:ContractWithCustomerAssetNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfMy0zLTEtMS0xOTM5Mzc_bf66a025-e548-4107-9560-0cddd2ea528e">504</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfNS0xLTEtMS0xOTM5Mzc_7667c64a-fbd2-4720-89ab-e8d53e085e0e">53</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:RestrictedCash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfNS0zLTEtMS0xOTM5Mzc_2947a668-f96a-43d1-8071-6a407a13640e">148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherPrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfNi0xLTEtMS0xOTM5Mzc_ec791aa1-fe8b-4075-b415-b3dfd342a29c">1,050</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherPrepaidExpenseCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfNi0zLTEtMS0xOTM5Mzc_5a5477ed-3de7-419e-832b-7aa9d57acd45">1,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfNy0xLTEtMS0xOTM5Mzc_2064284a-43ca-415e-85e5-24d951a39fa0">5,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherAssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjMzYjA3Mjc0YmI0ZjQ1MDJhM2E2NzQwNDFmOWYwNjUxL3RhYmxlcmFuZ2U6MzNiMDcyNzRiYjRmNDUwMmEzYTY3NDA0MWY5ZjA2NTFfNy0zLTEtMS0xOTM5Mzc_8523dd87-1a6e-4f47-8c02-7017501779ba">5,795</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfOtherAssetsNoncurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RleHRyZWdpb246OWU2ZGYzZjRmNWYxNGI1NmI5OWRlODFhNjY3N2RjYzlfNDkx_71c7f04d-c161-4e4b-893c-93eb42c7f495" continuedAt="id70e255dc80443c4bc854cfa4e1c6c3f" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="bmy:EquityInvestmentsNonCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfMS0xLTEtMS0xOTM5Mzc_7fba640a-e5bf-4f5b-95d3-a3b7fea17f17">2,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="bmy:EquityInvestmentsNonCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfMS0zLTEtMS0xOTM5Mzc_d84607e7-0fc9-4da2-b152-51e694a42bc2">2,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfMi0xLTEtMS0xOTM5Mzc_c618fcf1-cee2-4e3a-9985-475bca72123e">523</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:InventoryNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfMi0zLTEtMS0xOTM5Mzc_df1a6339-01c0-421d-93cc-56278ddd7394">484</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfMy0xLTEtMS0xOTM5Mzc_60309d9a-35ce-4cf6-9885-fde6378f3efb">1,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfMy0zLTEtMS0xOTM5Mzc_0b2bb549-1a67-4f26-aa4f-4ae3a308c028">1,220</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNC0xLTEtMS0xOTM5Mzc_0fcf6f47-2662-4ce8-8a8a-27a5e7ca0a80">299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNC0zLTEtMS0xOTM5Mzc_99f05909-3dcd-4c89-9712-2385acf59cc5">285</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="bmy:ResearchAndDevelopmentNonCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNS0xLTEtMS0xOTM5Mzc_bfa335ff-f972-491b-8448-ec6e9419b96a">485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="bmy:ResearchAndDevelopmentNonCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNS0zLTEtMS0xOTM5Mzc_2d92d022-811e-4e3b-a656-e4ec5ed92c37">496</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNi0xLTEtMS0xOTM5Mzc_b8f35eb0-1fa6-4156-8d40-4cd2007209dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:RestrictedCashNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNi0zLTEtMS0xOTM5Mzc_499975d6-4c44-4229-9f9c-08a03ac3c6ab">54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNy0xLTEtMS0xOTM5Mzc_78f9e47d-be29-4177-b781-f476dc0867de">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherAssetsMiscellaneousNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfNy0zLTEtMS0xOTM5Mzc_9c6dab20-722f-4b71-acb1-40fdfd542b67">214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfOC0xLTEtMS0xOTM5Mzc_85d9079f-c809-4d83-9262-8fa1697b6674">4,868</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmM1OTMxOWMyNGMyZTQyMGViMWYzNzYwM2M2MTFiMjMxL3RhYmxlcmFuZ2U6YzU5MzE5YzI0YzJlNDIwZWIxZjM3NjAzYzYxMWIyMzFfOC0zLTEtMS0xOTM5Mzc_0ad94044-a5c6-4ef3-ac3e-f76d1d565fa6">4,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:continuation id="id70e255dc80443c4bc854cfa4e1c6c3f">(a)&#160;&#160;&#160;&#160;Restricted cash primarily consists of funds restricted for annual Company contributions to the defined contribution plan in the U.S. and escrow for litigation settlements. Cash is restricted when withdrawal or general use is contractually or legally restricted. As of March&#160;31, 2022 restricted cash was $<ix:nonFraction unitRef="usd" contextRef="i346eafc8325f4939af4f85fbfc5a4e5b_I20220331" decimals="-6" name="us-gaap:RestrictedCashAndCashEquivalentsNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RleHRyZWdpb246OWU2ZGYzZjRmNWYxNGI1NmI5OWRlODFhNjY3N2RjYzlfMTA2Mg_aa25c858-94a5-42c4-a907-3141f9369245">210</ix:nonFraction> million.</ix:continuation> </span></div></ix:continuation><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i930b0dcaf27c46cdb221578564fef2ea"><div style="margin-top:5pt;text-align:justify"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RleHRyZWdpb246OWU2ZGYzZjRmNWYxNGI1NmI5OWRlODFhNjY3N2RjYzlfNDgz_a79a2a22-020b-402d-85bb-3f134f76692e" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rebates and discounts</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="bmy:AccruedRebatesAndReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMS0xLTEtMS0xOTM5Mzc_9e953b00-84af-4346-abdf-0316260a610d">5,824</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="bmy:AccruedRebatesAndReturns" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMS0zLTEtMS0xOTM5Mzc_64bb695c-3161-46c4-9b3e-8e1118d494f6">6,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMi0xLTEtMS0xOTM5Mzc_838f7c7e-6678-4306-a568-44c5e23e3289">1,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMi0zLTEtMS0xOTM5Mzc_8a6fc97e-b8ae-48b0-afc0-0c989d8d6388">942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employee compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMy0xLTEtMS0xOTM5Mzc_fe398b17-c25d-4aa3-9676-2bb0319bc2f7">589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMy0zLTEtMS0xOTM5Mzc_43b345a4-8c7d-477d-86eb-b86a93329812">1,425</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="bmy:AccruedResearchAndDevelopment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNC0xLTEtMS0xOTM5Mzc_d204b6f9-1f1b-4089-a713-391cbffcc3a2">1,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="bmy:AccruedResearchAndDevelopment" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNC0zLTEtMS0xOTM5Mzc_9875ce3b-c47d-4a6d-9031-e84ed39285b0">1,359</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividends</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:DividendsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNS0xLTEtMS0xOTM5Mzc_f8d5202d-75da-4733-9459-b1676cf936d3">1,197</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:DividendsPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNS0zLTEtMS0xOTM5Mzc_656d5f53-4364-4553-82be-8a35d4d28631">1,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="bmy:AccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNi0xLTEtMS0xOTM5Mzc_e487b575-29fc-412a-9063-c4e23bc57f42">319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="bmy:AccruedInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNi0zLTEtMS0xOTM5Mzc_42a10d8a-abcb-4370-8455-c5524f11cde4">321</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalties</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AccruedRoyaltiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNy0xLTEtMS0xOTM5Mzc_1dce747d-7986-4025-baa5-7228f2301c06">409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AccruedRoyaltiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfNy0zLTEtMS0xOTM5Mzc_2ddf9ef0-7861-4001-95d9-b2617e44d305">431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfOC0xLTEtMS0xOTM5Mzc_f0dcf9de-09c4-4d25-9618-41c2d7e6c4f5">171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfOC0zLTEtMS0xOTM5Mzc_e3689b31-dde7-4c58-bec7-1f697a2c0e36">136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMTAtMS0xLTEtMTkzOTM3_6ee68764-1118-4a91-a4d8-56f6a71f3523">2,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMTAtMy0xLTEtMTkzOTM3_7ff9c46d-1229-4320-90c6-900c2566ec6a">2,074</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other current liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMTEtMS0xLTEtMTkzOTM3_ee5a5cc7-fa2b-4ab2-b7b4-56cf7d0bd8d2">13,139</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOmIwMTMzNjM2OGI0OTQxNzI4NTA1Y2E0MTA1NGIzOWJkL3RhYmxlcmFuZ2U6YjAxMzM2MzY4YjQ5NDE3Mjg1MDVjYTQxMDU0YjM5YmRfMTEtMy0xLTEtMTkzOTM3_cc0c2491-47b1-4f6c-b00d-bd841eccd538">14,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RleHRyZWdpb246OWU2ZGYzZjRmNWYxNGI1NmI5OWRlODFhNjY3N2RjYzlfNDky_37cadca9-2a2b-4b56-84ab-d6332db3b748" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes </span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfMS0xLTEtMS0xOTM5Mzc_a63a97ba-7813-4270-9743-a81ac5863a6e">3,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AccruedIncomeTaxesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfMS0zLTEtMS0xOTM5Mzc_0228e5bc-b78f-4931-bd7f-db4a065b319a">3,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfMi0xLTEtMS0xOTM5Mzc_760f94c4-0578-4d34-8e18-c6f8ad96589a">399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfMi0zLTEtMS0xOTM5Mzc_6e9635da-8f3a-4e34-8c9a-bb3b83d356ec">402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfMy0xLTEtMS0xOTM5Mzc_7d9f5030-0a3a-4784-9fac-00b120ea0889">1,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfMy0zLTEtMS0xOTM5Mzc_20c9d53c-3a00-4edf-94a8-4facd536fce7">1,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:DeferredIncomeNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNC0xLTEtMS0xOTM5Mzc_fa89fe61-c425-42cc-8639-3ec99fb68b7b">308</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:DeferredIncomeNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNC0zLTEtMS0xOTM5Mzc_0401d0cd-27bb-4d32-b315-42086cc270eb">283</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNS0xLTEtMS0xOTM5Mzc_681fdfd6-d2dc-4848-ad2c-0a5082ae247b">387</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNS0zLTEtMS0xOTM5Mzc_b7686451-eeb8-4607-bda6-a742a26718aa">349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNi0xLTEtMS0xOTM5Mzc_2ae00dbf-a91b-4d0c-8bc4-4c0ff84e8e24">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherAccruedLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNi0zLTEtMS0xOTM5Mzc_e3bc276e-bf0d-4d48-b587-1b8d53ef3afc">303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNy0xLTEtMS0xOTM5Mzc_dcff01b2-e599-42f2-9911-93ce5f23932a">6,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84Mi9mcmFnOjllNmRmM2Y0ZjVmMTRiNTZiOTlkZTgxYTY2NzdkY2M5L3RhYmxlOjZlOGJjZGVkNGIxNjQ5MmJiM2RlN2RkYjI0MDExMWM0L3RhYmxlcmFuZ2U6NmU4YmNkZWQ0YjE2NDkyYmIzZGU3ZGRiMjQwMTExYzRfNy0zLTEtMS0xOTM5Mzc_57e5f12f-3d57-4eb4-8269-7536dfb64ea3">6,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_85"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 16. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMjY1MA_eed9afeb-72b3-4f69-aacf-2a927455e6f9" continuedAt="ib1902642983047be84ccf30903ef446c" escape="true">EQUITY</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ib1902642983047be84ccf30903ef446c" continuedAt="iaf891c5fd23842fdb165e6b57a92fc0f"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfStockholdersEquityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMjY3Mw_5213d670-ff6c-4f23-aa29-411563443d13" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the three months ended March 31, 2023: </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.444%"><tr><td style="width:1.0%"></td><td style="width:30.743%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.626%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.721%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.933%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.302%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.346%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.721%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.498%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.520%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and shares in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaacb967952a84c929370c1cb0330584a_I20221231" decimals="-6" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi0xLTEtMS0xOTM5Mzc_f374cdd4-25cc-401f-bf5f-cd7ef941560a">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaacb967952a84c929370c1cb0330584a_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi0zLTEtMS0xOTM5Mzc_805d6b35-2365-4efa-9950-67fb46d2fbae">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2b8d04f91f24ab3b1bd4cadae97cd15_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi01LTEtMS0xOTM5Mzc_8f610b8c-49d5-42ad-8022-f295f2176490">45,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e3fe6d813fb473a96593961f0613f55_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi03LTEtMS0xOTM5Mzc_1f8fb9fc-cfca-4737-a2e1-0166ce5e1f13">1,281</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07ad784c18b14feaa7917cf92952a3bb_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi05LTEtMS0xOTM5Mzc_9e51d5d3-6b7d-4626-a848-2def8a87b8ef">25,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4908dc165f094814bdc03777b63fb228_I20221231" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi0xMS0xLTEtMTkzOTM3_3b9cd25e-dffa-4469-884b-518a1eabc826">825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4908dc165f094814bdc03777b63fb228_I20221231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi0xMy0xLTEtMTkzOTM3_94b6fb3b-f08a-404a-9d60-f9a4edc35057">38,618</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i348f12df9a624cae9f58f9b3c31d39ed_I20221231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMi0xNS0xLTEtMTkzOTM3_e54f1bc6-a2f5-4808-8425-de62d33344e0">57</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c74a80333814fbaa942fa8f31104499_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMy05LTEtMS0xOTM5Mzc_6998f663-4daf-4af2-82c0-a803bcfb597f">2,262</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b6c8f98ac334b77bf25a681324b57f4_D20230101-20230331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfMy0xNS0xLTEtMTkzOTM3_fe112449-d538-4459-a092-57a32d7932e5">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idf6faba6b2d14225a15359de6482cf78_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNC03LTEtMS0xOTM5Mzc_5acd1a0e-3126-4583-89e5-5b0bd20f6f8b">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared $<ix:nonFraction unitRef="usdPerShare" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNS0wLTEtMS0yMTYxNjYvdGV4dHJlZ2lvbjo5YmNmNDlmYmFhMjU0MGU2ODViNDAyMGNkMDIwMDI0Zl8xNjQ5MjY3NDQxNzI0_766000fe-0fc2-4783-b008-234303ef1c13">0.57</ix:nonFraction> per share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c74a80333814fbaa942fa8f31104499_D20230101-20230331" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNS05LTEtMS0xOTM5Mzc_4c2406d8-3d80-48ed-bcd0-6c502b01d73d">1,197</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id6d9986c20824a5f97eef514fd6a36eb_D20230101-20230331" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNi0xMS0xLTEtMTkzOTM3_f0872950-e296-4cb0-8872-2c7d8f827e27">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id6d9986c20824a5f97eef514fd6a36eb_D20230101-20230331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNi0xMy0xLTEtMTkzOTM3_226515cf-bda1-42e8-b79a-4eb9883a0725">250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i66f6c8d4c2724b14ae661ab77a33fa56_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNy01LTEtMS0xOTM5Mzc_2b8e402f-692f-41e1-9df7-36e7de8a8c79">25</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="id6d9986c20824a5f97eef514fd6a36eb_D20230101-20230331" decimals="-6" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNy0xMS0xLTEtMTkzOTM3_801548f0-74ae-42d4-a924-aa2d242f2a61">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6d9986c20824a5f97eef514fd6a36eb_D20230101-20230331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfNy0xMy0xLTEtMTkzOTM3_ff78f8a1-a2ad-439c-a27e-1c90ba2f224d">60</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibda2aa440a934e82a577fb958f23e939_I20230331" decimals="-6" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS0xLTEtMS0xOTM5Mzc_7364dfa8-9cda-4ea1-971b-58af0c516a62">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda2aa440a934e82a577fb958f23e939_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS0zLTEtMS0xOTM5Mzc_484b0012-38e8-41c7-96fd-877f4ebc3656">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffe2252e37b146c6bd1dc58ef04b15ce_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS01LTEtMS0xOTM5Mzc_764da0e9-e8d9-4d89-b4cf-6a3355fc0865">45,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i99c36bec5b554b1f8b32d6267ac52c8b_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS03LTEtMS0xOTM5Mzc_3954f2be-4c13-45f4-baeb-2461b1667eac">1,368</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d4801a688a148d1bbef6616d73a97b9_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS05LTEtMS0xOTM5Mzc_e24f37ff-8406-4489-b18a-ec642ec3209d">26,568</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3941b5a9b1234e72b36561a89af511d3_I20230331" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS0xMS0xLTEtMTkzOTM3_4c1b65ee-53e3-454d-a4aa-88b049932677">823</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3941b5a9b1234e72b36561a89af511d3_I20230331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS0xMy0xLTEtMTkzOTM3_f7ac40b6-f4ff-47d4-88c9-9fe8093a652e">38,808</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4792b9bd5d914473a84cba87ee6517b9_I20230331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOmM0MGVkYjRhY2M3OTQxYWQ4YTA5MjE2MjA2Y2Q1MjJlL3RhYmxlcmFuZ2U6YzQwZWRiNGFjYzc5NDFhZDhhMDkyMTYyMDZjZDUyMmVfOS0xNS0xLTEtMTkzOTM3_0305bc56-ef03-4f9f-a7e2-88518b442c63">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes changes in equity for the three months ended March 31, 2022:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:30.699%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.618%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.057%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.291%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.339%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.506%"></td><td style="width:0.1%"></td></tr><tr style="height:24pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Capital&#160;in Excess of Par Value of&#160;Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars and shares in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iab8c8cc0509f4dd19eff9d892f06c4df_I20211231" decimals="-6" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi0xLTEtMS0xOTM5Mzc_5603db5a-75c8-4755-aa87-9b0e3d5cbd18">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8c8cc0509f4dd19eff9d892f06c4df_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi0zLTEtMS0xOTM5Mzc_f5adacb8-5f87-4684-aa0d-0936e23436a1">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icd8e035725b3442db86565959545c35a_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi01LTEtMS0xOTM5Mzc_281b03fa-3cb5-42df-b440-3ad5a0762e40">44,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie716e8002a604614bf64186acced27ad_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi03LTEtMS0xOTM5Mzc_7a832b2d-8066-4544-b9cc-270c7cd5d842">1,268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic73d338c52b542ddae2377e527c62f2c_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi05LTEtMS0xOTM5Mzc_0487a997-850a-4c09-ae85-b8d166ab4f85">23,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i062ca60f3e7247c4b8d90925c36406d5_I20211231" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi0xMS0xLTEtMTkzOTM3_e563ddcb-82b5-4ad2-a1a2-0cb3712f1767">747</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i062ca60f3e7247c4b8d90925c36406d5_I20211231" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi0xMy0xLTEtMTkzOTM3_882d625b-a705-48f3-9433-a8dd3efbccfd">31,259</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68d187be7b0471c86033eada0951b2b_I20211231" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMi0xNS0xLTEtMTkzOTM3_41569577-1e91-466b-8372-6b9a8c895df9">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cc25cac945148a18864b628022c5492_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMy05LTEtMS0xOTM5Mzc_7778ee7f-b2ea-4d55-82e3-3a6aaecba379">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3af1b75f0b44a79abbf15f10c511c29_D20220101-20220331" decimals="-6" name="us-gaap:ProfitLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfMy0xNS0xLTEtMTkzOTM3_94d3c107-bb29-4486-ac31-8282edaad019">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eb982410931493f88491ecf96248f25_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNC03LTEtMS0xOTM5Mzc_d1f24432-941b-4550-b4ff-44c78bdf1ee2">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash dividends declared $<ix:nonFraction unitRef="usdPerShare" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="2" name="us-gaap:CommonStockDividendsPerShareDeclared" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNS0wLTEtMS0yMTc2NzEvdGV4dHJlZ2lvbjoxYzgzMTRkYjVjMjU0ODg3YTlhMzE2OWRlODEwZTcyZV8xNjQ5MjY3NDQxNzI0_ba778cd7-4837-4bab-84bb-69159086acd5">0.54</ix:nonFraction> per share</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1cc25cac945148a18864b628022c5492_D20220101-20220331" decimals="-6" name="us-gaap:DividendsCommonStockCash" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNS05LTEtMS0xOTM5Mzc_3752643c-22ad-4ec1-8cf1-c618d35abba0">1,150</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share repurchase program</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i71d99781047f4d6ab3714d4919eef6f2_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNi01LTEtMS0xOTM5Mzc_2754dc36-d41b-43a2-835c-1f26dbbf5545">750</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ida75d697bc6043da9dc1a66ef54149fc_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNi0xMS0xLTEtMTkzOTM3_b739392e-c49d-4bbf-8a39-4b0c883c7a86">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida75d697bc6043da9dc1a66ef54149fc_D20220101-20220331" decimals="-6" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNi0xMy0xLTEtMTkzOTM3_29041630-bae9-4df9-befd-7ed7cc657ba6">4,250</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71d99781047f4d6ab3714d4919eef6f2_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNy01LTEtMS0xOTM5Mzc_9e435132-a0c2-4be0-8363-711f93475d90">145</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ida75d697bc6043da9dc1a66ef54149fc_D20220101-20220331" decimals="-6" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNy0xMS0xLTEtMTkzOTM3_50fadc78-02cc-4d4b-b6c2-3f13fc3c140a">18</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida75d697bc6043da9dc1a66ef54149fc_D20220101-20220331" decimals="-6" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfNy0xMy0xLTEtMTkzOTM3_77aed5ef-545a-4dc5-8217-1037c75efc67">322</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4506a3f2ee45401d9643dde5c3b241dd_I20220331" decimals="-6" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS0xLTEtMS0xOTM5Mzc_3152bfcc-fb3b-49ac-a8dc-2cb53df41e02">2,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4506a3f2ee45401d9643dde5c3b241dd_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS0zLTEtMS0xOTM5Mzc_561f8a3b-dafe-457e-967f-7b59b9f165f9">292</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6b9651239b0491abf8341b486a23dc1_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS01LTEtMS0xOTM5Mzc_e1edd3e8-c928-48fb-9947-2a84424fc304">43,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d753b05e49247a7998fcd56ba7831aa_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS03LTEtMS0xOTM5Mzc_a55d68d6-307b-41a2-ba77-8e32671bdccd">1,229</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3207d415b9154ca9b0988b77bdf66bf8_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS05LTEtMS0xOTM5Mzc_b0e5f669-6b02-490e-8895-46f511563463">23,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic21692a74de649678999f109fd39cfab_I20220331" decimals="-6" name="us-gaap:TreasuryStockCommonShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS0xMS0xLTEtMTkzOTM3_beee47b4-f442-4d75-a29b-e8202648f6fc">794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic21692a74de649678999f109fd39cfab_I20220331" decimals="-6" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS0xMy0xLTEtMTkzOTM3_d5bb5e15-07eb-4fb1-b682-dba19314a1f1">35,187</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59d5a4da3d5948e495ffaf1f84fe5f34_I20220331" decimals="-6" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjJhYmY3OGRkMGYxNjQxMjQ5NTdhYzhlMGViZGNiOTNlL3RhYmxlcmFuZ2U6MmFiZjc4ZGQwZjE2NDEyNDk1N2FjOGUwZWJkY2I5M2VfOS0xNS0xLTEtMTkzOTM3_5611a8c4-f0f0-4aa1-a37e-1a761bf6670c">65</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS repurchased <ix:nonFraction unitRef="shares" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTA5OTUxMTYzNTE0OQ_d902cacd-074e-4b88-8572-65f5e9f6826b">3.7</ix:nonFraction>&#160;million shares of its common stock for $<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTA5OTUxMTYzNTE4Mw_ad2607c9-bac1-419e-b4cc-36c12f1f0979">250</ix:nonFraction>&#160;million in the first quarter of 2023. The remaining share repurchase capacity under the BMS share repurchase program was approximately $<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-8" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTA5OTUxMTYzNDk4OQ_9d4587e2-a7ce-427d-b168-ddf6252af3ed">6.9</ix:nonFraction>&#160;billion as of March 31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2022, BMS entered into accelerated share repurchase ("ASR") agreements to repurchase an aggregate amount of $<ix:nonFraction unitRef="usd" contextRef="i597908d9a603482f9546e5ee2009c406_I20220331" decimals="-8" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTA1Mg_fe93f996-001a-4336-b6de-7de61384a260">5.0</ix:nonFraction>&#160;billion of the Company's common stock. The ASR agreements were funded with cash on-hand and <ix:nonFraction unitRef="shares" contextRef="i972712cf0b124b2b81b3419d5de38db0_D20220101-20220331" decimals="-6" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTE3OQ_2d0acc05-c3f9-4709-9b75-5388c50975a8">65</ix:nonFraction>&#160;million shares of common stock (85% of the $<ix:nonFraction unitRef="usd" contextRef="i597908d9a603482f9546e5ee2009c406_I20220331" decimals="-8" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTIxNw_c83e04f5-6a52-49d0-8454-e27ce17e97c5">5.0</ix:nonFraction>&#160;billion aggregate repurchase price) were received by BMS and included in treasury stock. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="iaf891c5fd23842fdb165e6b57a92fc0f"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMjY2OQ_90810fea-7f11-4ebb-8b66-e5c49197c957" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the changes in Other comprehensive income by component:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.796%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31, 2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pretax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Tax</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">After&#160;Tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recognized in Other comprehensive income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNC0xLTEtMS0xOTM5Mzc_abdebf3f-fa3f-41e9-a561-cd030a1866b0">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNC0zLTEtMS0xOTM5Mzc_137035df-d4cc-4f6f-b85c-72a52f13ca5e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNC01LTEtMS0xOTM5Mzc_28856ab7-3084-4573-91ac-e62a9a0a9f22">10</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNC03LTEtMS0xOTM5Mzc_2d8479db-3990-46aa-b006-c8f1e444810d">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNC05LTEtMS0xOTM5Mzc_b772ac88-064c-47e0-a99d-934ca31571b9">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNC0xMS0xLTEtMTkzOTM3_ed586a0c-7eba-4d4a-a696-51c23b9e35fe">104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassified to net earnings</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNS0xLTEtMS0xOTM5Mzc_6e4323c6-4dd6-49ea-a636-89e987079654">133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNS0zLTEtMS0xOTM5Mzc_13a14737-f25a-42e0-8895-e414cd6f541b">19</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNS01LTEtMS0xOTM5Mzc_94862b5c-da42-4f21-964f-2708ad96d17e">114</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNS03LTEtMS0xOTM5Mzc_7992bfd1-797f-4c71-b11b-43b19bc771ce">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNS05LTEtMS0xOTM5Mzc_4c3a62b2-caee-416b-ad9b-3b1e55c10df5">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNS0xMS0xLTEtMTkzOTM3_8609a6d1-7f58-499c-9b86-fdaa0ebfde53">73</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNi0xLTEtMS0xOTM5Mzc_8f0d2ea4-be27-4608-af45-4ff21e181527">146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNi0zLTEtMS0xOTM5Mzc_fd36e482-2169-458d-9e21-4e19682b3203">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNi01LTEtMS0xOTM5Mzc_fab69e1d-2e5e-4521-b48d-eee57b490194">124</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNi03LTEtMS0xOTM5Mzc_fa558e81-079f-4b3a-8649-1bebfcb662d3">35</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNi05LTEtMS0xOTM5Mzc_84864cd7-8fdc-445e-b615-a1aa52c43513">4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfNi0xMS0xLTEtMTkzOTM3_8f6cd966-1a1a-47c3-85f9-093a374d771a">31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Pension and postretirement benefits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Actuarial gains/(losses)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfOS0xLTEtMS0xOTM5Mzc_b4ed0393-27bd-44da-ba74-f18baf0bd042">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfOS0zLTEtMS0xOTM5Mzc_91ecb6db-78fb-46ee-9387-5d2da0f02ebb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfOS01LTEtMS0xOTM5Mzc_27341f28-4cdb-428b-9ee1-6872d1d42b13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfOS03LTEtMS0xOTM5Mzc_d7a299d2-c3d6-4021-b06e-f1ffb425d01a">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfOS05LTEtMS0xOTM5Mzc_69f7e3f5-a7ab-4345-9745-350bf5d4a603">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfOS0xMS0xLTEtMTkzOTM3_dd0e8972-b2b7-44cb-b156-8bb10a658884">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTAtMS0xLTEtMTkzOTM3_9c8a92f8-64e4-4b8e-9038-b7c307e4176b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTAtMy0xLTEtMTkzOTM3_7a05bfc6-8626-42d2-aa06-1579316f9b49">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTAtNS0xLTEtMTkzOTM3_4c1560c8-3318-4c6d-9fc6-012b943a03a5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTAtNy0xLTEtMTkzOTM3_fa4e1494-cb36-453d-8e97-ad46e9a8818d">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTAtOS0xLTEtMTkzOTM3_6db717e2-bb18-4cc6-8392-f97d659636d7">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTAtMTEtMS0xLTE5MzkzNw_c2af871c-b8af-4896-bb0b-81616dacd36f">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTEtMS0xLTEtMTkzOTM3_05d422e3-f856-49b5-9c65-3ffe0bf3d60e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTEtMy0xLTEtMTkzOTM3_e48607e7-f416-4c88-b72d-a0ba76342005">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTEtNS0xLTEtMTkzOTM3_83d004bc-7b4b-4731-9d2f-5fa141d6e536">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTEtNy0xLTEtMTkzOTM3_a9d8887f-bd46-4706-8463-99d09b07e406">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeFinalizationOfPensionAndNonPensionPostretirementPlanValuationTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTEtOS0xLTEtMTkzOTM3_0c9cae2d-ebce-429a-8d7a-6cf82a4e86e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossFinalizationOfPensionAndNonPensionPostretirementPlanValuationNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTEtMTEtMS0xLTE5MzkzNw_f6df1ae7-6c09-44ba-a1d0-3c5a07fa023d">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTItMS0xLTEtMTkzOTM3_69b3040c-9626-41c0-86dd-ed6094df28e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTItMy0xLTEtMTkzOTM3_51e07a26-5250-4b81-a28d-88dca3882bac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTItNS0xLTEtMTkzOTM3_15769c23-c2e8-49e5-a692-5583907b7e56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTItNy0xLTEtMTkzOTM3_e0e471d6-cdf6-4767-b962-842ba8d7e518">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTItOS0xLTEtMTkzOTM3_3c7ab37a-c3cd-4056-a810-589e9ba32bef">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTItMTEtMS0xLTE5MzkzNw_b106473e-01d8-4ea7-9a85-a1e47eb67449">21</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Marketable debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized (losses)/gains</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTUtMS0xLTEtMTkzOTM3_d427175e-a2f2-4049-8a60-554e7d5e8276">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTUtMy0xLTEtMTkzOTM3_b3de8b8d-e59e-4c45-b520-1f824838997e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTUtNS0xLTEtMTkzOTM3_3b27b969-448e-41cb-94bb-f73012196711">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTUtNy0xLTEtMTkzOTM3_99f6dd64-2493-4a93-81de-4ec71d11c2bc">2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTUtOS0xLTEtMTkzOTM3_f86fcba1-3463-41a1-a3f4-6e05a983c480">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTUtMTEtMS0xLTE5MzkzNw_d5191b08-c6f1-400e-8551-b297a42b8e22">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTctMS0xLTEtMTkzOTM3_98a366d6-4a78-4e4b-89cd-ff4c9db79941">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTctMy0xLTEtMTkzOTM3_1d1890bb-2e7f-4405-aef5-3bb6276db08e">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTctNS0xLTEtMTkzOTM3_0bc114bb-9087-4fff-88ee-6a684fcc4a57">37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTctNy0xLTEtMTkzOTM3_c3c6e4e5-cfa0-4fb2-89ca-a856d6313720">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTctOS0xLTEtMTkzOTM3_a13b0426-bff0-444d-b6b1-6313be9f3ea5">6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTctMTEtMS0xLTE5MzkzNw_2ee5f046-7b00-4161-9b85-c4a8879dd4a6">12</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTktMS0xLTEtMTkzOTM3_9dcfd0f2-b739-4150-a190-cf3219d907a5">111</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTktMy0xLTEtMTkzOTM3_314b459d-8d60-450c-83a7-3ccf6fe142e9">24</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTktNS0xLTEtMTkzOTM3_19ba9e2b-3d93-46e4-9961-255b8dceee56">87</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTktNy0xLTEtMTkzOTM3_f2500186-2a9c-43b6-a72c-f0ddef12d1b4">54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTktOS0xLTEtMTkzOTM3_64f7e841-8b5d-4b7b-885c-992ad2a5c3eb">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjIwZDFlYWE5NzRlODRlNGVhZDQ1OTRmYjhiNGViYjJiL3RhYmxlcmFuZ2U6MjBkMWVhYTk3NGU4NGU0ZWFkNDU5NGZiOGI0ZWJiMmJfMTktMTEtMS0xLTE5MzkzNw_152f0dab-4f3d-4ce8-9529-d24df7d5dbb9">39</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Included in Cost of products sold and Other (income)/expense, net. Refer to "&#8212;Note 9. Financial Instruments and Fair Value Measurements" for further information.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">Included in Other (income)/expense, net.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMjY3NQ_7bd2d3bb-b953-43e5-820f-e0a4c672ab69" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accumulated balances related to each component of Other comprehensive income, net of taxes, were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives qualifying as cash flow hedges</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfMS0xLTEtMS0xOTM5Mzc_4807a9f8-aa5a-49c6-9495-5ad0c1325229">108</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AociLossCashFlowHedgeCumulativeGainLossAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfMS0zLTEtMS0xOTM5Mzc_9dc91eea-77bd-4597-b12b-a34f5fc8d890">232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pension and postretirement benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfMi0xLTEtMS0xOTM5Mzc_170850c8-74bb-4b74-88bd-a21c0dda161c">623</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfMi0zLTEtMS0xOTM5Mzc_a02eea21-e0ec-4ff7-95d0-86d17ec74186">623</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfNC0xLTEtMS0xOTM5Mzc_2ff35837-dcd4-4440-9b05-53e89c56ae26">853</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfNC0zLTEtMS0xOTM5Mzc_1dab6432-cb74-45bf-a5c1-b2a80f5f9f5a">890</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfNS0xLTEtMS0xOTM5Mzc_0f5935a3-b179-45d7-88dd-1e30eb113cd5">1,368</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RhYmxlOjNkZDQwMDljMzUyMjQ2ZTBhMTQ5OTkxYzFkMmZjOWE5L3RhYmxlcmFuZ2U6M2RkNDAwOWMzNTIyNDZlMGExNDk5OTFjMWQyZmM5YTlfNS0zLTEtMS0xOTM5Mzc_9e655e78-68af-453a-bfb9-497eda46bf36">1,281</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Included in Foreign currency translation are net investment hedge gains of $<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTA5OTUxMTYzMjYxMw_c6a5457d-fb11-45d9-88d2-deac8b392255">118</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i173cd3ea7b2b49529ff5d4c934429570_I20221231" decimals="-6" name="us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTax" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV84NS9mcmFnOjk3NTUyZGJiOTAzNTRlNDZhODgxZTg3N2MyMDRhY2EwL3RleHRyZWdpb246OTc1NTJkYmI5MDM1NGU0NmE4ODFlODc3YzIwNGFjYTBfMTA5OTUxMTYzMjU5OQ_0be70f76-439b-4acb-bd29-b2e95dde0d55">125</ix:nonFraction>&#160;million as of March 31, 2023 and December 31, 2022, respectively.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_91"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 17. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RleHRyZWdpb246M2ViNjk0NWJiYjQzNDk1Zjk2NWFmZGQ5NjVkYjAyODlfNDI0_8ceba4fb-7c40-494b-8df4-0bf264f8c69d" continuedAt="i11f6ca14f1424eebbc3da2cc5c70bd63" escape="true">EMPLOYEE STOCK BENEFIT PLANS</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i11f6ca14f1424eebbc3da2cc5c70bd63" continuedAt="i22ead6d69175440d9863ce6efe14ce2e"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RleHRyZWdpb246M2ViNjk0NWJiYjQzNDk1Zjk2NWFmZGQ5NjVkYjAyODlfNDI1_bb3dce3a-18d3-4bbe-bffb-5b61cd6aa6ca" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense was as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d5ed5411a6f44adad6a2fafa7a07b71_D20230101-20230331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfMi0xLTEtMS0xOTM5Mzc_07be8d1d-aa7e-4943-8efc-d73355430eea">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78cff693ad5a4423abe55a1f70a20cbd_D20220101-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfMi0zLTEtMS0xOTM5Mzc_99e55b19-ca84-40a3-9572-9b8e55f867fd">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic40cc8e1a8704933a5e9e7779a3257e8_D20230101-20230331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfMy0xLTEtMS0xOTM5Mzc_05133ac6-7b5b-4764-85a9-9d15b89faec9">51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2d6f04e5b6a421bab39cccd2a64bca3_D20220101-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfMy0zLTEtMS0xOTM5Mzc_a710083c-9741-47c6-afd6-0dd56a68c6e8">48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9528bb81e4942ea87d6a91f7811416b_D20230101-20230331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfNC0xLTEtMS0xOTM5Mzc_195a60a3-e6e1-4ad0-bc05-cb1abe0755da">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52b2c97066a745b09e18d1483477cdfc_D20220101-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfNC0zLTEtMS0xOTM5Mzc_a138c5c0-42c0-431e-8c02-3b2f05bc68f3">51</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Stock-based compensation expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfNi0xLTEtMS0xOTM5Mzc_b7d8f767-7a62-4f8e-b69e-e389ca7702dc">122</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfNi0zLTEtMS0xOTM5Mzc_df14df22-fbf9-4c13-ba78-1bf243d0cc55">107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfOC0xLTEtMS0xOTM5Mzc_d306a7ce-8668-486b-a6ec-ae2fd397d9e4">25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjAwMGZkZDJiMDAwNDQzM2Y5MWEwOGU5YjExMmM1Y2NlL3RhYmxlcmFuZ2U6MDAwZmRkMmIwMDA0NDMzZjkxYTA4ZTliMTEyYzVjY2VfOC0zLTEtMS0xOTM5Mzc_d61be646-161a-4b24-be7a-995521e28a5f">22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Income tax benefit excludes excess tax benefits from share-based compensation awards that were vested or exercised of $<ix:nonFraction unitRef="usd" contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RleHRyZWdpb246M2ViNjk0NWJiYjQzNDk1Zjk2NWFmZGQ5NjVkYjAyODlfMjE3_44bf8ecb-3f52-4a4d-bdc2-2c21afbb1dee">18</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib73c538160af4bc6ac51cb0e60675043_D20220101-20220331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromExerciseOfStockOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RleHRyZWdpb246M2ViNjk0NWJiYjQzNDk1Zjk2NWFmZGQ5NjVkYjAyODlfMjI0_49f68101-36e4-4ae2-83be-3264b7112a87">40</ix:nonFraction> million for the three months ended March&#160;31, 2023 and 2022, respectively.</span></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="bmy:ScheduleOfShareBasedCompensationAdditionalInformationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RleHRyZWdpb246M2ViNjk0NWJiYjQzNDk1Zjk2NWFmZGQ5NjVkYjAyODlfNDI5_c1cab906-e002-4510-ad23-54f7ba081408" escape="true"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of units granted and the weighted-average fair value on the grant date for the three months ended March 31, 2023 were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Units in millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i11aa5d30ad2e4cf0a7f5b87650286b64_D20230101-20230331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOmI0YTQ5ZDczYzY5ZDRlY2I5Mzg5OTI0MGU1YmUzYjY3L3RhYmxlcmFuZ2U6YjRhNDlkNzNjNjlkNGVjYjkzODk5MjQwZTViZTNiNjdfMi0xLTEtMS0xOTM5Mzc_81b326f8-e3b6-4fbc-9180-40c2dd325a90">8.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i11aa5d30ad2e4cf0a7f5b87650286b64_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOmI0YTQ5ZDczYzY5ZDRlY2I5Mzg5OTI0MGU1YmUzYjY3L3RhYmxlcmFuZ2U6YjRhNDlkNzNjNjlkNGVjYjkzODk5MjQwZTViZTNiNjdfMi0zLTEtMS0xOTM5Mzc_06920e24-7ee6-4eb0-aec0-21907092637c">60.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie85008ffba0c418b907e7b2edc3a23e0_D20230101-20230331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOmI0YTQ5ZDczYzY5ZDRlY2I5Mzg5OTI0MGU1YmUzYjY3L3RhYmxlcmFuZ2U6YjRhNDlkNzNjNjlkNGVjYjkzODk5MjQwZTViZTNiNjdfMy0xLTEtMS0xOTM5Mzc_9ef8641f-6284-47f0-bacd-f03ea85ae6a8">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie85008ffba0c418b907e7b2edc3a23e0_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOmI0YTQ5ZDczYzY5ZDRlY2I5Mzg5OTI0MGU1YmUzYjY3L3RhYmxlcmFuZ2U6YjRhNDlkNzNjNjlkNGVjYjkzODk5MjQwZTViZTNiNjdfMy0zLTEtMS0xOTM5Mzc_881b0ea3-d7c1-4821-905f-a8997e74db3c">58.15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i917a6c3322bf456581cd7294c96b0493_D20230101-20230331" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOmI0YTQ5ZDczYzY5ZDRlY2I5Mzg5OTI0MGU1YmUzYjY3L3RhYmxlcmFuZ2U6YjRhNDlkNzNjNjlkNGVjYjkzODk5MjQwZTViZTNiNjdfNC0xLTEtMS0xOTM5Mzc_a4a03a33-b38f-4ea8-a0f0-69e347e50d67">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i917a6c3322bf456581cd7294c96b0493_D20230101-20230331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOmI0YTQ5ZDczYzY5ZDRlY2I5Mzg5OTI0MGU1YmUzYjY3L3RhYmxlcmFuZ2U6YjRhNDlkNzNjNjlkNGVjYjkzODk5MjQwZTViZTNiNjdfNC0zLTEtMS0xOTM5Mzc_38f4a4f0-e009-4e44-b01d-3d90dba3b894">64.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><ix:continuation id="i22ead6d69175440d9863ce6efe14ce2e"><ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:ScheduleOfUnrecognizedCompensationCostNonvestedAwardsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RleHRyZWdpb246M2ViNjk0NWJiYjQzNDk1Zjk2NWFmZGQ5NjVkYjAyODlfNDIz_980e3be9-3eb2-492a-b57c-99b3f4438215" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:62.460%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.586%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock&#160;Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Market Share&#160;Units</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Performance Share Units</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrecognized compensation cost</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90e84082105e45269a4ddf3f2b924403_I20230331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjdmMmFkMzEzYWQ1MjQyMzdhMGEyNDFkZGRmMzg2OTA4L3RhYmxlcmFuZ2U6N2YyYWQzMTNhZDUyNDIzN2EwYTI0MWRkZGYzODY5MDhfMS0zLTEtMS0xOTM5Mzc_c5c9c007-345f-48f9-982c-b81012932fb6">1,125</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa01413dd4ef4e92b1e5f19fc5bc3d5d_I20230331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjdmMmFkMzEzYWQ1MjQyMzdhMGEyNDFkZGRmMzg2OTA4L3RhYmxlcmFuZ2U6N2YyYWQzMTNhZDUyNDIzN2EwYTI0MWRkZGYzODY5MDhfMS01LTEtMS0xOTM5Mzc_57a1c936-ad7f-4a29-ae20-55c0bc5915cb">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c11a22415bf463a8cafb058afaacf34_I20230331" decimals="-6" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjdmMmFkMzEzYWQ1MjQyMzdhMGEyNDFkZGRmMzg2OTA4L3RhYmxlcmFuZ2U6N2YyYWQzMTNhZDUyNDIzN2EwYTI0MWRkZGYzODY5MDhfMS03LTEtMS0xOTM5Mzc_e3a14fe3-5e1e-4f2e-92d4-a2a413b9cc69">165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected weighted-average period in years of compensation cost to be recognized</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i11aa5d30ad2e4cf0a7f5b87650286b64_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjdmMmFkMzEzYWQ1MjQyMzdhMGEyNDFkZGRmMzg2OTA4L3RhYmxlcmFuZ2U6N2YyYWQzMTNhZDUyNDIzN2EwYTI0MWRkZGYzODY5MDhfMi0zLTEtMS0xOTM5Mzc_c85ac1d0-f035-4dc8-8ef8-cb499856629c">3.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie85008ffba0c418b907e7b2edc3a23e0_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjdmMmFkMzEzYWQ1MjQyMzdhMGEyNDFkZGRmMzg2OTA4L3RhYmxlcmFuZ2U6N2YyYWQzMTNhZDUyNDIzN2EwYTI0MWRkZGYzODY5MDhfMi01LTEtMS0xOTM5Mzc_bf6b709d-bcd4-4fd7-90f4-d96c236be9c5">3.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i917a6c3322bf456581cd7294c96b0493_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85MS9mcmFnOjNlYjY5NDViYmI0MzQ5NWY5NjVhZmRkOTY1ZGIwMjg5L3RhYmxlOjdmMmFkMzEzYWQ1MjQyMzdhMGEyNDFkZGRmMzg2OTA4L3RhYmxlcmFuZ2U6N2YyYWQzMTNhZDUyNDIzN2EwYTI0MWRkZGYzODY5MDhfMi03LTEtMS0xOTM5Mzc_d71cd79f-e8ee-49bd-ba87-249846764f4e">2.2</ix:nonNumeric></span></td></tr></table></ix:nonNumeric></ix:continuation></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_94"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 18. <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMzgyNTA_0dc449ba-9a0e-43ed-979f-fb555889447c" continuedAt="id4acc87bf2db40ccac876f61aa8d994b" escape="true">LEGAL PROCEEDINGS AND CONTINGENCIES</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="id4acc87bf2db40ccac876f61aa8d994b" continuedAt="ia7eefa671e3d470c9c062c7403fba5d1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and certain of its subsidiaries are involved in various lawsuits, claims, government investigations and other legal proceedings that arise in the ordinary course of business. These claims or proceedings can involve various types of parties, including governments, competitors, customers, partners, suppliers, service providers, licensees, licensors, employees, or shareholders, among others. These matters may involve patent infringement, antitrust, securities, pricing, sales and marketing practices, environmental, commercial, contractual rights, licensing obligations, health and safety matters, consumer fraud, employment matters, product liability and insurance coverage, among others. The resolution of these matters often develops over a long period of time and expectations can change as a result of new findings, rulings, appeals or settlement arrangements. Legal proceedings that are significant or that BMS believes could become significant or material are described below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While BMS does not believe that any of these matters, except as otherwise specifically noted below, will have a material adverse effect on its financial position or liquidity as BMS believes it has substantial claims and/or defenses in the matters, the outcomes of BMS's legal proceedings and other contingencies are inherently unpredictable and subject to significant uncertainties. There can be no assurance that there will not be an increase in the scope of one or more of these pending matters or any other or future lawsuits, claims, government investigations or other legal proceedings will not be material to BMS's financial position, results of operations or cash flows for a particular period. Furthermore, failure to successfully enforce BMS's patent rights would likely result in substantial decreases in the respective product revenues from generic competition.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted, BMS is unable to assess the outcome of the respective matters nor is it able to estimate the possible loss or range of losses that could potentially result for such matters. Contingency accruals are recognized when it is probable that a liability will be incurred and the amount of the related loss can be reasonably estimated. Developments in legal proceedings and other matters that could cause changes in the amounts previously accrued are evaluated each reporting period. For a discussion of BMS&#8217;s tax contingencies, see " &#8212;Note 7. Income Taxes."</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INTELLECTUAL PROPERTY</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-PD-1 and Anti-PD-L1 &#8212; U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2015, Dana-Farber Cancer Institute ("Dana-Farber") filed a complaint in the U.S. District Court for the District of Massachusetts seeking to correct the inventorship on up to <ix:nonFraction unitRef="patent" contextRef="ib59c6e4a5c1c488fbf9892f2e7f21e74_D20150901-20150930" decimals="INF" name="us-gaap:LossContingencyPatentsAllegedlyInfringedNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTM0MQ_2ba5d02b-ac9b-4343-9081-d0d70b87cde3">six</ix:nonFraction> related U.S. patents directed to methods of treating cancer using PD-1 and PD-L1 antibodies. Specifically, Dana-Farber sought to add two scientists as inventors to these patents. In October 2017, Pfizer was allowed to intervene in the case alleging that one of the scientists identified by Dana-Farber was employed by a company eventually acquired by Pfizer during the relevant period. In May 2019, the District Court issued a decision ruling that the two scientists should be added as inventors to the patents, which decision was affirmed on appeal. In June 2019, Dana-Farber filed a new lawsuit in the District of Massachusetts against BMS seeking damages as a result of the decision adding the scientists as inventors. In February 2021, BMS filed a motion to dismiss that complaint. In August 2021, the Court denied the motion to dismiss, but ruled that Dana-Farber's claims for damages before May 17, 2019&#8212;the date of the District Court's ruling that Dana-Farber was a co-inventor of the patents&#8212;are preempted by federal patent law. On January 25, 2023, the Court held a hearing on a motion filed by BMS requesting that the Court enter summary judgment in BMS' favor. In April 2023, BMS and Dana-Farber entered into a settlement agreement and these litigations were dismissed.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 17, 2022, BMS filed a lawsuit in U.S. District Court for the District of Delaware against AstraZeneca Pharmaceuticals LP and AstraZeneca UK Ltd (collectively, "AZ") alleging that AZ's marketing of the PD-L1 antibody Imfinzi infringes certain claims of U.S. Patent Nos. 9,580,505, 9,580,507, 10,138,299, 10,308,714, 10,266,594, 10,266,595, 10,266,596 and 10,323,092. A trial has been scheduled to begin on April 22, 2024. On April 26, 2023, BMS filed an additional lawsuit against AZ in U.S. District Court for the District of Delaware alleging that AZ's marketing of the PD-L1 antibody Imfinzi infringes U.S. Patent No. 9,402,899.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="ia7eefa671e3d470c9c062c7403fba5d1" continuedAt="i9869b2d753b84860a51909300c85c355"><div style="text-align:justify"><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAR-T &#8212; U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2017, Juno and Sloan Kettering Institute for Cancer Research ("SKI") filed a complaint for patent infringement against Kite Pharma, Inc. ("Kite") in the U.S. District Court for the Central District of California. The complaint alleged that Kite's </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product infringes certain claims of U.S. Patent No. 7,446,190 (the "'190 Patent") concerning CAR-T cell technologies. Kite filed an answer and counterclaims asserting non-infringement and invalidity of the '190 Patent. In December 2019, following an eight-day trial, the jury rejected Kite's defenses, finding that Kite willfully infringed the '190 Patent and awarding to Juno and SKI a reasonable royalty consisting of a $<ix:nonFraction unitRef="usd" contextRef="ife4c00620e3f4227b0f107ac12a3b75b_D20191201-20191231" decimals="-6" name="us-gaap:PaymentsForRoyalties" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTI3MQ_3d01343a-d143-442d-bb78-a6f646287012">585</ix:nonFraction>&#160;million upfront payment and a <ix:nonFraction unitRef="number" contextRef="i00f02f6049c84c88a97ca32784154910_I20191231" decimals="3" name="bmy:RoyaltyGuaranteesCommitmentsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTI5MQ_33a9b50b-5be0-430e-8776-07e14e890ffb">27.6</ix:nonFraction>% running royalty on Kite's sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> through the expiration of the '190 Patent in August 2024. In January 2020, Kite renewed its previous motion for judgment as a matter of law and also moved for a new trial, and Juno filed a motion seeking enhanced damages, supplemental damages, ongoing royalties, and prejudgment interest. In March 2020, the Court denied both of Kite's motions in their entirety. In April 2020, the Court granted in part Juno's motion and entered a final judgment awarding to Juno and SKI approximately $<ix:nonFraction unitRef="usd" contextRef="i19139b5b67d7410eac12e965d900e982_D20200401-20200430" decimals="-8" name="us-gaap:PaymentsForRoyalties" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTMyNA_b0e9313c-7f00-4c91-a28a-57755bff0634">1.2</ix:nonFraction>&#160;billion in royalties, interest and enhanced damages and a <ix:nonFraction unitRef="number" contextRef="i489f54c5481c45389d5768b529b57a7c_I20200430" decimals="3" name="bmy:RoyaltyGuaranteesCommitmentsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTMwNA_56c8fd1f-8858-4d08-97d8-c4d1017a8c7f">27.6</ix:nonFraction>% running royalty on Kite's sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* from December 13, 2019 through the expiration of the '190 Patent in August 2024. In April 2020, Kite appealed the final judgment to the U.S. Court of Appeals for the Federal Circuit and the Court held an oral hearing on July 6, 2021. In August 2021, a Federal Circuit panel reversed the jury verdict and district court decision and found the '190 Patent to be invalid. In October 2021, Juno and SKI filed a petition with the Federal Circuit for panel and en banc rehearing, which the Federal Circuit denied on January 14, 2022. On June 13, 2022, Juno and SKI filed a petition for a writ of certiorari with the U.S. Supreme Court, which the Court denied on November 7, 2022. On November 23, 2022, Juno and SKI filed a petition for rehearing with the Court, which the Court denied on January 9, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CTLA-4 &#8212; U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 23, 2023, BMS filed a lawsuit in U.S. District Court for the District of Delaware against AstraZeneca Pharmaceuticals LP and AstraZeneca AB (collectively, "AZ AB") alleging that AZ AB's marketing of the CTLA-4 antibody Imjudo infringes certain claims of U.S. Patent Nos. 9,320,811 and 9,273,135. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - Europe</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020 and January 2021, Sandoz Limited ("Sandoz") and Teva Pharmaceutical Industries Ltd. ("Teva Limited"), respectively, filed lawsuits in the United Kingdom seeking revocation of the UK apixaban composition of matter patent and related Supplementary Protection Certificate ("SPC"). BMS subsequently filed counterclaims for infringement in both actions. A trial took place in February 2022 and in a judgment issued on April 7, 2022, the judge found the UK apixaban composition of matter patent and related SPC invalid. On November 2, 2022, BMS was granted permission from the Court of Appeal to appeal the judgment and a hearing took place on April 19-20, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar lawsuits have been filed in various other countries in Europe seeking revocation of our composition of matter patents and SPCs relating to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and trials have been held in certain of those cases, including in Norway and France. In May 2022, a Dutch court issued a decision denying a request by BMS for a preliminary injunction that would have prevented an at-risk generic launch in the Netherlands by Sandoz prior to a full trial on the validity of the Dutch composition of matter patent and SPC. In April 2023, BMS again requested that a preliminary injunction be issued against Sandoz in the Netherlands. In addition, BMS requested that a preliminary injunction be issued against Stada in the Netherlands. On April 26, 2023, a combined preliminary injunction hearing was held.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the above decisions in the UK and the Netherlands, generic manufacturers have begun marketing generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the UK and the Netherlands, and may seek to market generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in additional countries in Europe, prior to the expiration of our patents, which may lead to additional infringement and invalidity actions involving </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patents being filed in various countries in Europe. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2022, a trial was held in Sweden regarding Teva's challenge to the validity of the Swedish apixaban composition of matter patent and related SPC, and a decision was issued on November 2, 2022, confirming their validity and rejecting Teva's claims. In September 2022, BMS filed a request for a preliminary injunction against Teva in Denmark, but the request was denied in December 2022, based on the finding that there is no imminent threat of a launch by Teva in Denmark. In January 2023, the court in Finland granted BMS's request that a preliminary injunction be entered against Teva, prohibiting Teva from offering, storing or selling generic Eliquis products in Finland that have obtained price and reimbursement. On February 17, 2023, the court in Ireland also granted BMS's request that a preliminary injunction be entered against Teva in Ireland.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 24, 2023 and March 4, 2023, BMS received Notice Letters from Biocon and ScieGen, respectively, notifying BMS that they had filed ANDAs containing paragraph IV certifications seeking approval of generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. In response, in April 2023, BMS filed patent infringement actions against Biocon and ScieGen in the U.S. District Court for the District of Delaware. On April 25, 2023, BMS entered into a confidential settlement agreement with ScieGen, settling all outstanding claims in the litigation with ScieGen. The settlement with ScieGen does not affect BMS's projected exclusivity period for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i9869b2d753b84860a51909300c85c355" continuedAt="i787e0ee9b17f4e56a6cdc8a0dffdd5d0"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> &#8211; U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, BMS received a Notice Letter from Accord notifying BMS that Accord had filed an ANDA containing a paragraph IV certification seeking approval of a generic version of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. and challenging U.S. Patent No. 8,846,628 (the "'628 Patent"), an FDA Orange Book-listed formulation patent covering </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which expires in 2030. In response, BMS filed a patent infringement action against Accord in the U.S. District Court for the District of Delaware. A trial has been scheduled to begin on March 18, 2024. In February 2023, Apotex Inc. filed a request for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review of the '628 Patent. BMS's response to the request is due on May 15, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2023, BMS received an additional Notice Letter from Accord notifying BMS that Accord had filed an ANDA containing a paragraph IV certification challenging U.S. Patent No. 11,571,436 (the "'436 patent"), a newly-listed FDA Orange-Book formulation patent covering </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which expires in 2029. In response, BMS filed an additional patent infringement action against Accord in the U.S. District Court for the District of Delaware.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - Australia</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sanofi was notified that, in August 2007, GenRx Proprietary Limited ("GenRx") obtained regulatory approval of an application for clopidogrel bisulfate 75mg tablets in Australia. GenRx, formerly a subsidiary of Apotex Inc., subsequently changed its name to Apotex ("GenRx-Apotex"). In August 2007, GenRx-Apotex filed an application in the Federal Court of Australia seeking revocation of Sanofi's Australian Patent No.&#160;597784 (Case No. NSD 1639 of 2007). Sanofi filed counterclaims of infringement and sought an injunction. On September&#160;21, 2007, the Federal Court of Australia granted Sanofi's injunction. A subsidiary of BMS was subsequently added as a party to the proceedings. In February 2008, a second company, Spirit Pharmaceuticals Pty. Ltd., also filed a revocation suit against the same patent. This case was consolidated with the GenRx-Apotex case. On August&#160;12, 2008, the Federal Court of Australia held that claims of Patent No.&#160;597784 covering clopidogrel bisulfate, hydrochloride, hydrobromide, and taurocholate salts were valid. The Federal Court also held that the process claims, pharmaceutical composition claims, and claim directed to clopidogrel and its pharmaceutically acceptable salts were invalid. BMS and Sanofi filed notices of appeal in the Full Court of the Federal Court of Australia ("Full Court") appealing the holding of invalidity of the claim covering clopidogrel and its pharmaceutically acceptable salts, process claims, and pharmaceutical composition claims. GenRx-Apotex appealed. On September&#160;29, 2009, the Full Court held all of the claims of Patent No.&#160;597784 invalid. In March 2010, the High Court of Australia denied a request by BMS and Sanofi to hear an appeal of the Full Court decision. The case was remanded to the Federal Court for further proceedings related to damages sought by GenRx-Apotex. BMS and GenRx-Apotex settled, and the GenRx-Apotex case was dismissed. The Australian government intervened in this matter seeking maximum damages up to <ix:nonFraction unitRef="aud" contextRef="i4d07349c8cef4e61981e90034abd80a9_D20100301-20100331" decimals="-6" name="us-gaap:LossContingencyDamagesPaidValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTIxOA_a12b5738-49bc-488c-a527-89416ee1add1">449</ix:nonFraction>&#160;million AUD ($<ix:nonFraction unitRef="usd" contextRef="i807bbc34413a49f2b3a1bd3b88436021_D20100301-20100331" decimals="-6" name="us-gaap:LossContingencyDamagesPaidValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTI0NA_c533ff35-6f77-4dde-8141-2b7236ea5047">301</ix:nonFraction>&#160;million), plus interest, which would be split between BMS and Sanofi, for alleged losses experienced for paying a higher price for branded </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> during the period when the injunction was in place. BMS and Sanofi dispute that the Australian government is entitled to any damages. A trial was concluded in September 2017. In April 2020, the Federal Court issued a decision dismissing the Australian government's claim for damages. In May 2020, the Australian government appealed the Federal Court's decision and an appeal hearing concluded in February 2021. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sprycel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2022, BMS received a Notice Letter from Xspray Pharma AB ("Xspray"), Nanocopoeia, LLC ("Nanocopoeia") and Handa Oncology, LLC ("Handa"), respectively, notifying BMS that each had filed a 505(b)(2) NDA application containing paragraph IV certifications seeking approval of a dasatinib product in the U.S. and challenging two FDA Orange Book-listed monohydrate form patents expiring in 2025 and 2026. In February 2022, BMS filed a patent infringement action against Xspray in the U.S. District Court for the District of New Jersey. In May 2022, BMS filed a patent infringement action against Nanocopoeia in the U.S. District Court for the District of Minnesota. In November 2022, BMS filed a patent infringement action against Handa in the U.S. District Court for the Northern District of California. No trial dates have been scheduled in any of these actions. Both Xspray and Nanocopoeia filed motions for a judgment based on the pleadings. On March 24, 2023, the Minnesota court denied Nanocopoeia's motion. On April 25, 2023, the New Jersey court denied Xspray's motion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> - U.S.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 15, 2021, Actelion Pharmaceuticals LTD and Actelion Pharmaceuticals US, INC ("Actelion") filed a complaint for patent infringement in the United States District Court for the District of New Jersey against BMS and Celgene for alleged infringement of U.S. Patent No. 10,251,867 (the "'867 Patent"). The Complaint alleges that the sale of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> infringes certain claims of the '867 Patent and Actelion is seeking damages and injunctive relief. No trial date has been scheduled.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i787e0ee9b17f4e56a6cdc8a0dffdd5d0" continuedAt="ic81f91274a3d4b4289f4f936b1bedba2"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRICING, SALES AND PROMOTIONAL PRACTICES LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plavix*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> State Attorneys General Lawsuits</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and certain Sanofi entities are defendants in a consumer protection action brought by the attorney general of Hawaii relating to the labeling, sales and/or promotion of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*. In February 2021, a Hawaii state court judge issued a decision against Sanofi and BMS, imposing penalties in the total amount of $<ix:nonFraction unitRef="usd" contextRef="ia9fff68fd41f46f0b5f79d52f510a8af_D20210201-20210228" decimals="-6" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTE2NQ_af845f08-bb79-4c4b-aad2-92d37c9ede3d">834</ix:nonFraction>&#160;million, with $<ix:nonFraction unitRef="usd" contextRef="i7485741c1fa8485b841b4582095e2ce9_D20210201-20210228" decimals="-6" name="us-gaap:LossContingencyDamagesSoughtValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTE5Mg_697125d6-a3fb-4292-96f3-a2ba2c4278f6">417</ix:nonFraction>&#160;million attributed to BMS. Sanofi and BMS appealed the decision. On March 15, 2023, the Hawaii Supreme Court issued its decision, reversing in part and affirming in part the trial court decision, vacating the penalty award and remanding the case for a new trial and penalty determination.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRODUCT LIABILITY LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS is a party to various product liability lawsuits. Plaintiffs in these cases seek damages and other relief on various grounds for alleged personal injury and economic loss. As previously disclosed, in addition to lawsuits, BMS also faces unfiled claims involving its products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Abilify*</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and Otsuka are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Plaintiffs allege </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> caused them to engage in compulsive gambling and other impulse control disorders. Cases have been filed in state and federal courts and additional cases are pending in Canada. The Judicial Panel on Multidistrict Litigation consolidated the federal court cases for pretrial purposes in the U.S. District Court for the Northern District of Florida. In February 2019, BMS and Otsuka entered into a master settlement agreement establishing a proposed settlement program to resolve all </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> compulsivity claims filed as of January 28, 2019 in the MDL as well as various state courts, including California and New Jersey. To date, the vast majority of cases have been dismissed based on participation in the settlement program or failure to comply with settlement related court orders and all remaining cases in the U.S. MDL litigation have since been resolved. Three inactive cases remain in New Jersey State court. There are <ix:nonFraction unitRef="lawsuit" contextRef="ic41a7b117f4d4e6ab13b8a793bc5b7a9_I20230331" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTA5OA_01d75a3c-d0d0-404f-bea2-ba90ec5ba988">eleven</ix:nonFraction> cases pending in Canada (<ix:nonFraction unitRef="lawsuit" contextRef="ic41a7b117f4d4e6ab13b8a793bc5b7a9_I20230331" decimals="INF" name="bmy:LossContingencyPendingClaimsNumberClassAction" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTEzMA_f834e7e5-b994-47fd-920a-4bcb4863ee92">four</ix:nonFraction> class actions, <ix:nonFraction unitRef="lawsuit" contextRef="ic41a7b117f4d4e6ab13b8a793bc5b7a9_I20230331" decimals="INF" name="bmy:LossContingencyPendingClaimsNumberIndividualInjuryClaims" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTEzNw_8fa94b0d-5a52-4a94-93bb-5f5265ccce6d">seven</ix:nonFraction> individual injury claims). Out of the <ix:nonFraction unitRef="lawsuit" contextRef="ic41a7b117f4d4e6ab13b8a793bc5b7a9_I20230331" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTE0NQ_a1a7e47f-20b1-49d1-a35b-eb5a05804fb7">eleven</ix:nonFraction> cases, only <ix:nonFraction unitRef="lawsuit" contextRef="ic41a7b117f4d4e6ab13b8a793bc5b7a9_I20230331" decimals="INF" name="bmy:LossContingencyPendingClaimsNumberActive" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTE1MA_aa5a6b25-c01b-4229-9337-78010d76c3fd">two</ix:nonFraction> are active (the class actions in Quebec and Ontario), both of which class actions have now been certified.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Onglyza*</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BMS and AstraZeneca are co-defendants in product liability litigation related to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Plaintiffs assert claims, including claims for wrongful death, as a result of heart failure or other cardiovascular injuries they allege were caused by their use of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In February 2018, the Judicial Panel on Multidistrict Litigation ordered all the federal </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza* </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cases to be transferred to an MDL in the U.S. District Court for the Eastern District of Kentucky. A significant majority of the claims are pending in the MDL, with others pending in a coordinated proceeding in California Superior Court in San Francisco ("JCCP"). On September 24, 2021, the JCCP court granted defendants' motion to exclude plaintiffs' only general causation expert and on January 5, 2022, the MDL court likewise granted defendants' motion to exclude plaintiffs' expert. On March 30, 2022, the JCCP court granted summary judgment to defendants, thus effectively dismissing the <ix:nonFraction unitRef="lawsuit" contextRef="i9b4fe50bec2c45748e74cea112ead142_I20220330" decimals="INF" name="us-gaap:LossContingencyPendingClaimsNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTA4OA_36048054-5ea3-4ac1-9110-c04e31f509ef">18</ix:nonFraction> claims previously pending in California state court. Plaintiffs have filed an appeal, on which a California Court of Appeal heard arguments on March 28, 2023. On April 19, 2023, the Court denied plaintiffs' appeal. Defendants filed a summary judgment motion in the MDL as well, which the MDL court granted on August 2, 2022. Plaintiffs in the MDL then moved to alter or amend the MDL court's order, and defendants opposed. On November 3, 2022, the MDL court denied plaintiffs motion to alter or amend its summary judgment order. Plaintiffs filed their Notice of Appeal on December 2, 2022. As part of BMS's global diabetes business divestiture, BMS sold </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to AstraZeneca in February 2014 and any potential liability with respect to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is expected to be shared with AstraZeneca.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Celgene Securities Litigations</span></div><div style="text-align:justify"><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 2018, </span><span style="color:#191c1f;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">two</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> putative class actions were filed against Celgene and certain of its officers in the U.S. District Court for the District of New Jersey (the "Celgene Securities Class Action"). The complaints allege that the defendants violated federal securities laws by making misstatements and/or omissions concerning (1) trials of GED-0301, (2) Celgene's 2020 outlook and projected sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Otezla*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and (3) the new drug application for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Court consolidated the two actions and appointed a lead plaintiff, lead counsel, and co-liaison counsel for the putative class. In February 2019, the defendants filed a motion to dismiss plaintiff''s amended complaint in full. In December 2019, the Court denied the motion to dismiss in part and granted the motion to dismiss in part (including all claims arising from alleged misstatements regarding GED-0301). Although the Court gave the plaintiff leave to re-plead the dismissed claims, it elected not to do so, and the dismissed claims are now dismissed with prejudice. In November 2020, the Court granted class certification with respect to the remaining claims. In March 2023, the Court granted the defendants leave to file a motion for summary judgment in the Celgene Securities Class Action, with briefing expected to be completed in or around July 2023.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="ic81f91274a3d4b4289f4f936b1bedba2" continuedAt="id8df3954f91a466aa14ece834128e66f"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In April 2020, certain Schwab management investment companies on behalf of certain Schwab funds filed an individual action in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action against the same remaining defendants in that action (the "Schwab Action"). In July 2020, the defendants filed a motion to dismiss the plaintiffs' complaint in full. In March 2021, the Court granted in part and denied in part defendants' motion to dismiss consistent with its decision in the Celgene Securities Class Action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The California Public Employees' Retirement System in April 2021 (the "CalPERS Action"); DFA Investment Dimensions Group Inc., on behalf of certain of its funds; and American Century Mutual Funds, Inc., on behalf of certain of its funds, in July 2021 (respectively the "DFA Action" and the "American Century Action"), and GIC Private Limited in September 2021 (the "GIC Action"), filed separate individual actions in the U.S. District Court for the District of New Jersey asserting largely the same allegations as the Celgene Securities Class Action and the Schwab individual action against the same remaining defendants in those actions. In October 2021, these actions were consolidated for pre-trial proceedings with the Schwab Action. The Court also consolidated any future direct actions raising common questions of law and fact with the Schwab Action.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No trial dates have been scheduled in any of the above Celgene Securities Litigations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Value Rights Litigations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, an action was filed against BMS in the U.S. District Court for the Southern District of New York asserting claims of alleged breaches of a Contingent Value Rights Agreement ("CVR Agreement") entered into in connection with the closing of BMS's acquisition of Celgene Corporation in November 2019. The successor trustee under the CVR Agreement alleges that BMS breached the CVR Agreement by allegedly failing to use "diligent efforts" to obtain FDA approval of liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) before a contractual milestone date, thereby avoiding a $<ix:nonFraction unitRef="usd" contextRef="i86a96cbd433c48ec9f16fa3b1e3beef4_I20210630" decimals="-8" name="us-gaap:ContractualObligation" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTA3MQ_809d0511-0097-45ae-a008-d6fee85e04a5">6.4</ix:nonFraction>&#160;billion potential obligation to holders of the contingent value rights governed by the CVR Agreement and by allegedly failing to permit inspection of records in response to a request by the successor trustee. The successor trustee seeks damages in an amount to be determined at trial and other relief, including interest and attorneys' fees. BMS disputes the successor trustee's allegations and filed a motion to dismiss on July 23, 2021. On June 24, 2022, the Court denied BMS's motion to dismiss.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, alleged former Celgene stockholders filed a complaint in the U.S. District Court for the Southern District of New York asserting claims on behalf of a putative class of Celgene stockholders who received CVRs in the BMS merger with Celgene for violations of sections 14(a) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act") relating to the joint proxy statement. That action later was consolidated with another action filed in the same court, and a consolidated complaint thereafter was filed asserting claims on behalf of a class of CVR acquirers, whether in the BMS merger with Celgene or otherwise, for violations of sections 11, 12(a)(2), and 15 of the Securities Act of 1933 (the "Securities Act") and sections 10(b), 14(a) and 20(2) of the Exchange Act. The complaint alleges that the February 22, 2019 joint proxy statement was materially false or misleading because it failed to disclose that BMS allegedly had no intention to obtain FDA approval for liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by the applicable milestone date in the CVR Agreement and that certain statements made by BMS or certain BMS officers in periodic SEC filings, earnings calls, press releases, and investor presentations between December 2019 and November 2020 were materially false or misleading for the same reason. Defendants moved to dismiss the complaint. On March 1, 2023, the Court entered an opinion and order granting defendants' motion and dismissed the complaint in its entirety. The claims under Sections 11, 12(a)(2), and 15 of the Securities Act and Section 14(a) of the Exchange Act were dismissed with prejudice. The claims under Sections 10(a) and 20(a) of the Exchange Act were dismissed with leave to file a further amended complaint which plaintiffs filed on April 14, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, an alleged purchaser of CVRs filed a complaint in the Supreme Court of the State of New York for New York County asserting claims on behalf of a putative class of CVR acquirers for violations of sections 11(a) and 12(a)(2) of the Securities Act of 1933. The complaint alleges that the registration statement filed in connection with the proposed merger transaction between Celgene and BMS was materially false or misleading because it failed to disclose that allegedly BMS had no intention at the time to obtain FDA approval for liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by the contractual milestone date. The complaint asserts claims against BMS, the members of its board of directors at the time of the joint proxy statement, and certain BMS officers who signed the registration statement. BMS removed the action to the U.S. District Court for the Southern District of New York. The plaintiff filed a motion to remand the action to the state court, which the Court granted on September 19, 2022. Defendants have moved to stay the action pending resolution of the federal action or, in the alternative, to dismiss the complaint.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="id8df3954f91a466aa14ece834128e66f" continuedAt="i625b107d88504e8790c301863e48ed3a"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2021, an alleged Celgene stockholder filed a complaint in the Superior Court of New Jersey, Union County asserting claims on behalf of two separate putative classes, one of acquirers of CVRs and one of acquirers of BMS common stock, for violations of sections 11(a), 12(a)(2), and 15 of the Securities Act. The complaint alleges that the registration statement filed in connection with the proposed merger transaction between Celgene and BMS was materially false or misleading because it failed to disclose that allegedly BMS had no intention at the time to obtain FDA approval for liso-cel (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) by the contractual milestone date. The complaint asserts claims against BMS, the members of its board of directors at the time of the joint proxy statement, certain BMS officers who signed the registration statement and Celgene's former chairman and chief executive officer. BMS removed the action to the U.S. District Court for the District of New Jersey and filed a motion to transfer the action to the U.S. District Court for the Southern District of New York. The plaintiff filed a motion to remand the action to the state court, which the Court granted on September 22, 2022. Defendants moved to stay the action pending resolution of the federal action and, in the alternative, to dismiss the complaint. On February 17, 2023, the Court granted defendants' motion to stay and declined to reach the merits of defendants' motion to dismiss. The Court deemed the action stayed pending resolution of the federal action, subject to plaintiff's right to seek to vacate the stay should changed circumstances warrant such relief, and filed a written order staying the case for 200 days.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No trial dates have been scheduled in any of the above CVR Litigations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OTHER LITIGATION</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Litigations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning in November 2014, certain putative class action lawsuits were filed against Celgene in the U.S. District Court for the District of New Jersey alleging that Celgene violated various antitrust, consumer protection, and unfair competition laws by (a) allegedly securing an exclusive supply contract for the alleged purpose of preventing a generic manufacturer from securing its own supply of thalidomide active pharmaceutical ingredient, (b) allegedly refusing to sell samples of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand drugs to various generic manufacturers for the alleged purpose of bioequivalence testing necessary for ANDAs to be submitted to the FDA for approval to market generic versions of these products, (c) allegedly bringing unjustified patent infringement lawsuits in order to allegedly delay approval for proposed generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and/or (d) allegedly entering into settlements of patent infringement lawsuits with certain generic manufacturers that allegedly have had anticompetitive effects. The plaintiffs, on behalf of themselves and putative classes of third-party payers, sought injunctive relief and damages. The various lawsuits were consolidated into a master action for all purposes. In March 2020, Celgene reached a settlement with the class plaintiffs. In October 2020, the Court entered a final order approving the settlement and dismissed the matter. That settlement did not resolve the claims of certain entities that opted out of the settlement, and who have since filed new suits advancing related theories. As described below, those suits, together with a suit by certain specialty pharmacies and a new putative class action suit, are pending.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2019, Humana Inc. ("Humana"), which opted out of the above settlement, filed a lawsuit against Celgene in the U.S. District Court for the District of New Jersey. Humana's complaint makes largely the same claims and allegations as were made in the now settled </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> antitrust class action litigation. The complaint purports to assert claims on behalf of Humana and its subsidiaries in several capacities, including as a direct purchaser and as an indirect purchaser, and seeks, among other things, treble and punitive damages, injunctive relief and attorneys' fees and costs. In May 2019, Celgene filed a motion to dismiss Humana's complaint. In April 2022, the Court issued an order denying Celgene's motion to dismiss. That order addressed only Celgene's argument that certain of Humana's claims were barred by the statute of limitations. The Court's order did not address Celgene's other grounds for dismissal and instead directed Celgene to present those arguments in a renewed motion to dismiss following the filing of amended complaints. In May 2022, Humana filed an amended complaint against Celgene and BMS asserting the same claims based on additional factual allegations. Celgene and BMS have filed a motion to dismiss Humana's amended complaint, which was fully briefed in November 2022. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United HealthCare Services, Inc. ("UHS"), Blue Cross Blue Shield Association ("BCBSA"), BCBSM Inc., Health Care Service Corporation ("HCSC"), Blue Cross and Blue Shield of Florida Inc., Cigna Corporation ("Cigna"), Molina Healthcare, Inc. ("Molina") and several MSP related entities (MSP Recovery Claims, Series LLC; MSPA Claims 1, LLC; MAO-MSO Recovery II, LLC, Series PMPI, a segregated series of MAO-MSO Recovery II, LLC; MSP Recovery Claims Series 44, LLC; MSP Recovery Claims PROV, Series LLC; and MSP Recovery Claims CAID, Series LLC (together, "MSP")) filed lawsuits making largely the same claims and allegations as were made in the now settled class action litigation and in the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Humana</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> opt-out action. Certain of the matters have made additional claims related to copay assistance for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. These cases are now pending in the U.S. District Court for the District of New Jersey. Celgene and BMS's motion to dismiss the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Humana </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">amended complaint applies to these other opt&#8209;out actions as well, and these other opt&#8209;out actions will proceed as described above with respect to that </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Humana </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">opt-out action. No trial dates have been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2021, Molina sued Celgene and BMS in San Francisco Superior Court. Molina's complaint makes largely the same claims and allegations as were made in the now settled class action litigation. In June 2022, the San Francisco Superior Court dismissed <ix:nonFraction unitRef="claim" contextRef="ib2602abf9fb744d1b514e7cd6d92d706_I20220630" decimals="INF" name="bmy:LossContingencyPendingClaimsNumberClassAction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTA0NA_770803c0-2d9c-420a-9590-8620c3337276">63</ix:nonFraction> of Molina&#8217;s claims, which Molina later reasserted in the District of New Jersey as described above, and stayed the remaining <ix:nonFraction unitRef="claim" contextRef="ib2602abf9fb744d1b514e7cd6d92d706_I20220630" decimals="INF" name="bmy:LossContingencyPendingClaimsNumberDismissed" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTA1MA_eedccef6-a63b-4a1a-a332-c22cae67ba6a">4</ix:nonFraction> claims. No activity is expected in this case until disposition of the New Jersey actions.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i625b107d88504e8790c301863e48ed3a" continuedAt="i918d0e17a34742ec8446a86fcfa38364"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain other entities that opted out of the now&#8209;settled class action have also filed summonses related to <ix:nonFraction unitRef="lawsuit" contextRef="if83448985121404b8a86bb8584503c4f_I20230331" decimals="INF" name="bmy:LossContingencyPendingClaimsNumberClassAction" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTA1Ng_13fe3b9b-4c9b-4e26-b028-2662a145d60d">two</ix:nonFraction> actions in the Philadelphia County Court of Common Pleas in connection with the allegations made by Humana and other opt&#8209;out entities. Those actions have been placed in deferred status pending further developments in the above opt&#8209;out cases.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2022, certain specialty pharmacies filed an action as direct purchasers against Celgene, BMS, and certain generic manufacturers in the U.S. District Court for the District of New Jersey. The action makes largely the same claims and allegations against Celgene and BMS as were made with respect to Revlimid in the now settled class action litigation, and seek injunctive relief and damages under the Sherman Antitrust Act. Also in November 2022, a putative class of end-payor plaintiffs filed an action against Celgene, BMS, and certain generic manufacturers in the U.S. District Court for the District of New Jersey. The class complaint brings claims based on Celgene's allegedly anticompetitive settlements of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patent litigation, seeking damages under state antitrust and consumer protection laws and injunctive relief under federal antitrust law. In March 2023, Celgene, BMS, and the generic defendants served consolidated motions to dismiss these two actions. No trial dates have been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2018, Humana filed a lawsuit against Celgene in the Pike County Circuit Court of the Commonwealth of Kentucky. Humana's complaint alleges Celgene engaged in unlawful off-label marketing in connection with sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Thalomid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and asserts claims against Celgene for fraud, breach of contract, negligent misrepresentation, unjust enrichment and violations of New Jersey's Racketeer Influenced and Corrupt Organizations Act ("NJ RICO"). The complaint seeks, among other things, treble and punitive damages, injunctive relief and attorneys' fees and costs. Humana subsequently dismissed its claims for breach of contract voluntarily. A trial for this matter began on January 31, 2023. On January 25, 2023, the Court granted Celgene's summary judgment motion on Humana's claims for violations of NJ RICO and dismissed those claims. On March 2, 2023, following a multi-week trial, the jury returned a full defense verdict in Celgene's favor on Humana's claims of fraud and negligent misrepresentation. The parties are awaiting the judge's decision on the remaining equitable claim of unjust enrichment, which is to be decided by the judge pursuant to Kentucky law.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, Celgene filed suit against Humana Pharmacy, Inc. ("HPI"), a Humana subsidiary, in Delaware Superior Court. Celgene's complaint alleges that HPI breached its contractual obligations to Celgene by assigning claims to Humana that Humana is now asserting. The complaint seeks damages for HPI's breach as well as a declaratory judgment. On February 14, 2023, the Court granted summary judgment in favor of Celgene on its breach of contract claims. A trial limited to damages has been scheduled for July 31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">BeiGene Arbitration Matter</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 5, 2017, Celgene Logistics S&#224;rl ("Celgene Logistics") and BeiGene, Ltd. (together with its assignees, "BeiGene"), entered into a License and Supply Agreement (the "LSA") pursuant to which BeiGene was granted, among other things, an exclusive license to distribute and commercialize </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Vidaza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in China. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BeiGene initiated an arbitration proceeding against Celgene Logistics and BMS at the International Chamber of Commerce in June 2020, asserting various claims, including breach of contract under the LSA. In October 2021, Celgene Logistics delivered notice to BeiGene terminating the LSA with respect to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A final hearing on the merits was held in June 2022, and the parties have completed post-hearing briefing and closing arguments.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">MSK Contract Litigation</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 1, 2022, Memorial Sloan Kettering Cancer Center and Eureka Therapeutics, Inc. (collectively, "Plaintiffs") filed a complaint against BMS, Celgene and Juno (collectively, "Defendants"). In June 2022, Plaintiffs filed an amended complaint. Plaintiffs allege that Defendants breached a license agreement by allegedly failing to use commercially reasonable efforts to develop, manufacture, and commercialize a certain chimeric antigen receptor product and by failing to pay Plaintiffs a running royalty of at least <ix:nonFraction unitRef="number" contextRef="ie45c0ee3f040490991410c1a6b57a08c_I20220401" decimals="INF" name="bmy:RoyaltyGuaranteesCommitmentsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTAzNQ_1babb46b-344c-4629-8a10-e8b1027aa920">1.5</ix:nonFraction>% of worldwide sales of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> allegedly owed to Plaintiffs under the license agreement. Defendants disagree with plaintiffs' claims, and filed a motion to dismiss the amended complaint in July 2022. No trial date has been scheduled.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GOVERNMENT INVESTIGATIONS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Like other pharmaceutical companies, BMS and certain of its subsidiaries are subject to extensive regulation by national, state and local authorities in the U.S. and other countries in which BMS operates. As a result, BMS, from time to time, is subject to various governmental and regulatory inquiries and investigations as well as threatened legal actions and proceedings. It is possible that criminal charges, substantial fines and/or civil penalties, could result from government or regulatory investigations.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><ix:continuation id="i918d0e17a34742ec8446a86fcfa38364"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ENVIRONMENTAL PROCEEDINGS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously reported, BMS is a party to several environmental proceedings and other matters, and is responsible under various state, federal and foreign laws, including CERCLA, for certain costs of investigating and/or remediating contamination resulting from past industrial activity at BMS's current or former sites or at waste disposal or reprocessing facilities operated by third parties.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERCLA and Other Remediation Matters</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to CERCLA and other remediation matters for which BMS is responsible under various state, federal and international laws, BMS typically estimates potential costs based on information obtained from the U.S. Environmental Protection Agency, or counterpart state or foreign agency and/or studies prepared by independent consultants, including the total estimated costs for the site and the expected cost-sharing, if any, with other "potentially responsible parties," and BMS accrues liabilities when they are probable and reasonably estimable. BMS estimated its share of future costs for these sites to be $<ix:nonFraction unitRef="usd" contextRef="i1bde7edbb7c14fa0b263eca4aead487e_I20230331" decimals="-6" name="us-gaap:AccruedLiabilitiesCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV85NC9mcmFnOjhjMWI1NzExZTQ3MDRjOThiNzEyY2RiZWVkZjkyYTUwL3RleHRyZWdpb246OGMxYjU3MTFlNDcwNGM5OGI3MTJjZGJlZWRmOTJhNTBfMTA5OTUxMTc0NTAxNw_488c8934-ba3e-4341-9132-c9d9e4d5c288">89</ix:nonFraction>&#160;million as of March&#160;31, 2023, which represents the sum of best estimates or, where no best estimate can reasonably be made, estimates of the minimal probable amount among a range of such costs (without taking into account any potential recoveries from other parties). The amount includes the estimated costs for any additional probable loss associated with the previously disclosed North Brunswick Township High School Remediation Site.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_97"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management&#8217;s discussion and analysis of results of operations and financial condition is provided as a supplement to and should be read in conjunction with the consolidated financial statements and related footnotes included elsewhere in this Quarterly Report on Form 10-Q to enhance the understanding of our results of operations, financial condition and cash flows.</span></div><div><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_100"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE SUMMARY</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal strategy is to combine the resources, scale and capability of a large pharmaceutical company with the speed, agility and focus on innovation typically found in the biotech industry. Our priorities are to continue to renew and diversify our portfolio through launching new medicines, advancing our early, mid and late-stage pipeline, and executing disciplined business development. Our focus is on discovering, developing and delivering transformational medicines for patients facing serious diseases in the following core therapeutic areas: (i) oncology with a priority in certain tumor types; (ii) hematology with opportunities to broaden our franchise and sustain a leadership position in multiple myeloma; (iii) immunology with priorities in relapsing multiple sclerosis, psoriasis, psoriatic arthritis, lupus, RA and inflammatory bowel disease; (iv) cardiovascular disease (v) fibrotic disease with priorities in lung and liver, and (vi) neuroscience with a focus on neurodegenerative disease. We remain committed to maintaining a strong investment grade credit rating and returning capital to shareholders. For further information on our strategy, see "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations&#8212;Executive Summary&#8212;Strategy" in our 2022 Form 10-K. Refer to the Summary of Abbreviated Terms at the end of this Quarterly Report on Form 10-Q for terms used throughout the document.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2023, we received approvals in the EU and Japan for three products, which further expanded our geographical reach in immunology and hematology, including (i) approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in combination with chemotherapy for the neoadjuvant treatment of patients with resectable NSCLC (Japan); (ii) EC approval for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sotyktu </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for moderate-to-severe plaque psoriasis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and (iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EC approval for an additional indication for anemia associated with non-transfusion-dependent beta thalassemia for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reblozyl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues decreased by 3% during the first quarter of 2023 due to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">generic erosion and 2% foreign exchange impact, partially offset by In-Line Products (primarily </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and New Product Portfolio (primarily </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdualag</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). The $0.48 increase in GAAP EPS primarily resulted from specified items, including lower equity investment losses in the first quarter of 2023, higher litigation and other settlements income in the first quarter of 2023 and debt redemption charge in the first quarter of 2022. After adjusting for specified items, non-GAAP EPS increased $0.09 as a result of lower Acquired IPRD charges, lower weighted-average common shares outstanding, higher royalties and interest income partially offset by lower revenues.</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions, except per share data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,337&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,648&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-GAAP financial measures, including non-GAAP earnings and related EPS information, are adjusted to exclude specified items that represent certain costs, expenses, gains and losses and other items impacting the comparability of financial results. For further information and reconciliations relating to our non-GAAP financial measures refer to "&#8212;Non-GAAP Financial Measures."</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_103"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Economic and Market Factors</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Governmental Actions</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products continue to be subject to increasing pressures across the portfolio from pharmaceutical market access and pricing controls and discounting, changes to tax and importation laws and other restrictions in the U.S., the EU and other regions around the world that result in lower prices, lower reimbursement rates and smaller populations for whom payers will reimburse, which can negatively impact our results of operations (including intangible asset impairment charges), operating cash flow, liquidity and financial flexibility. For example, some of the provisions of the IRA signed into law in August 2022, were as follows: (i) the government is to negotiate prices for certain high-cost Medicare Part D and Part B drugs, (ii) manufacturers are to pay an inflation-based rebate for Medicare Part B and Part D drugs, and (iii) Medicare Part D redesign. In addition, there were changes made to U.S. tax laws, including (i) a 15% minimum tax that generally applies to U.S. corporations, and a (ii) a non-deductible 1% excise tax provision on net stock repurchases, to be applied to repurchases beginning in 2023. Implementation of this legislation is expected to be carried out through upcoming actions by regulatory authorities, the outcome of which is uncertain. We continue to evaluate the impact of the IRA legislation on our results of operations and it is possible that these changes may result in a material impact on our business and results of operations. Furthermore, countries are expected to make changes to their tax laws and updates to international tax treaties to implement the agreement by the Organization for Economic Co-operation and Development to establish a global minimum tax. See risk factors on these items included under "Part I&#8212;Item 1A. Risk Factors&#8212;Product, Industry and Operational Risks&#8212;Increased pricing pressure and other restrictions in the U.S. and abroad continue to negatively affect our revenues and profit margins" and "&#8212;Changes to tax regulations could negatively impact our earnings" in our 2022 Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_109"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Product and Pipeline Approvals</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the significant approvals received in 2023 as of April&#160;27, 2023:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Product</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Approval</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Opdivo</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Japan's Ministry of Health, Labour and Welfare approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> plus chemotherapy for the neoadjuvant treatment of patients with resectable NSCLC.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Sotyktu</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sotyktu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:17.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:66.540%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%">Reblozyl</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reblozyl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment in adult patients of anemia associated with non-transfusion-dependent beta thalassemia. </span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Refer to "&#8212;Product and Pipeline Developments" for the developments in our marketed products and late-stage pipeline since the start of the first quarter of 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_112"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Divestitures, Licensing and Other Arrangements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to "Item 1. Financial Statements&#8212;Note 3. Alliances" and "&#8212;Note 4. Divestitures, Licensing and Other Arrangements" for information on significant divestitures, licensing and other arrangements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_115"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_118"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regional Revenues</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The composition of the changes in revenues was as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:57.314%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.748%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.804%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign Exchange</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,033&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,694&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,727&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,337&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,648&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Other revenues include royalties and alliance-related revenues for products not sold by our regional commercial organizations.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Foreign exchange impacts were derived by applying the prior period average currency rates to the current period sales.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United States</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 4% during the first quarter of 2023 primarily due to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Eliquis, Opdivo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and our New Product Portfolio partially offset by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">generic erosion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Average U.S. net selling prices increased 1% compared to the same period a year ago.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 16% during the first quarter of 2023 primarily due to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Eliquis </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">generic erosion, foreign exchange and lower average net selling prices partially offset by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and New Product Portfolio demand.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No single country outside the U.S. contributed more than 10% of total revenues during the first quarter of 2023 and 2022. Our business is typically not seasonal.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_121"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GTN Adjustments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation of gross product sales to net product sales by each significant category of GTN adjustments was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.305%"><tr><td style="width:1.0%"></td><td style="width:70.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.851%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.851%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.499%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.852%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,650&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Charge-backs and cash discounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,091)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,763)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid and Medicare rebates</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,482)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,084)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other rebates, returns, discounts and adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,667)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,495)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total GTN adjustments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,240)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,342)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net product sales</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,048&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,308&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN adjustments percentage</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reductions to provisions for product sales made in prior periods resulting from changes in estimates were $87&#160;million and $74&#160;million during the three months ended March&#160;31, 2023 and 2022, respectively. GTN adjustments are primarily a function of product sales volume, regional and payer channel mix, contractual or legislative discounts and rebates. U.S. GTN adjustments percentage increased primarily due to product mix and higher government channel rebates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_124"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Revenues</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.055%"><tr><td style="width:1.0%"></td><td style="width:61.789%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.798%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.799%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-Line Products</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Eliquis </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">869&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,064&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdivo </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Pomalyst/Imnovid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">832&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">826&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">557&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Orencia </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">764&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">792&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">202&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sprycel </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Yervoy </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">508&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">314&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mature and other products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total In-Line Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,883&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,096&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.111%"><tr><td style="width:1.0%"></td><td style="width:61.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.042%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Product Portfolio</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Reblozyl</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abecma</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Opdualag</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Zeposia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Breyanzi</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Onureg</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Inrebic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Camzyos</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Sotyktu</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total New Product Portfolio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">588&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total In-Line Products and New Product Portfolio</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,348&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,330&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,018&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-top:5pt;padding-left:9pt;padding-right:9pt;text-align:center;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.111%"><tr><td style="width:1.0%"></td><td style="width:61.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.522%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.042%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.5pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recent LOE Products</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Revlimid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,797&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,541&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,038&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(72)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Abraxane</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 24.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Recent LOE Products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,989&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,703&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,337&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,648&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-U.S.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Change in excess of 100%.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Recent LOE Products includes products with significant decline in revenue from a prior reporting period as a result of a loss of exclusivity.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_127"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">In-Line Products</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (apixaban)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212; an oral Factor Xa inhibitor, indicated for the reduction in risk of stroke/systemic embolism in NVAF and for the treatment of DVT/PE and reduction in risk of recurrence following initial therapy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues</span><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increased 19% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjU1OA_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> primarily due to higher demand and to a lesser extent higher average net selling prices.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 18% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjU2MQ_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> primarily due to generic erosion in Canada and the UK, foreign exchange impacts of 5% and lower average net selling prices. Excluding foreign exchange impacts, revenues decreased by 13%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Following the May 2021 expiration of regulatory exclusivity for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in Europe, and court decisions in (i) the United Kingdom finding the UK apixaban composition of matter patent and related SPC invalid and (ii) the Netherlands denying a BMS request for a preliminary injunction that would have prevented an at-risk generic launch, generic manufacturers have begun marketing generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the UK and the Netherlands, and may seek to market generic versions of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in additional countries in Europe, prior to the expiration of our patents, which has led to additional infringement and invalidity actions involving our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> patents being filed in various countries in Europe. We believe in the innovative science behind </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the strength of our intellectual property, which we will defend against infringement. Refer to "Item 1. Financial Statements&#8212;Note 18. Legal Proceedings and Contingencies&#8212;Intellectual Property" for further information.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(nivolumab)&#160;&#8212;&#160;a fully human monoclonal antibody that binds to the PD-1 on T and NKT cells that has been approved for several anti-cancer indications including bladder, blood, CRC, head and neck, RCC, HCC, lung, melanoma, MPM, stomach and esophageal cancer. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> regimen also is approved in multiple markets for the treatment of NSCLC, melanoma, MPM, RCC, CRC and various gastric and esophageal cancers. There are several ongoing potentially registrational studies for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> across other tumor types and disease areas, in monotherapy and in combination with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and various anti-cancer agents.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 17% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjUwOQ_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> due to higher demand across multiple indications and to a lesser extent higher average net selling prices partially offset by declining second-line eligibility across tumor indications. The higher demand was related to the following indications: the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> combinations for NSCLC, various gastric, esophageal and bladder cancers.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues increased 11% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjUxNg_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> due to higher demand as a result of additional indication launches and core indications partially offset by foreign exchange impacts of 7%. Excluding foreign exchange impacts, revenues increased 18%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst/Imnovid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(pomalidomide) &#8212; a proprietary, distinct, small molecule that is administered orally and modulates the immune system and other biologically important targets. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst/Imnovid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is indicated for patients with multiple myeloma who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues decreased 2% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjUyNA_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> due to lower demand partially offset by higher average net selling prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues increased 7% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjUzMg_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> primarily due to higher demand partially offset by lower average net selling prices and foreign exchange impacts of 5%. Excluding foreign exchange impacts, revenues increased by 12%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Orencia </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(abatacept) &#8212; a fusion protein indicated for adult patients with moderate to severe active RA and PsA and is also indicated for reducing signs and symptoms in certain pediatric patients with moderately to severely active polyarticular JIA.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues decreased 5% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjUzOQ_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> primarily due to lower average net selling prices.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues increased 1% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjU0Nw_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> due to higher demand partially offset by foreign exchange impacts of 9%. Excluding foreign exchange impacts, revenues increased by 10%.</span></div><div style="padding-left:36pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">BMS is not aware of any </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Orencia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> biosimilars on the market in the U.S., EU and Japan. Formulation and additional patents expire in 2026 and beyond. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sprycel </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(dasatinib)&#160;&#8212;&#160;an oral inhibitor of multiple tyrosine kinase indicated for the first-line treatment of patients with Philadelphia chromosome-positive CML in chronic phase and the treatment of adults with chronic, accelerated, or myeloid or lymphoid blast phase CML with resistance or intolerance to prior therapy, including </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gleevec* </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(imatinib mesylate) and the treatment of children and adolescents aged 1 year to 18 years with chronic phase Philadelphia chromosome-positive CML.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues decreased 3% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjQ3NA_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> due to lower average net selling prices.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 25% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzI3NDg3NzkxMTY3MTI_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> due to lower demand as a result of generic erosion and foreign exchange impacts of 6%. Excluding foreign exchange impacts, revenues decreased by 19%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">In the U.S., BMS entered into settlement agreements with certain third parties to sell generic dasatinib products beginning in September 2024, or earlier in certain circumstances. In the EU, generic dasatinib products have entered the market. In Japan, the composition of matter patent has been extended to 2024 for the treatment of non-imatinib-resistant CML, but generics have been approved for other indications.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ipilimumab)&#160;&#8212;&#160;a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma. The </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> regimen also is approved in multiple markets for the treatment of NSCLC, melanoma, MPM, RCC, CRC and esophageal cancer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 1% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjQ4NA_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric>.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 5% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjQ5MQ_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> primarily due to foreign exchange impacts of 8% partially offset by higher demand as a result of additional indication launches and core indications. Excluding foreign exchange impacts, revenues increased by 3%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mature and other products &#8212; includes all other products, including those which have lost exclusivity in major markets, OTC products, royalty revenue and mature products.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 20% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjQ5Nw_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> primarily due to continued generic erosion and foreign exchange impacts of 4%. Excluding foreign exchange impacts, revenues decreased by 16%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">New Product Portfolio</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reblozyl </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(luspatercept-aamt) &#8212; an erythroid maturation agent indicated for the treatment of anemia in adult patients with transfusion dependent and non-transfusion dependent beta thalassemia who require regular red blood cell transfusions and for the treatment of anemia failing an ESA in adult patients with very low- to intermediate-risk MDS who have ring sideroblasts and require RBC transfusions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 18% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTg0MjUwMw_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> primarily due to higher demand.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (idecabtagene vicleucel) &#8212; is a B-cell maturation antigen-directed genetically modified autologous CAR&#8211;T cell therapy indicated for the treatment of adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in May 2021.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues increased 111% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzI3NDg3NzkxMjU2ODU_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> primarily due to higher demand enabled by additional manufacturing capacity.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdualag </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(nivolumab and relatlimab-rmbw) &#8212; a combination of nivolumab, a PD-1 blocking antibody, and relatlimab, a LAG-3 blocking antibody, indicated for the treatment of adult and pediatric patients 12 years of age or older with unresectable or metastatic melanoma. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Opdualag</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in March 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ozanimod) &#8212; </span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an oral immunomodulatory drug used to treat relapsing forms of multiple sclerosis, to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults and to treat moderately to severely active UC in adults. </span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Zeposia</span><span style="color:#242424;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in June 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (lisocabtagene maraleucel) &#8212; is a CD19-directed genetically modified autologous CAR-T cell therapy indicated for the treatment of adult patients with certain types of relapsed or refractory large B-cell lymphoma after one or more lines of systemic therapy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in April 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (azacitidine) &#8212; an oral hypomethylating agent that incorporates into DNA and RNA, indicated for continued treatment of adult patients with AML who achieved first complete remission or complete remission with incomplete blood count recovery following intensive induction chemotherapy and are not able to complete intensive curative therapy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onureg</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in September 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inrebic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (fedratinib) &#8212; an oral kinase inhibitor indicated for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Inrebic</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in August 2019.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Camzyos </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(mavacamten) &#8212; a cardiac myosin inhibitor indicated for the treatment of adults with symptomatic obstructive HCM to improve functional capacity and symptoms. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Camzyos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in April 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sotyktu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (deucravacitinib) &#8212; an oral, selective, allosteric tyrosine kinase 2 inhibitor indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sotyktu</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was launched in September 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Recent LOE Products </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(lenalidomide)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an oral immunomodulatory drug that in combination with dexamethasone is indicated for the treatment of patients with multiple myeloma. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;as a single agent is also indicated as a maintenance therapy in patients with multiple myeloma following autologous hematopoietic stem cell transplant.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues decreased 24% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTgxNzcwOTA_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> primarily due to generic erosion and to a lesser extent lower average net selling prices. </span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">International revenues decreased 72% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTgxNzcwOTc_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> primarily due to generic erosion across several European countries and to a lesser extent lower average net selling prices and foreign exchange impacts of 1%. Excluding foreign exchange impacts, revenues decreased by 71%.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In the U.S., certain third parties have been granted volume-limited licenses to sell generic lenalidomide beginning in March 2022 or thereafter. Pursuant to these licenses, several generics have entered or are expected to enter the U.S. market with volume-limited quantities of generic lenalidomide. In the EU, generic lenalidomide products have entered the market. Global revenues for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> are expected to decline to approximately $6.5 billion in 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abraxane </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(paclitaxel albumin-bound particles for injectable suspension)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a solvent-free protein-bound chemotherapy product that combines paclitaxel with albumin using our proprietary </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Nab</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology platform, and is used to treat breast cancer, NSCLC and pancreatic cancer, among others.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">U.S. revenues decreased 6% during the first quarter of <ix:nonNumeric contextRef="i7becddee9c014d3c8c07eb5ef71be8f2_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjQxOTRmNDI3ZDI4ZDQ3ODk4M2YxODJmNTRjM2FhODQ5L3NlYzo0MTk0ZjQyN2QyOGQ0Nzg5ODNmMTgyZjU0YzNhYTg0OV8xMjcvZnJhZzo0YmM4MjZmNDE1MmE0ZDk3YjI2N2YxYjgzMDZiYmM0OC90ZXh0cmVnaW9uOjRiYzgyNmY0MTUyYTRkOTdiMjY3ZjFiODMwNmJiYzQ4XzU0OTc1NTgxNzcxMDM_03eb23ba-de83-49dc-aad1-1ee7b376bbd2">2023</ix:nonNumeric> due to the impact from authorized generic sales in 2023 and lower demand partially offset by manufacturing delays in the first quarter of 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_130"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Estimated End-User Demand</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the SEC Consent Order described under "&#8212; SEC Consent Order" in our 2022 Form 10-K, we monitor inventory levels on hand in the U.S. wholesaler distribution channel and outside of the U.S. in the direct customer distribution channel. We are obligated to disclose products with levels of inventory in excess of one month on hand or expected demand, subject to a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de minimis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> exception. There were no products in the U.S. wholesaler distribution channel with estimated levels of inventory in excess of one month as of March 31, 2023. Estimated levels of inventory outside of the U.S. in the direct distribution channel in excess of one month on hand were not material to our results of operations as of December 31, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., we generally determine our months on hand estimates using inventory levels of product on hand and the amount of out-movement provided by our three largest wholesalers, which accounted for approximately 82% of total gross sales of U.S. products during the three months ended March 31, 2023. Factors that may influence our estimates include generic competition, seasonality of products, wholesaler purchases in light of increases in wholesaler list prices, new product launches, new warehouse openings by wholesalers and new customer stockings by wholesalers. In addition, these estimates are calculated using third-party data, which may be impacted by their recordkeeping processes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;are distributed in the U.S. primarily through contracted pharmacies under the Lenalidomide&#160;REMS (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> REMS&#160;programs, respectively. These are proprietary risk-management distribution programs tailored specifically to provide for the safe and appropriate distribution and use of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pomalyst</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Internationally, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revlimid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Imnovid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;are distributed under mandatory risk-management distribution programs tailored to meet local authorities' specifications to provide for the products' safe and appropriate distribution and use. These programs may vary by country and, depending upon the country and the design of the risk-management program, the product may be sold through hospitals or retail pharmacies.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Camzyos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> is only available through a restricted program called the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Camzyos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> REMS Program. Product distribution is limited to REMS certified pharmacies, and enrolled pharmacies must only dispense to patients who are authorized to receive </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Camzyos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-U.S. businesses have significantly more direct customers. Information on available direct customer product level inventory and corresponding out-movement information and the reliability of third-party demand information varies widely. We limit our direct customer sales channel inventory reporting to where we can influence demand. When this information does not exist or is otherwise not available, we have developed a variety of methodologies to estimate such data, including using historical sales made to direct customers and third-party market research data related to prescription trends and end-user demand. Given the difficulties inherent in estimating third-party demand information, we evaluate our methodologies to estimate direct customer product level inventory and to calculate months on hand on an ongoing basis and make changes as necessary. Factors that may affect our estimates include generic competition, seasonality of products, price increases, new product launches, new warehouse openings by direct customers, new customer stockings by direct customers and expected direct customer purchases for governmental bidding situations. As such, all of the information required to estimate months on hand in the direct customer distribution channel for non-U.S. business during the three months ended March&#160;31, 2023 is not available prior to the filing of this Quarterly Report on Form 10-Q. We will disclose any product with levels of inventory in excess of one month on hand or expected demand for the current quarter, subject to a </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de minimis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> exception, in our next quarterly report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_133"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expenses</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:70.805%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.801%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.803%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,566&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,831&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,321&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,260&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPRD</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(413)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Expenses</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,567&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,961&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;In excess of +/- 100%.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Excludes amortization of acquired intangible assets.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Products Sold</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of products sold increased by $95 million during the first quarter of 2023 primarily due to higher profit sharing and royalties ($182 million) driven by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eliquis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> revenue growth and product mix partially offset by the elimination of the Puerto Rico excise tax and foreign exchange, including related hedging settlements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Marketing, Selling and Administrative</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing, selling and administrative expense decreased $69 million during the first quarter of 2023 primarily due to the timing of charitable giving ($150 million) and foreign currency impacts partially offset by higher costs to support new product launches.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense increased by $61 million during the first quarter of 2023 primarily due to the purchase of a priority review voucher ($95 million) expected to be used with an on-going development program and higher costs to support the overall portfolio partially offset by an inventory purchase price adjustment in 2022 ($87 million).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquired IPRD</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired IPRD charges resulting from upfront or contingent milestone payments in connection with asset acquisitions or licensing of third-party intellectual property rights were as follows:</span></div><div style="margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:74.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.585%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Dragonfly milestone</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Immatics upfront license fee</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evotec designation fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired IPRD charges</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">333&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Acquired Intangible Assets</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amortization of acquired intangible assets decreased by $161 million during the first quarter of 2023 primarily due to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Abraxane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> marketed product right being fully amortized in the fourth quarter of 2022.</span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other (Income)/Expense, Net</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other (income)/expense, net changed by $1.1 billion during the first quarter of 2023 primarily due to equity investments, litigation and other settlements and other items discussed below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.916%"><tr><td style="width:1.0%"></td><td style="width:74.360%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.814%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.509%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.817%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">288&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">326&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty and licensing income </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(363)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(306)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Royalty income - divestitures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(188)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(171)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">644&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture gains </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and other settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(325)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investment income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(413)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Interest expense decreased in the first quarter of 2023 compared to the first quarter of 2022 due to additional debt maturities. Refer to "Item 8. Financial Statements and Supplementary Data&#8212;Note 10. Financing Arrangements" for further information. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Royalties increased in the first quarter of 2023 primarily due to higher </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* and diabetes business divestiture royalties. Refer to "Item 8. Financial Statements and Supplementary Data&#8212;Note 4. Divestitures, Licensing and Other Arrangements" for further information.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Equity investments generated lower losses in the first quarter of 2023 compared to the first quarter of 2022 primarily driven by fair value adjustments for investments that have readily determinable fair value. Refer to "Item 8. Financial Statements and Supplementary Data&#8212;Note 9. Financial Instruments and Fair Value Measurements" for more information.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Integration expenses decreased in the first quarter of 2023 primarily due to lower consulting fees to implement Celgene integration initiatives related to processes and systems. </span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Loss on debt redemption during the first quarter of 2022 resulted from the early redemption of long-term debt of $5.2 billion.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Divestiture gains during the first quarter 2022 resulted from the divestiture of product rights for several mature products.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Litigation and other settlements include $400 million of income related to the Nimbus' TYK2 program change of control provision and additional settlement costs related to commercial disputes regarding intellectual property matters in the first quarter of 2023 and $40 million of income resulting from a settlement resolving all legal claims and business interests relating to Nimbus' TYK2 inhibitor in the first quarter of 2022.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Investment income increased during the first quarter of 2023 primarily due to higher interest rates.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Provision for restructuring includes exit and other costs primarily related to certain restructuring activities discussed further at "Item 8. Financial Statements and Supplementary Data&#8212;Note 6. Restructuring".</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_136"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:74.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.585%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings before income taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,687&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">503&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">404&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impact of specified items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effective tax rate excluding specified items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 5.7% decrease in our effective tax rate is primarily due to jurisdictional earnings mix resulting from amortization of acquired intangible assets, equity investment losses, litigation and other settlements, as well as releases of income tax reserves of $89 million related to the resolution of Celgene's 2009-2011 IRS audits, partially offset by the impact of changes in our Puerto Rico tax decree that eliminated a previously creditable excise tax.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 0.4% decrease in Non-GAAP tax rate was due to the aforementioned tax reserve releases, partially offset by changes to our Puerto Rico tax decree.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_139"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-GAAP financial measures, such as non-GAAP earnings and related EPS information, are adjusted to exclude certain costs, expenses, gains and losses and other specified items that are evaluated on an individual basis. These items are adjusted after considering their quantitative and qualitative aspects and typically have one or more of the following characteristics, such as being highly variable, difficult to project, unusual in nature, significant to the results of a particular period or not indicative of past or future operating results. These items are excluded from non-GAAP earnings and related EPS information because the Company believes they neither relate to the ordinary course of the Company's business nor reflect the Company's underlying business performance. Similar charges or gains were recognized in prior periods and will likely reoccur in future periods, including (i) amortization of acquired intangible assets, including product rights that generate a significant portion of our ongoing revenue and will recur until the intangible assets are fully amortized, (ii) unwind of inventory purchase price adjustments, (iii) acquisition and integration expenses, (iv) restructuring costs, (v) accelerated depreciation and impairment of property, plant and equipment and intangible assets, (vi) costs of acquiring a priority review voucher, (vii) divestiture gains or losses, (viii) stock compensation resulting from acquisition-related equity awards, (ix) pension, legal and other contractual settlement charges, (x) equity investment and contingent value rights fair value adjustments (including fair value adjustments attributed to limited partnership equity method investments), (xi) income resulting from the change in control of the Nimbus Therapeutics TYK2 Program and (xii) amortization of fair value adjustments of debt acquired from Celgene in our 2019 exchange offer, among other items. Deferred and current income taxes attributed to these items are also adjusted for considering their individual impact to the overall tax expense, deductibility and jurisdictional tax rates. We also provide international revenues for our priority products excluding the impact of foreign exchange. We calculate foreign exchange impacts by converting our current-period local currency financial results using the prior period average currency rates and comparing these adjusted amounts to our current-period results. Reconciliations of these non-GAAP measures to the most comparable GAAP measures are included in Exhibit 99.1 to our Form 8-K filed on April&#160;27, 2023 and are incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-GAAP information is intended to portray the results of our baseline performance, supplement or enhance management, analysts and investors' overall understanding of our underlying financial performance and facilitate comparisons among current, past and future periods. This information is not intended to be considered in isolation or as a substitute for the related financial measures prepared in accordance with GAAP and may not be the same as or comparable to similarly titled measures presented by other companies due to possible differences in method and in the items being adjusted. We encourage investors to review our consolidated financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specified items were as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory purchase price accounting adjustments</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Site exit and other costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of products sold</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Site exit and other costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing, selling and administrative</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD impairments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Priority review voucher</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory purchase price accounting adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,417&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(27)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity investment losses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Integration expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Divestiture gains</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(211)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on debt redemption</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation and other settlements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(335)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for restructuring</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income)/expense, net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(70)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">768&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase to pretax income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes on items above</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(398)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase to net earnings</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,062&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Includes amortization of purchase price adjustments to Celgene debt.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_142"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliations from GAAP to Non-GAAP were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:74.838%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.585%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions, except per share data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to BMS used for diluted EPS calculation &#8211; GAAP</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Specified items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net earnings attributable to BMS used for diluted EPS calculation &#8211; Non-GAAP</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding &#8211; diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,164&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings per share attributable to BMS &#8211; GAAP</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS attributable to specified items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted EPS attributable to BMS &#8211; Non-GAAP</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.96&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_145"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FINANCIAL POSITION, LIQUIDITY AND CAPITAL RESOURCES</span></div><div><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_148"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net debt position was as follows:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in Millions</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,995&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,123&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketable debt securities &#8211; current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and marketable debt securities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,269&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,253&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term debt obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,752)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,264)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,078)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(35,056)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net debt position</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28,561)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,067)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_151"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing cash, cash equivalents and marketable debt securities, together with our ability to generate cash from operations and our access to short-term and long-term borrowings, are sufficient to satisfy our existing and anticipated cash needs, including dividends, capital expenditures, milestone payments, working capital, income taxes, restructuring initiatives, business development, business combinations, asset acquisitions, repurchase of common stock, debt maturities, as well as any debt repurchases through redemptions or tender offers. During the first quarter of 2023, our net debt position decreased by $1.5&#160;billion primarily driven by $3.0 billion of cash provided by operations partially offset by $1.4&#160;billion of dividends and common stock repurchases.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, $1.6&#160;billion of debt matured and was repaid including $750&#160;million 2.750% Notes and $890&#160;million 3.250% Notes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our share repurchase program, we repurchased 3.7&#160;million shares of common stock for $250&#160;million in the first quarter of 2023. The remaining share repurchase capacity under the share repurchase program was $6.9&#160;billion as of March 31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2023, we paid dividends of $1.2 billion and declared dividend of $0.57 per common share. The decision to authorize dividends is made on a quarterly basis by our Board of Directors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Annual capital expenditures are expected to be approximately $1.2 billion and 1.4 billion in 2023 and 2024, respectively. We continue to make capital expenditures in connection with the expansion of our manufacturing capabilities, research and development and other facility-related activities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no borrowings outstanding under our $5.0 billion revolving credit facility as of March 31, 2023 and December 31, 2022. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our commercial paper program, we may issue a maximum of $5.0 billion unsecured notes that have maturities of not more than 366 days from the date of issuance. There were no commercial paper borrowings outstanding as of March&#160;31, 2023.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_157"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a discussion of cash flow activities:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flow provided by/(used in):</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,970&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,812&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(210)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,050)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,653)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $842 million decrease in cash provided by operating activities compared to the first quarter of 2022 was due to changes in working capital requirements reflecting the timing of cash collections and payments in the ordinary course of business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $305 million change in cash used in investing activities compared to 2022 was primarily due to changes in the amount of marketable debt securities held ($529&#160;million), lower divestitures proceeds ($175 million) partially offset by lower Acquired IPRD payments ($316 million).</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $2.6 billion decrease in cash used in financing activities compared to 2022 was primarily due to lower repurchases of common stock ($4.8 billion) partially offset by changes in net debt borrowings ($1.7 billion) and lower proceeds from stock option exercises ($425 million).</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_160"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product and Pipeline Developments</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our R&amp;D programs are managed on a portfolio basis from early discovery through late-stage development and include a balance of early-stage and late-stage programs to support future growth. Our late-stage R&amp;D programs in Phase III development include both investigational compounds for initial indications and additional indications or formulations for marketed products. The following are the developments in our marketed products and our late-stage pipeline since the start of the first quarter of 2023:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Product</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Indication</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Developments</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr style="height:54pt"><td colspan="3" rowspan="5" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Opdivo</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Melanoma</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Announced that the FDA has accepted the sBLA and the EMA has validated the Type II variation MAA for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Opdivo </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">as monotherapy in the adjuvant setting for the treatment of patients with completely resected stage IIB or IIC melanoma. The submissions were based on results from the Phase III CheckMate -76K trial. In the U.S., the FDA has assigned a PDUFA goal date of October 13, 2023. </span></div></td></tr><tr style="height:44pt"><td colspan="3" rowspan="2" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">NSCLC</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Ono, our alliance partner for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> in Japan, announced the Japan's Ministry of Health, Labour and Welfare's supplemental approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> plus chemotherapy for the neoadjuvant treatment of patients with resectable NSCLC. The approval is based on results from the Phase III CheckMate -816 trial.</span></div></td></tr><tr style="height:65pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Announced three-year results from the Phase III CheckMate -816 trial, demonstrating sustained clinical benefits with three cycles of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> in combination with platinum-based chemotherapy for the neoadjuvant treatment of patients with resectable NSCLC. While overall survival (OS) remained immature at this analysis, there was a continued encouraging trend in OS favoring neoadjuvant </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> with chemotherapy over chemotherapy alone, long-term improvement in event-free survival (EFS) and time to distant metastasis. </span></div></td></tr><tr style="height:54pt"><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">RCC</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Announced three-year results from the Phase III CheckMate -9ER demonstrating sustained overall survival and objective response rate benefits the treatment with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> in combination with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Cabometyx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">*</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">(cabozantinib) versus sunitinib in the first-line treatment of advanced RCC. In addition, an exploratory biomarker analysis demonstrated that improvements in median progression-free survival and overall survival were sustained regardless of PD-L1 status.</span></div></td></tr><tr style="height:65pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">UC</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">February 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Announced three-year results from the Phase III CheckMate -274 trial demonstrating significant sustained clinical benefits with </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> for the adjuvant treatment of patients with surgically resected, high-risk muscle-invasive UC and continuous improvement in disease-free survival, non-urothelial tract recurrence-free survival, distant metastasis-free survival and second progression-free survival compared to placebo across all-randomized patients and in patients whose tumor cells express PD-L1 &#8805;1%.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Reblozyl</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Beta Thalassemia</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Announced EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Reblozyl</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> for the treatment in adult patients of anemia associated with non-transfusion-dependent beta thalassemia. The approval is based on results from the Phase II BEYOND study.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Abecma</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Multiple Myeloma</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced with our alliance partner, 2seventy bio, Inc., that the FDA accepted the sBLA for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for the treatment of adult patients with relapsed and refractory multiple myeloma who have received an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody. The FDA has assigned a PDUFA goal date of December 16, 2023. The EMA has also validated our Type II variation for the extension of indication for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> to treat adult patients with relapsed or refractory multiple myeloma who have received an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody. Validation of the application confirms the submission is complete and begins the procedure and scientific assessment. In addition, the Japan's Ministry of Health, Labour and Welfare has accepted our sNDA for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Abecma</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> in patients who have received at least two prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-CD38 monoclonal antibody, and have experienced disease progression or relapse after the last therapy. The three regulatory applications are based on results from the Phase III KarMMa-3 study.</span></div></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Product</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Indication</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Date</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Developments</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr style="height:65pt"><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Breyanzi</span></td><td colspan="3" rowspan="2" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Lymphoma</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Announced that the CHMP of the EMA has recommended approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> for the treatment of adult patients with diffuse large B-cell lymphoma, high grade B-cell lymphoma, primary mediastinal large B-cell lymphoma and follicular lymphoma grade 3B, who relapsed within 12 months from completion of, or are refractory to, first-line chemoimmunotherapy. The positive opinion is based on results from the Phase III TRANSFORM trial evaluating </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Breyanzi</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%"> compared to the standard of care.</span></div></td></tr><tr style="height:54pt"><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">January 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Announced positive topline results from the Phase II portion of the TRANSCEND CLL 004, a Phase I/II, open-label, single-arm, multicenter study evaluating </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:112%">Breyanzi </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">in adults with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma. The Phase II portion of the study met the primary endpoint of complete response rate compared to historical control.</span></div></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Sotyktu</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Plaque Psoriasis</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced EC approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Sotyktu </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy. The approval was based on Phase III POETYK PSO-1 and POETYK PSO-2 clinical trials as well as additional data from the POETYK PSO long-term extension trial.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Camzyos</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Obstructive HCM</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">April 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Announced that the CHMP of the EMA has recommended approval of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Camzyos</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> for the treatment of symptomatic (New York Heart Association class II-III) obstructive HCM in adult patients. The positive opinion is based on results from the Phase III EXPLORER-HCM and VALOR-HCM trials.</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:11.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:63.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">milvexian</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Thrombosis</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">March 2023</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:112%">Announced with our alliance partner Janssen Pharmaceuticals Inc., the launch of the Phase III Librexia program studying milvexian, an investigational oral factor XIa inhibitor (antithrombotic). The Librexia program will provide important data across three indication-seeking studies: Librexia STROKE, Librexia ACS and Librexia AF.<br/>&#160;<br/>The Librexia STROKE trial will evaluate milvexian in addition to standard of care antiplatelet therapy for stroke prevention in patients after an acute ischemic stroke or high-risk transient ischemic attack. The Librexia ACS trial will evaluate event reduction in acute coronary syndromes in addition to standard of care antiplatelet therapy. The Librexia AF trial will investigate milvexian compared to apixaban in the prevention of stroke in patients with atrial fibrillation.</span></td></tr></table></div><div><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_166"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenue and expenses. Our critical accounting policies are those that significantly impact our financial condition and results of operations and require the most difficult, subjective or complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of this uncertainty, actual results may vary from these estimates. For a discussion of our critical accounting policies, refer to "Item 7. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations" in our 2022 Form 10-K. There have been no material changes to our critical accounting policies during the three months ended March 31, 2023. For information regarding the impact of recently adopted accounting standards, refer to "Item 1. Financial Statements&#8212;Note 1. Basis of Presentation and Recently Issued Accounting Standards."</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_169"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Special Note Regarding Forward-Looking Statements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report on Form 10-Q (including documents incorporated by reference) and other written and oral statements we make from time to time contain certain "forward-looking" statements within the meaning of Section&#160;27A of the Securities Act, and Section&#160;21E of the Exchange Act. You can identify these forward-looking statements by the fact they use words such as "should," "could," "expect," "anticipate," "estimate," "target," "may," "project," "guidance," "intend," "plan," "believe," "will" and other words and terms of similar meaning and expression in connection with any discussion of future operating or financial performance. One can also identify forward-looking statements by the fact that they do not relate strictly to historical or current facts. Such forward-looking statements are based on our current expectations and projections about our future financial results, goals, plans and objectives and involve inherent risks, assumptions and uncertainties, including internal or external factors that could delay, divert or change any of them in the next several years, and could cause our future financial results, goals, plans and objectives to differ materially from those expressed in, or implied by, the statements. These statements are likely to relate to, among other things, our goals, plans and objectives regarding our financial position, results of operations, cash flows, market position, product development, product approvals, sales efforts, expenses, performance or results of current and anticipated products, our business development strategy and in relation to our ability to realize the projected benefits of our acquisitions of Celgene, MyoKardia, and Turning Point, the impact of the COVID-19 pandemic on our operations and the development and commercialization of our products, potential laws and regulations to lower drug prices, market actions taken by private and government payers to manage drug utilization and contain costs, the expiration of patents or data protection on certain products, including assumptions about our ability to retain marketing exclusivity of certain products, and the outcome of contingencies such as legal proceedings and financial results. No forward-looking statement can be guaranteed. This Quarterly Report on Form 10-Q, our 2022 Form 10-K, particularly under the section "Item 1A. Risk Factors," and our other filings with the SEC, include additional information on the factors that we believe could cause actual results to differ materially from any forward-looking statement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe that we have been prudent in our plans and assumptions, no assurance can be given that any goal or plan set forth in forward-looking statements can be achieved and readers are cautioned not to place undue reliance on such statements, which speak only as of the date made. Additional risks that we may currently deem immaterial or that are not presently known to us could also cause the forward-looking events discussed in this Quarterly Report on Form 10-Q not to occur. Except as otherwise required by applicable law, we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, changed circumstances or otherwise after the date of this Quarterly Report on Form 10-Q.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_172"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a discussion of our market risk, refer to "Item 7A. Quantitative and Qualitative Disclosures about Market Risk" in our 2022 Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_175"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;4. CONTROLS AND PROCEDURES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management carried out an evaluation, under the supervision and with the participation of its chief executive officer and chief financial officer, of the effectiveness of the design and operation of its disclosure controls and procedures, as defined in Exchange Act Rules 13a-15(e) and 15d-15(e), as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that as of March&#160;31, 2023, such disclosure controls and procedures are effective.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in the Company's internal control over financial reporting during the quarter ended March&#160;31, 2023, that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_178"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II&#8212;OTHER INFORMATION</span></div><div><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_181"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1. LEGAL PROCEEDINGS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information pertaining to legal proceedings can be found in "Item 1. Financial Statements&#8212;Note 18. Legal Proceedings and Contingencies," to the interim consolidated financial statements, and is incorporated by reference herein.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_184"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. RISK FACTORS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes from the risk factors disclosed in the Company's 2022 Form 10-K.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i4194f427d28d478983f182f54c3aa849_187"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the surrenders of our equity securities during the three months ended March 31, 2023:&#160;</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:34.505%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.477%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.477%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.477%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.479%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of Shares&#160;Purchased</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average&#160;Price Paid per&#160;Share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Number of Shares&#160;Purchased&#160;as Part of Publicly Announced Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Approximate Dollar Value of Shares&#160;that May Yet Be Purchased Under the Programs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(b)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Dollars in millions, except per share data</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 1 to 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,169&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1 to 28, 2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,169&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 1 to 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,292,071&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.34&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,749,847&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three months ended March 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,335,834&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,749,847&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:9.13pt">Includes shares repurchased as part of publicly announced programs and shares of common stock surrendered to the Company to satisfy tax withholding obligations in connection with the vesting of awards under our long-term incentive program.</span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.68pt">In May 2010, the Board of Directors authorized the repurchase of up to $3.0&#160;billion of our common stock. Following this authorization, the Board subsequently approved additional authorizations, including most recently, in February 2020, January 2021 and December 2021, in the amount $5.0 billion, $2.0&#160;billion and $15.0&#160;billion, respectively, to the share repurchase authorization. The remaining share repurchase capacity under the program was approximately $6.9&#160;billion as of March&#160;31, 2023. Refer to "Item 1. Financial Statements&#8212;Note 17. Equity" of the 2022 Form 10-K for information on the share repurchase program.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_190"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;6. EXHIBITS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Exhibits (listed by number corresponding to the Exhibit Table of Item&#160;601 in Regulation S-K).</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:7.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.721%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit&#160;No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31a.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex31a_20230331.htm">Section 302 Certification Letter.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31b.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex31b_20230331.htm">Section 302 Certification Letter.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32a.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex32a_20230331.htm">Section 906 Certification Letter.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32b.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="bmyex32b_20230331.htm">Section 906 Certification Letter.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Indicates, in this Quarterly Report on Form 10-Q, brand names of products, which are registered trademarks not solely owned by the Company or its subsidiaries.&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Abilify</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is a trademark of Otsuka Pharmaceutical Co., Ltd.;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Atripla</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Gilead Sciences, LLC.; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cabometyx</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Exelixis, Inc.;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Onglyza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of AstraZeneca AB; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gleevec</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Novartis AG; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Keytruda</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is a trademark of Merck Sharp &amp; Dohme Corp; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Otezla</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Amgen Inc.; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plavix</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Sanofi; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tecentriq</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is a trademark of Genentech, Inc.; and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Yescarta</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;is a trademark of Kite Pharma, Inc. Brand names of products that are in all italicized letters, without an asterisk, are registered trademarks of BMS and/or one of its subsidiaries.</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_193"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SUMMARY OF ABBREVIATED TERMS</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bristol-Myers Squibb Company and its consolidated subsidiaries may be referred to as Bristol Myers Squibb, BMS, the Company, we, our or us in this Quarterly Report on Form 10-Q, unless the context otherwise indicates. Throughout this Quarterly Report on Form 10-Q we have used terms which are defined below:</span></div><div style="margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.040%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022 Form 10-K</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual Report of the Company on Form 10-K for the fiscal year ended December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIBOR</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">London Interbank Offered Rate</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AML</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">acute myeloid leukemia</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LOE</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">loss of exclusivity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amylin</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amylin Pharmaceuticals, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MAA</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">marketing authorization application</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ANDA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abbreviated New Drug Application</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MDL</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">multi-district litigation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AstraZeneca</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AstraZeneca PLC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MDS</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">myelodysplastic syndromes</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASR</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">accelerated share repurchase </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MPM</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">malignant pleural mesothelioma</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BLA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Biologics License Application</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MyoKardia</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MyoKardia, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CAR-T</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">chimeric antigen receptor T-cell</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NDA</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CD38</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">cyclic ADP ribose hydrolase</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NKT</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">natural killer T cells</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene Corporation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NSCLC</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">non-small cell lung cancer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Celgene Acquisition Plan</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and integration plan implemented as a result of the acquisition of Celgene in 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">NVAF</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">non-valvular atrial fibrillation</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CERCLA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Comprehensive Environmental Response, Compensation and Liability Act</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OTC</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">over-the-counter</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cheplapharm</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cheplapharm Arzneimittel GmbH</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Otsuka</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Otsuka Pharmaceutical Co., Ltd.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CHMP</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Committee for Medicinal Products for Human Use</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PD-1</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">programmed cell death protein 1</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CML</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">chronic myeloid leukemia</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PD-L1</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">programmed death-ligand 1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CRC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">colorectal carcinoma</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pfizer, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dragonfly</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dragonfly Therapeutics, Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PsA</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">psoriatic arthritis</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EC</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Commission</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarterly Report on Form 10-Q</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Quarterly Report of the Company on Form 10-Q for the quarterly period ended March 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EMA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Medicines Agency</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">research and development</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EPS</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">earnings per share</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RA</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">rheumatoid arthritis</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exchange Act </span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Securities Exchange Act of 1934</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RBC</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">red blood cell</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EU</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Union</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RCC</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">renal cell carcinoma</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FASB</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financial Accounting Standards Board</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">REMS</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">risk evaluation and mitigation strategy</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FDA</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Food and Drug Administration</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanofi</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sanofi S.A.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GAAP</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">generally accepted accounting principles</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">sBLA</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">supplemental Biologics License Application</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GTN</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">gross-to-net</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">sNDA</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">supplemental New Drug Application</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HCC</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">hepatocellular carcinoma</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SEC</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S. Securities and Exchange Commission</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">HCM</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">hypertrophic cardiomyopathy</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">SPC</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplementary Protection Certificate</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immatics</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Immatics Biotechnologies GmbH.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Takeda</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Takeda Pharmaceutical Company Limited</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IPRD</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">in-process research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turning Point</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Turning Point Therapeutics, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IRA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inflation Reduction Act signed into law in August 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UC</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ulcerative colitis</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IRS</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal Revenue Service</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">U.S.</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JIA</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">juvenile idiopathic arthritis</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">UK</span></td><td colspan="3" style="background-color:#cceeff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Juno</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Juno Therapeutics, Inc.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">VAT</span></td><td colspan="3" style="background-color:#ffffff;border-right:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">value added tax</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LAG-3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">lymphocyte activation gene-3</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;border-right:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i4194f427d28d478983f182f54c3aa849_196"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:4.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.319%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BRISTOL-MYERS SQUIBB COMPANY<br/>(REGISTRANT)</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 27, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Giovanni Caforio, M.D.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Giovanni Caforio, M.D.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chairman of the Board and Chief Executive Officer</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 27, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ David V. Elkins</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">David V. Elkins</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</span></div></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><noscript><img src="https://www.sec.gov/akam/13/pixel_32cda1fc?a=dD1mNWU0ODJjODJkNzUzYmRkNjFjMzJiOTg2YzQ1MjNjYzI0ZDZjYmEyJmpzPW9mZg==" style="visibility: hidden; position: absolute; left: -999px; top: -999px;" /></noscript></body></html>
